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Abstract
Intrinsically disordered proteins (IDPs) are abundant in cells and have central roles in
protein-protein interaction networks. Many are involved in cancer, aging and
neurodegenerative diseases. The structure and dynamics of IDPs is intimately related to their
interactions with binding partners. Because IDPs are inherently flexible and do not have a
single conformation, conventional methods and conditions for determining structure and
dynamics of globular proteins may not be directly applicable. Nuclear magnetic resonance
(NMR) spectroscopy is one of the primary techniques characterizing the structures and
dynamics of IDPs, but one cannot rely solely on NMR data. A primary aim of this work was
to use Molecular Dynamics (MD) simulations in conjunction with NMR and other
biophysical techniques to achieve a deeper understanding of the structure and dynamics of
IDPs. To establish suitable parameters and force field choice for simulating IDPs, extensive
MD simulations were performed and the results were compared to experimental data. Using
computational and experimental techniques, the interactions between peptides from 9
disordered proteins with a common target were interrogated. The findings allowed us to
determine key factors in modulating the affinities of the various interactions and highlighted
the importance of Linear Motifs (LMs) in IDP target recognition and binding. IDP binding
was also investigated from the perspective of the binding partner. The backbone resonances
of the ~32 kDa target were assigned and the binding interface was mapped in the presence of
a peptide from a disordered binding partner. Chemical shift changes distant from the
interaction site indicated that IDP binding is a complex process, which should be studied
from the perspectives of the partner and target. Because IDPs are highly sensitive to
environmental conditions, the effects of molecular crowding on the dynamics of IDPs were
also investigated. I found that crowding might have differential effects on the conformational
propensities of distinct regions of some IDPs. This information will help to understand the
behavior of IDPs in cellular environments and to determine suitable conditions for accurately
studying them. This work has helped to improve the understanding of how IDP structure and
dynamics relate to target binding.
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1

Introduction

1.1

Intrinsically disordered proteins
Intrinsically disordered proteins (IDPs) are a biologically functional class of

proteins that comprise ~30% of the eukaryotic proteome (1-4). The abundance of IDPs in
organisms suggests that they are essential for numerous functions. It was once thought
that a protein must adopt a defined three-dimensional structure to function properly;
however, the discovery of biologically active disordered proteins illustrates that IDPs
carry out their functions through different mechanisms than globular proteins. The
defined conformation of a globular protein is often important for stabilizing a single
interaction site, allowing it to partake in a specific and high affinity interaction. In
contrast, the different possible conformations of an IDP often allow for specific, but
generally lower affinity interactions with numerous different targets (5). These properties
are well suited to their roles in signaling pathways, where reversible binding and the
ability to interact with multiple partners is often required (5).

Figure 1.1 NMR structural ensembles of the intrinsically disordered Thylakoid
soluble phosphoprotein TSP9 and globular protein, Ubiquitin.

2

Thylakoid soluble phosphoprotein TSP9 (left, PDB id: 2FFT) and Ubiquitin
(right, PDB id: 1D3Z).

The structural differences between IDPs and globular proteins (Figure 1.1) illustrate
that disorder is encoded in their sequences. IDPs have different amino acid compositions
than globular proteins. They are enriched in charged, polar and the structure-breaking
residues, glycine and proline (1, 6). Hydrophobic and aromatic content is also lower in
IDPs (1, 6). As a result, IDPs usually lack hydrophobic cores, which stabilize globular
proteins. Due to the absence of hydrophobic cores, IDPs are more dynamic compared to
globular proteins. Ordered regions of globular proteins undergo relatively small
fluctuations around their equilibrium backbone atom positions over time. In comparison,
IDPs usually exhibit significant changes in their φ and ψ angles over time and may not
have specific equilibrium values (6). Although IDPs lack stable tertiary structures, they
may contain elements of secondary structure, which are often crucial for their
functionality (eg. target binding).
The dynamic properties of IDPs are intimately related to the timescale of
conformational exchange within the ensemble (Figure 1.1), which govern target
recognition and how these proteins function. Different structures in the ensemble can
participate in the interactions with distinct targets; therefore, the rate of exchange
between conformers can have significant impact on the protein function (7, 8).

1.2

Target binding by IDPs
Protein-protein interaction (PPI) networks are essential for most biological

functions. IDPs often act as hubs in PPI networks, where they regulate biochemical
processes through low-affinity and high-specificity protein-protein interactions (2).
Although IDPs are involved in crucial biological functions, such as signal transduction
and transcription (5), there is relatively limited data, compared to globular proteins,
describing how they interact with binding partners. Knowledge of the mechanisms that

3

IDPs employ to bind to their targets will aid in development of therapeutic approaches
targeting these interactions (9).
Studies have shown that the unique structural properties of IDPs are important for
their ability to act as hubs in PPI networks (10-12). Like proteins in the unfolded state,
IDPs do not adopt completely random coil conformations (13-16). Many IDPs have
considerable conformational propensities (17-19). Segments of IDPs that contain residual
structure may act as molecular recognition features (MoRFs) for binding to their targets
(17, 19). MoRFs are defined as 5-25 residue target binding regions, which may contain
residual structure in their unbound states (17). It is possible for IDPs to contain multiple
MoRFs along their sequence allowing them to interact with different binding partners.
Also, binding to different targets can cause a MoRF to adopt completely different
structures (17, 20, 21). For example, the same region of the intrinsically disordered Nterminal of p53 can adopt a helix or a sheet depending on its binding partners (21).
Some IDPs interact with targets through preformed structural elements (PSEs)
that resemble the bound state (19, 22-24), while others may couple conformational
changes with target binding (coupled folding and binding model). For IDPs that bind
using PSEs, the binding region structure is already formed in the unbound state. In the
coupled folding and binding model, the IDP undergoes a disorder-to-order transition
upon binding to a target (2). Binding of IDPs may also be modulated by a combination of
these two mechanisms (25).

bind to their targets is poorly understood. In the case of the binding of the phosphorylated kinase inducible domain of
CREB (pKID) to the KIX domain of CBP, we find that the mechanism more nearly approximates the lower of these
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two possibilities, with the formation of unstructured encounter complexes and an intermediate, partly folded complex
before formation of the final, fully folded complex.

Figure 1.2 Mechanisms of target binding by IDPs.
Possible mechanism(s) for the interaction between the intrinsically disordered
phosphorylated kinase inducible activation domain (pKID) and KIX domain of the
CREB binding protein (26). Usage of this figure has been granted by the Nature
Publishing Group (licence number 2993681394339).

1.3

IDPs and diseases

nnn%eXkli\%Zfd&eXkli\

IDPs have been found to be associated with cancers, neurodegenerative diseases
and aging (5, 27). Because their structural plasticity often allows them to interact with a
large number of targets, IDPs are enriched in signaling networks (5). They have been
shown to be involved in various activities, such as signal transduction, apoptosis, cell
differentiation, and neuron function (28). In addition to missignalling diseases, IDPs are
also involved in diseases related to protein misfolding (5). Mutations, exposure to toxins,
aberrant posttranslational modifications and other factors can lead to misfolding of these

(
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proteins, which can have serious consequences. The term ‘misfolding’ may seem
counterintuitive because IDPs do not adopt stable folds. However, in several
neurodegenerative disorders, the normal, disordered form of a protein may convert to a
‘misfolded’ conformation that is prone to aggregation. The build up of non-functional,
ordered and highly stable amyloid fibrils in various tissues can result in specific
pathological conditions depending on the protein (5). Because IDPs typically have low
structural preferences compared to folded proteins, it is thought that they can transform
into an aggregate-prone conformation more easily. Understanding the links between
sequence, structure and target binding by IDPs is crucial for improving our understanding
of their roles in disease and developing treatments and cures.

1.4

Techniques for characterizing IDPs
Nuclear magnetic resonance spectroscopy (NMR) and X-ray crystallography are

commonly used methods to obtain atomic details of protein structure and dynamics. The
dynamic nature of IDPs makes acquiring diffracting crystals of them in unbound states
nearly impossible (29). Therefore, NMR is the primary technique for studying the
structure and dynamics of IDPs (30, 31). NMR can yield a wealth of data, but there are
limitations. Data collected by NMR are averaged over time and represent an ensemble
average. For globular proteins, the protein core is stable and the ensemble average is
usually a good representation of a true physical state. For highly flexible polymers, like
IDPs, the ensemble average may not represent a realistic physical state. To
comprehensively study the structure and dynamics of IDPs, and their relationship to
target binding, NMR techniques were combined with molecular dynamics (MD)
simulations and other biophysical techniques, such as isothermal calorimetry (ITC) for
many of the projects in this thesis. A brief introduction to each of these techniques is
provided below.
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1.4.1

NMR spectroscopy
NMR is a technique used to determine the chemical environment of atoms (32-

35). This information can be used to learn about the structure, dynamics, chemical
environment, etc of the molecules that the atoms are contained in. The technique exploits
the magnetic properties of specific nuclei in order to obtain this information. In a
magnetic field (Bo), NMR active nuclei, atoms that have odd number of protons,
neutrons, or both, and spin values of ½ (eg. 1H, 15N, 13C) will precess in either spinaligned or spin-opposed orientations parallel to the field (Figure 1.3). Nuclei in the spinaligned state have a slightly lower energy and are slightly more populated than the spin
opposed nuclei. By applying electromagnetic radiation, in the form of radio waves, these
nuclei can be temporarily be excited to the higher energy, unaligned state. Data collected
during the return to the lower energy state gives information about the local environment
of the nuclei (chemical shift). This is the basis of all NMR experiments. Various types
and patterns of electromagnetic pulses are combined to generate specific NMR
experiments to obtain the desired information (eg. chemical environment, dynamics, etc)
about the nuclei.
NMR can be used to determine protein structures and numerous other properties,
such as dynamics. The process of determining a protein structure by NMR can be divided
into two parts: assignment and restraint collection. Assignment refers to the
determination of the chemical shift values of spin ½ nuclei. Next, restraints are gathered
(distances, angles, orientations, etc) for the assigned atoms, which are used to
computationally fold the polypeptide in such a way that the restraints are satisfied. The
two steps are not always mutually exclusive. For example, through space distance
restraints may be also used to assist with or verify the resonance assignment. For small
proteins and peptides (~30 residues or less), homonuclear NMR experiments (eg. 1H
signals only) may be sufficient to assign the proton resonances (via 1H-1H COSY and
TOCSY experiments) and determine the structure (via 1H-1H NOESY). This approach is
used in chapter 4 to assign and collect distance restraints for several ~20-mer peptides.
Due to spectral crowding and overlap in the 1H dimension, multidimensional,
heteronuclear experiments are required to assign and determine the structures of larger
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proteins and peptides. In chapter 5, several heteronuclear experiments were used to assign
backbone resonances for a ~32 kDa protein domain. In this case, the goal of assignment
was not to determine the structure. Instead, we used the assigned 1H-15N HSQC spectrum
to determine the residue-specific chemical shift changes upon addition of a peptide from
a binding partner. This allowed us to map the binding interface (chemical shift mapping)
onto a previously determined crystal structure. Furthermore, assignment of the 13Cα and
13

Cβ resonances allowed for the determination of secondary structure content of the

polypeptide. NMR can also be used to study protein dynamics. Relaxation measurements
allow one to determine motions occurring on ps-ns timescales, which can help to identify
structured and flexible regions of proteins. These types of experiments are employed in
chapter 6 to measure changes in the dynamics of IDPs under crowded conditions. The
experiments mentioned here are just a few examples of the uses of NMR.

Figure 1.3 The basis of NMR experiments.
NMR active nuclei precess in either spin-aligned or spin-opposed orientations
parallel to the field (Bo). Lower energy nuclei can be temporarily be excited to the
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higher energy state. Data collected as the nuclei return to equilibrium gives
information about the local environment of the nuclei.

1.4.2

MD simulations
MD is a simulation of the movement of particles, accomplished by solving

Newton’s equation of motion (2nd law) for a system of interacting particles:




dv i
d 2 ri

Fi = mi ai = mi
= mi 2
dt
dt
Where Fi is the force exerted on particle i, mi is the mass of particle i, ai is the

€

acceleration of particle i, vi is the velocity of particle i and ri is the position of particle i at
time t.
Using this equation, a trajectory (particle positions as a function of time) can be
calculated by integration once the initial positions and velocities of the particles are
known. The positions may come from a known structure (eg. Crystal or NMR protein
structure) and the velocities are often taken from a Maxwellian distribution at the desired
temperature. From these values, the forces on the particles (usually atoms) are calculated.
The particles are allowed to move for a short period of time (the timestep), and
integration gives their t+1 positions. Time is moved forward according to the timestep.
This process is repeated as long as necessary. A number of different integration
algorithms may be used, such as leap frog and velocity Verlet (36, 37).
The calculation of forces is the most time-consuming process in the generation of
a trajectory. The forces may also be expressed as the negative gradient of the potential
energy:


Fi = −∇ iV

€
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The potential energy function (V) is the sum of terms for bonded and non-bonded
energies. These energies are determined as a function of the atom positions (Cartesian
coordinates, r) in the system:
V (r) = E bonded + E non"bonded

The bonded interactions typically contain terms for stretching, angle-bending, dihedral
!

angle and, usually, a term for improper dihedral angles, which functions to maintain the
planarity of planar molecules (Figure 1.4):
E bonded = E bond "stretch + E angle"bend + E dihedral + E improper"dihedral

!

Figure 1.4 Bonded energy terms for MD simulations.
Figure usage granted under MesoBioNano (MBN) explorer academic license
agreement (http://www.mbnexplorer.com/academic-license-agreement) (38).
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The non-bonded energy consists of terms for Van der Waals and electrostatic interaction
energies. Van der Waals forces are approximated using the Lennard-Jones potential:
+$ # '12 $ # ' 6 .
VLJ = 4"-& ) * & ) 0
,% r ( % r ( /

Where ε is the well depth, σ is the distance where the inter-particle potential is zero and r
!

is the distance between the particles. Figure 1.5 illustrates examples of Lennard-Jones
potentials.

Figure 1.5 Examples of Lennard-Jones potentials.
r is the distance between particles in nanometers and the Lennard-Jones potential
is given in kJ/mol. All Lennard-Jones potentials include repulsive and attractive
components. Here, the grey curve has a greater attractive component compared to
the black one.

The Coulomb interactions between two charged particles is given by:

11

VC (rij ) =

qiq j
4 "# o# r rij

Where q is the charge on each particle, " r is the relative dielectric constant and rij is the

!

separation distance.

! of the energy terms are dictated by the force field being
The values associated with each
used for the simulation. Chapter 2 details some of the most commonly used force fields
for biomolecular simulations.
When conducting MD simulations of biomolecules, such as proteins, it is usually
desirable to mimic experimental, or laboratory conditions (eg. temperature, pressure).
Direct integration of Newton’s equation of motion will result in the system energy being
conserved, which corresponds to an isolated system. In contrast, laboratory experiments
are typically “open” systems. To reproduce experimental conditions it is usually desirable
to run simulations under the NPT ensemble, where the number of particles, pressure and
temperature of the system are kept constant. This is accomplished by coupling the system
to temperature and/or pressure baths. Thermostat (39, 40) and barostat (41-44) algorithms
can be employed to achieve the NPT ensemble.
One final concept that warrants introduction is that of periodic boundary
conditions (PBCs). Typically, in a simulation, it is desirable to mimic a bulk system (e.g.,
protein in solution); however, because this would be too computationally expensive, a
finite system with a small number of particles is preferred. Using PBCs, a finite system is
surrounded by translated copies of itself (Figure 1.6). This eliminates boundary effects
that would be present at the system edges if PBCs were not employed. In some cases, one
may want to perform a simulation without the use of PBCs (e.g., a crystal).
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Figure 3.1: Periodic boundary conditions in two dimensions.

MD simulations have become increasingly valuable tools in the field of
biochemistry.
Alder
the technique
in the
late 1950’s in
and
in 1959since fewer
better suited toBerni
the study
of invented
an approximately
spherical
macromolecule
solution,
solvent molecules are required to fill the box given a minimum distance between macromolecular
images. At the same time, rhombic dodecahedra and truncated octahedra are special cases of
triclinic unit
cells; the (46).
most general
space-filling
unitsimulation
cells that comprise
all possible
space-filling
boundary
conditions
The first
protein MD
was performed
in 1975
of the
shapes [18]. For this reason, GROMACS is based on the triclinic unit cell.

performed the first MD simulation – of a group of interacting hard spheres under periodic
bovine pancreatic trypsin inhibitor (BPTI) (47). Since then, advances in computing power
GROMACS uses periodic boundary conditions, combined with the minimum image convention:
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systems. They have become important predictive tools. Today, MD simulations
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GROMACS therefore also incorporates lattice sum methods such as Ewald Sum, PME and PPPM.

routinely used for NMR structure determination, refining X-ray crystal structures,

GROMACS supports triclinic boxes of any shape. The simulation box (unit cell) is defined by the
protein-ligand
docking,
drugbox
discovery/refinement,
protein
folding
and countless other
3 box vectors a,b
and c. The
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applications of MD simulations will expand correspondingly.
ax > 0,
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(3.1)
(3.2)

1
1
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(3.3)
2
2
2
Equations 3.1
can always be satisfied by rotating the box. Inequalities (3.2) and (3.3) can always
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the output trajectory it might therefore seem as if the simulation was done in a rectangular box.
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directly. Determination of these parameters allows one to derive the Gibbs free energy
and entropy changes (ΔG and ΔS, respectively) using the relationship:
"G = #RT lnK a = "H # T"S

Where R is the gas constant and T is the temperature.
!

Briefly, in an ITC experiment, a binding target is loaded into the sample cell and
subjected to a stepwise titration of precise volumes of ligand into the same cell (Figure
1.7). The reference cell contains water or buffer. A constant power is applied to the
reference cell heater. During the titration, sensitive thermocouples measure the
temperature differences between the reference and sample cells. In an exothermic
reaction, heat is evolved in the sample cell and the power to the heater is decreased. In an
endothermic reaction, heat is absorbed in the sample cell and the heater is activated. The
heat input required to maintain the same temperatures in the sample and reference cells is
measured throughout the experiment (Figure 1.8). Integration of the heat input with
respect to time as a function of the molar ratio ((ligand)/(target)) gives the
thermodynamic parameters of interest.

14

Figure 1.7 ITC instrument schematic.
Figure has been released to the public domain without conditions.
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Figure 1.8 Typical ITC data
The top panel shows the raw ITC data and the bottom panel shows the binding
isotherm.

1.5

Significance and aims
The primary aim of this work was to improve the understanding of how the

structure and dynamics of IDPs are related to target binding. To accomplish this,
experimental and computational techniques were used to investigate the molecular
mechanisms by which several IDPs interact with a common binding partner. The

16

common partner is the Kelch domain of Kelch-like ECH-associated protein 1 (Keap1).
This domain is a key component in regulating the cellular response to oxidative stress
(49). It adopts a β-propeller conformation that comprises an interaction site for numerous
proteins (50-55) (Figure 1.9, left). Perhaps the most important interaction that the Kelch
domain is involved in is with the transcription factor Nuclear factor erythroid 2-related
factor 2 (Nrf2). The intrinsically disordered Neh2 domain of Nrf2 can bind two Kelch
domain monomers via distinct motifs with different binding affinities (54, 56). Under
normal cellular conditions, association of both motifs with the Kelch domain leads to its
degradation (54) (Figure 1.9, right). However, when cells are exposed to conditions of
oxidative stress (eg. reactive oxygen species, toxins, etc), the lower affinity interaction is
disrupted, and Nrf2 is able to promote transcription of cytoprotective genes (54). Because
the overexpression of these genes may have clinical benefits, development of compounds
that induce the Keap1-Nrf2 pathway are being actively developed for various purposes
(see chapter 4 for details) (57). Moreover, misregulation of this pathway can result in
cancers, premature aging and neurodegenerative diseases (58, 59). In recent years,
numerous other proteins that bind to the same interface on the Kelch domain and share
similar binding motif sequences with Nrf2 have been discovered, but not extensively
studied (53, 60-66). Some of the proteins have been shown to promote cytoprotective
gene expression by disrupting the low affinity Nrf2-Kelch domain interaction (52, 62, 65,
66), while others have different, or unknown roles. Several of the works presented in this
thesis focus on the relationships between sequences and structures in controlling the
affinities of the various protein-protein interactions. The findings should be useful for
improving the general understanding of the mechanisms used by IDPs to interact with
targets, deciphering the biological roles of these interactions, and development of
therapeutic agents that target the Nrf2-Kelch domain interaction.
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Figure 1.9 The structure of the Kelch domain of Keap1 and its interaction with the
Neh2 domain of Nrf2.
Two-site binding is disrupted under conditions of oxidative stress preventing Nrf2
degradation and allowing promotion of cytoprotective gene expression. The
structure corresponding to PDB id 1X2R was obtained from (67) and rendered
with VMD (68).

1.6

Thesis outline
The following chapters (2-6) represent individual, first author publications, in

their unmodified forms. A primary aim of this work was to use Molecular Dynamics
(MD) simulations in conjunction with NMR and other biophysical techniques to achieve
a deeper understanding of the structure and dynamics of IDPs. Although NMR is a
powerful tool, the data represents an ensemble average, which can be limiting when
studying a molecule rapidly undergoing conformational changes like an IDP. Because
MD trajectories allow for the examination of discrete states and the interconversion
between conformations, they can be used to complement experimental techniques.
However, because IDPs have been recently discovered relative to their globular
counterparts, parameters and protocols for accurately simulating them have not been
widely established. Chapter 2 describes our efforts towards determining suitable
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parameters and force field selection for performing MD simulations of IDPs. This was
accomplished by performing extensive MD simulations of a peptide from the high
affinity motif of Nrf2 with 10 different force fields and different parameters. The results
were compared to experimental data. After determining suitable combinations of
parameters for simulating IDPs, we applied the methodology to more diverse IDP
systems. In chapters 3 and 4, we combine MD simulations with experimental techniques
to dissect the mechanisms used by 9 different IDPs for binding to a common target, the
Kelch domain of Keap1. Our findings provide valuable insights into the mechanisms
used by IDPs for target binding and should also help to elucidate the biological roles of
the various protein-protein interactions. In chapter 5, we report the backbone resonance
assignments for the Kelch domain of Keap1 and map its binding interface with a peptide
from the high affinity motif of Nrf2. This study was important for examining IDP binding
from the perspective of a target, allowing us to more thoroughly understand IDP
interactions. Chapter 6 focuses on determining how molecular crowding affects the
dynamics of IDPs. Inside cells, the concentration of macromolecules can reach up to 400
g/L. In such crowded environments, proteins are expected to behave differently than in
vitro. The dynamic properties of IDPs are intimately related to the timescale of
conformational exchange within the ensemble, which govern target recognition and how
these proteins function. Therefore, assessing how these properties are affected by
environmental conditions is crucial for accurately studying this class of proteins. The
major conclusions from this thesis and possible future directions are discussed in chapter
7.
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2.1 Abstract
We have compared molecular dynamics (MD) simulations of a β-hairpin forming
peptide derived from the protein Nrf2 with ten biomolecular force fields using trajectories
of at least one microsecond long. The total simulation time was 37.2 microseconds.
Previous studies have shown that different force fields, water models, simulation methods
and parameters can affect simulation outcomes. The MD simulations were done in
explicit solvent with a 16-mer Nrf2 β-hairpin forming peptide using Amber ff99SBILDN, Amber ff99SB*-ILDN, Amber ff99SB, Amber ff99SB*, Amber ff03, Amber
ff03*, GROMOS96 43a1p, GROMOS96 53a6, CHARMM27 and OPLS-AA/L force
fields. The effects of charge-groups, terminal capping and phosphorylation on the peptide
folding were also examined. Despite using identical starting structures and simulation
parameters, we observed clear differences amongst the various force fields and even
between replicates using the same force field. Our simulations show that the uncapped
peptide folds into a native-like β-hairpin structure at 310 K when Amber ff99SB-ILDN,
Amber ff99SB*-ILDN, Amber ff99SB, Amber ff99SB*, Amber ff03, Amber ff03*,
GROMOS96 43a1p or GROMOS96 53a6 were used. The CHARMM27 simulations were
able to form native hairpins in some of the elevated temperature simulations, while the
OPLS-AA/L simulations did not yield native hairpin structures at any temperatures
tested. Simulations that used charge-groups or peptide capping groups were not largely
different from their uncapped counterparts with single atom charge-groups. On the other
hand, phosphorylation of the threonine residue located at the β-turn significantly affected
the hairpin formation. To our knowledge, this is the first study comparing such a large set
of force fields with respect to β-hairpin folding. Such a comprehensive comparison will
offer useful guidance to others conducting similar types of simulations.
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2.2 Introduction
Atomistic molecular dynamics (MD) simulations are a versatile tool for studying
protein folding and function. They can provide detailed atomistic information, which may
be difficult to obtain by experimental techniques. Increases in computational power have
allowed for simulations to reach experimentally relevant time scales at the microsecond
level: MD simulations have been used to study the folding of peptides and small proteins
(1-9) and to model other biological systems. The current record for an atomistic
simulation of protein conformational changes, as far as we know, is 1 ms reached by
Shaw et al. (7) for the 58-residue protein BPTI.
One of the major challenges in protein folding simulations is choosing an
appropriate force field, see e.g. Ref (10). This is due to possible biases different force
fields have towards certain types of secondary structure (3, 11-14). Ideally, the force field
should be fully validated with experimental data, but that is typically not possible as it
would involve validation against different structures and other physical properties from a
large number of independent and fully validated experiments – mission impossible since
experiments have their own error sources due to, e.g., instrumentation. While a
completely transferable force field does not exist, modifications of existing force fields
have led to improvements in agreement with experimental data (15-22).
In this work, we compared 10 biomolecular force fields with respect to the folding
of a peptide derived from Nuclear factor erythroid 2-related factor 2 (Nrf2). Nrf2 is an
important transcription factor that regulates the expression of genes responsive to
oxidative stress (23, 24). The protein consists of six highly homologous regions (Neh1-6
domains). Structural analysis showed that the N-terminal Neh2 domain is intrinsically
disordered, a novel class of proteins that are extremely dynamic in nature (25-29). Under
homeostatic conditions, this domain binds two Kelch units of a Keap1 dimer through two
separate motifs: a high affinity ‘ETGE’ motif and a lower affinity ‘DLG’ motif (30).
Crystallographic data has shown that the ‘ETGE’ motif and its surrounding residues
(residues 75-83) form a β-hairpin structure upon binding to the Kelch domain of Keap1
(PDB ids: 2FLU and 1X2R) (30, 31). NMR-derived 1H, 1H NOEs suggest that residual
structure spanning from residues 74-85, likely in the form of a β-hairpin, also exists in the
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free-state of Neh2 (30, 31). Other experimental data has shown that a peptide containing
residues 74-87 can compete with the full-length Nrf2 for binding Keap1 (31). Here, we
chose to use a 16-mer human Nrf2 peptide with the sequence
72

AQLQLDEETGEFLPIQ87 for our MD simulations. This peptide contains the ‘ETGE’

motif and should be of sufficient length to form the necessary interactions to stabilize the
β-hairpin structure. It is noteworthy that the phosphorylation of Thr-80 has been shown to
impair the binding to Keap1 (31). Since Neh2 is largely disordered and lacks a tertiary
structure, this β-hairpin likely folds independently, making it a good target for folding
simulations (30).
In addition to Nrf2, several other proteins that contain ‘ETGE’-like motifs have
been shown to interact with the Kelch domain of Keap1. These include PGAM5 (32),
FAC1 (33), PTMA (34), p62 (35), WTX (36) and PALB2 (37). Some of these Keap1
interacting proteins have only been recently discovered, which suggests that this list of
targets may still be growing. Structures of PTMA (Prothymosin alpha) and p62 peptides
in complex with Keap1 indicate that their ‘ETGE’-like motifs bind to the same region as
the ‘ETGE’ motif of Nrf2 and form similar hairpin structures in their bound states (31,
34, 35). Interestingly, MD simulations from our previous work showed that the binding
motifs of Nrf2 and PTMA have tendency to form hairpin structures that resembled the
bound state conformation even in the absence of Keap1 (9). With the list of Keap1
binding partners seemingly expanding and MD simulations becoming an increasingly
important and predictive tool, it is important to establish appropriate simulation protocols
for these systems, including force field choice.
β-hairpins are a type of protein supersecondary structure consisting of two
hydrogen bonded antiparallel β-strands connected by a turn. These structural elements are
common in globular proteins because they reverse the direction of the protein backbone,
allowing the formation of compact structures. β-hairpin motifs are sometimes involved in
protein-protein interactions and it has been suggested that they can act as nucleation sites
for protein folding (31, 38-40). In this study, we compared folding simulations of a βhairpin peptide derived from the intrinsically disordered Neh2 domain. Starting from an
unfolded structure, we performed extensive (1-2 µs each, totaling 37.2 µs) atomistic
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molecular dynamics simulations using 10 different force fields (details in next section).
We selected these force fields primarily because they are commonly used in biomolecular
simulations, including those of β-hairpin folding (3, 9, 41, 42).
Force field selection is a key factor in the outcome of protein folding simulations.
Although force field modifications have led to improved agreements between MD
simulations and experimental data, continued testing and comparison with experimental
data is required to further these advances. While studies comparing different force fields
have been conducted previously, very few of them had included such a large set of force
fields with respect to folding of secondary structure elements (3, 14, 19, 43-45). Small
proteins and peptides with folding times on the microsecond timescale are excellent
systems to test and compare force fields; such trajectories provide reasonable sampling of
conformations and sufficient length to examine the stability of the force field.
In this work, we compare MD simulations of a β-hairpin forming peptide derived
from the protein Nrf2, performed with ten force fields. We assess their agreements with
experimental data. The effects of elevated temperatures, charge-groups (46, 47), peptide
capping and phosphorylation of Thr-80 with respect to β-hairpin formation were also
examined. Despite using identical starting structures and simulation parameters, we
observed clear differences amongst the various force fields and even between replicate
simulations using the same force field. Such a comprehensive comparison will offer
useful guidance to others conducting similar types of simulations and for improving force
fields.

2.3 Simulation methodology
The starting structure for our MD simulations was generated based upon the
amino acid sequence of a 16-mer human Nrf2 peptide (72AQLQLDEETGEFLPIQ87). We
used the Crystallography & NMR System (CNS) (48) to generate an extended structure,
which subsequently underwent simulated annealing. To avoid any potential bias to the
bound-state conformation, a structure from the annealing simulations that did not
resemble the bound state structure (PDB id: 2FLU) was chosen as the starting structure
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(31). The exact same starting structure was used for all simulations. For the
phosphorylated peptide (pThr-80) simulations, a dianionic phosphate group (PO42-) was
modeled onto residue Thr-80 of the same structure using chimera (49).

Force fields
We compared the peptide folding using the following force fields: Amber ff99SBILDN (15, 19, 20), Amber ff99SB*-ILDN (15, 17, 19, 20), Amber ff99SB (15, 19),
Amber ff99SB* (15, 17, 19), Amber ff03 (15, 16), Amber ff03* (15-17), GROMOS96
43a1p (50, 51), GROMOS96 53a6 (21, 22), CHARMM27 (version c32b1) with CMAP
(18, 52, 53) and OPLS-AA/L force fields (54-56). The ‘*’ designations on the Amber
force fields indicate the presence of a modification to the backbone dihedral potentials to
improve agreement with experimental data (17). The ‘ILDN’ designation indicates the
presence of a modification to the side-chain torsion potentials of isoleucine, leucine,
aspartate and asparagine to improve agreement with quantum-mechanical calculations
(20). Combination of the ‘ILDN’ and ff99SB* modifications has been demonstrated
recently (44, 57). For a recent summary of the evolution of the Amber ff99 and ff03
series of force fields see the results section of (44) The ‘p’ designation on the
GROMOS96 43a1 force field indicates the inclusion of phosphorylated amino acid
parameters to the otherwise unmodified 43a1 parameters (50). One major difference
between the GROMOS force fields and the others used in this study is that the GROMOS
force fields are united atom and do not explicitly have all hydrogen atoms. The ‘AA’ and
‘/L’ designations on the OPLS force field indicate all-atom and the inclusion of updated
dihedral parameters from the original distribution (56).
Simulations of the same peptide with residue Thr-80 phosphorylated (pThr-80)
were conducted with several of the above force fields in which phosphothreonine
parameters were available. These included Amber ff99SB-ILDN, GROMOS96 43a1p
and CHARMM27. Phosphothreonine parameters from (58) and (50) were used for the
Amber ff99SB-ILDN and GROMOS96 43a1p force field simulations, respectively.
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Phosphothreonine parameters included in the CHARMM27 force field distribution were
used (18, 53).
Simulation details
A. General parameters. Simulations were performed using GROMACS
(GROningen MAchine for Chemical Simulations) version 4.5 (47) Although GROMACS
was used in this work, we expect that our findings will be applicable to other simulation
software that utilizes the same force fields (59). Cubic boxes of linear size 6 nm were
used and periodic boundary conditions were applied in all directions. Sodium (Na+) and
chloride (Cl-) ions were added to neutralize the system and bring the salt concentration to
0.1 M. Na+ and Cl- parameters specific to each force field distribution were used (60).
Protein and non-protein atoms were coupled to their own temperature baths, which were
kept constant at 310 K using the Parrinello-Bussi algorithm (61). This approach has been
shown to perform very well in biomolecular simulations (46). Pressure was maintained
isotropically at 1 bar using the Parrinello-Rahman barostat (62). A 2-fs timestep was
employed. Prior to the production runs, the energy of each system was minimized using
the steepest descents algorithm. This was followed by 2 ps of position-restrained
dynamics with all non-hydrogen atoms restrained with a 1000 kJ mol-1 force constant.
Initial atom velocities were taken from a Maxwellian distribution at 310 K. All bond
lengths were constrained using the LINCS algorithm (63). A 1.0 nm cut-off was used for
Lennard-Jones interactions. Dispersion corrections for energy and pressure were applied.
Electrostatic interactions were calculated using the Particle-Mesh Ewald (PME) method
(64) with 0.12 nm grid-spacing and a 1.0 nm real-space cut-off. No reaction-field or
cutoff methods were tested as they have previously been shown be inferior to PME (65,
66). System coordinates were written out at 4 ps intervals during the production runs.
B. System-specific attributes. The protonation states of all ionizable residues were
chosen based on their most probable state at pH 7. Unless specified, simulations were
conducted with the amino and carboxyl terminals of the peptide left uncapped (NH3+ and
COO-, respectively) for each force field. When studying peptides from the interior of a
protein sequence, it is common to add capping groups to the ends. This neutralizes the
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unphysical charges introduced by the free N- and C-termini, which can potentially disrupt
the native structure. To study the effects of peptide capping, several simulations with the
N- and C-terminus capped with acetyl (ACE) and NH2 groups, respectively, were
performed (Table 2.1). The starting structure was solvated in SPC (simple point charge),
TIP3P or TIP4P (67, 68) water. The compatibility of these water models with ions has
been examined in detail by (60). A three-point water model (SPC or TIP3P) was
recommended by GROMACS for all of the force fields used in this study, with the
exception of OPLS-AA/L, in which the four-point (TIP4P) water model was the
recommended choice (Table 2.1). Simulations with TIP3P and TIP4P were conducted for
this force field (Table 2.1). The non-phosphorylated peptide systems each contained 17
Na+ and 13 Cl- ions, while for the pThr-80 systems two extra Na+ ions were added to
neutralize the dianionic phosphate group. For each force field, a simulation was
conducted without the use of charge-groups (single atom charge groups); GROMACS
uses the concept of charge groups to speed up simulations, see section “Domain
Decomposition” in (47) for details. It has recently been shown that in some situations
charge-groups can lead to pronounced unphysical effects (46). To examine the effect of
charge-groups, additional simulations were conducted with the GROMOS96 and OPLSAA/L force fields employing the default charge-groups for these force fields. Simulations
performed with charge-groups are denoted with brackets around the force field name in
the results section. For simulations conducted with the CHARMM27 force field, CMAP
correction was applied (18). A few of the simulations were duplicated in order to assess
reproducibility (Table 2.1). These systems did not use charge-groups, were prepared in
the same manner as stated above and were assigned different initial atom velocities than
their originals. Duplicated simulations are denoted with bracketed sequential numbering
beside the force field name in the results section. We also performed elevated
temperature simulations at 330, 350 and 370K with the Amber ff99SB*-ILDN (15, 17,
19, 20), Amber ff03*, (15-17) GROMOS96 53a6, (21, 22) CHARMM27 with CMAP
(18, 52, 53) and OPLS-AA/L force fields (54-56). Using the initial and final (after 1 µs)
system configurations at 310K, we reassigned the atom velocities at each higher
temperature and performed 0.2 µs MD simulations.
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In total, 28 individual 1 µs simulations were conducted and two of these
trajectories were extended to 2 µs (Amber ff99SB* and OPLS-AA/L). An additional 7.2
µs of simulations at elevated temperature were performed. The cumulative simulation
time was 37.2 µs. The simulations are summarized in Table 2.1.
Table 2.1 Summary of the MD simulations
Force field
Water
Elevated Cappedb
tempa
Amber ff99SBTIP3P
ILDN
(7038)
TIP3P
Y
(7030)
TIP3P
(7036)
Amber ff99SB*- TIP3P
Y
ILDN
(7038)
Amber ff99SB
TIP3P
(7038)
Amber ff99SB*f TIP3P
(7038)
Amber ff03
TIP3P
(7038)
Amber ff03*
TIP3P
Y
(7038)
GROMOS96
SPC
43a1p
(7035)
SPC
Y
(7030)
SPC
(7033)
SPC
Y
(7027)
GROMOS96
SPC
Y
53a6
(7035)
SPC
Y
Y
(7033)
CHARMM27
TIP3P
Y
(7038)
TIP3P
(7030)
OPLS-AA/Lf
TIP3P
Y
(7037)
TIP4P
(6969)

pThr80c

Charge- Duplicatee
groupsd
Y
Y

Y

Y
Y

Y

Y

Y

Y
Y

Y

Y
Y
Y
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a

‘Y’ indicates that elevated temperature simulations were performed at 330, 350
and 370 K from the initial and final (after 1µs) system configurations.
b
‘Y’ indicates that the N and C termini of the peptide was capped with with acetyl
(ACE) and NH2 groups, respectively. They were otherwise left uncapped (NH3+
and COO-, respectively).
c
‘Y’ indicates that residue Thr-80 was phosphorylated.
d
‘Y’ indicates that two simulations were performed: one with default GROMACS
charge-groups and one without charge-groups.
e
‘Y’ indicates that two simulations, each 1 µs, were performed. Duplicates were
always performed without charge-groups and were identical to the first simulation
except for their initial atom velocities.
f
The trajectory was extended to 2 µs.

Simulation analysis
We used either the full 1 µs trajectories or the last 0.1 µs for analysis. By restricting
some analyses to the last 0.1 µs, we allowed as much time as possible for the simulations
to converge to a stable conformation. Hydrogen bonds were analyzed as follows: A
hydrogen bond between a donor (D-H) and an acceptor (A) was considered to be formed
when the DA distance was less than 3.2 Å and the angle between the DA vector and the
D-H bond (AD-H angle) was less than 35°. These geometric criteria for defining
hydrogen bonds are consistent with those used in prior studies (69, 70). Secondary
structure content was assessed with the DSSP algorithm (71).

2.4 Results
We have compared the secondary structures and free- and bound-state contact
formations in MD simulations of a β-hairpin forming peptide derived from the
intrinsically disordered Neh2 domain of Nrf2 conducted with 10 different biomolecular
force fields. The DSSP algorithm was used to monitor the evolution of secondary
structures over the entire 1 µs trajectories. β-hairpin formation was identified by
inspection of the cluster center structures and the Cα-Cα atom pair distances during the
last 0.1 µs. Resemblance to the native state was gauged via the presence or absence of
experimentally determined 1H, 1H NOEs (30). We have also compared hydrogen bonds,
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RMSDs and backbone dihedral angles in the MD structures to the peptide in complex
with its binding target, Keap1 (31). The effects of elevated temperatures, terminal
capping, charge-groups and phosphorylation of Thr-80 on hairpin folding were also
assessed.

Assessing secondary structure formation at 310K
To compare the MD trajectories obtained with different force fields, we first
assessed the secondary structure content over the course of our simulations at 310K using
the program DSSP (71). In this analysis, we deemed simulations that had residues from
their β-turn regions (77DEET80) in “turn” conformations (yellow) flanked by residues in
β-sheet conformations (red) simultaneously, to have formed β-hairpins (Figure 2.1). For
the uncapped peptides, the Amber ff99SB-ILDN (1), Amber ff99SB*-ILDN, Amber
ff99SB (2), Amber ff99SB* (2), Amber ff03, Amber ff03*, GROMOS96 43a1p and
GROMOS96 53a6 (1 & 2) simulations, including those which used charge-groups,
appeared to adopt β-hairpins at some points in their trajectories (Figure 2.1A). Cluster
center structures from the last 0.1 µs of the simulations, with the potential β-turn region
(77DEET80) colored in black, are shown in Figure 2.2. The result clearly illustrates the 16mer peptide folds into β-hairpin conformations by using these force fields. Intriguingly,
the folding times vary greatly between ~0.05 µs and > 0.9 µs in these simulations (Figure
2.1A). The CHARMM27 simulations did not form hairpins and DSSP plots showed that
helical content was present in the peptide (Figures 2.1A & 2.2A). None of the OPLSAA/L simulations met our criteria for hairpin formation. Instead, these simulations were
enriched in “bend” conformations (green) (Figure 2.1A). While there was some transient
turn and β-sheet content in the expected locations, there were no pronounced β-hairpin
signatures (Figures 2.1A & 2.2A). Extending of the OPLS-AA/L trajectory (without
charge groups and TIP3P water) to 2 µs still did not yield a native-like hairpin (data not
shown).
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Figure 2.1 Secondary structure propensity analysis of the trajectories.
Secondary structure content was assessed with the DSSP algorithm (71): coil
(white), β-sheet (red), β-bridge (black), bend (green), turn (yellow), α-helix (blue)
and 310 helix (grey). A) Uncapped peptide. B) Capped peptide. C) pThr-80
peptide.

39

40

Figure 2.2 Cluster centroid structures from the last 0.1 µs of the simulations.
A single cluster represented all structures in each simulation and the center
structure was extracted. A) Uncapped peptide. B) Capped peptide. C) pThr-80
peptide.

There were clear differences between replicate runs using the same force fields.
Specifically, the Amber ff99SB-ILDN (2), Amber ff99SB (1) and Amber ff99SB* (1)
simulations did not converge upon β-hairpin conformations (Figures 2.1A & 2.2A). To
determine if a longer trajectory would lead to hairpin formation, we extended the Amber
ff99SB* (1) simulation to 2 µs. DSSP analysis, however, still was not indicative of a
hairpin structure (data not shown).
For the capped peptides, while the Amber ff99SB-ILDN (2), GROMOS96 43a1p
and GROMOS96 53a6 simulations yielded hairpin signatures throughout large parts of
the trajectories (Figure 2.1B), only the GROMOS96 force fields led to the formation of
well-defined β-hairpins in the last 0.1 µs of the simulations (Figure 2.2B). Again, there
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were differences between the two Amber ff99SB-ILDN replicates. While the Amber
ff99SB-ILDN (1) simulation did have turn and strand contents in the expected region, it
appeared to be transient and not as pronounced as the Amber ff99SB-ILDN (2) hairpin
signature (Figure 2.1B). Figure 2.2B shows that close to the end of the trajectory, Amber
ff99SB-ILDN (1) structure adopted a short non-native helix before the turn region while
hairpin structure that is slightly displaced from the expected location was observed in the
Amber ff99SB-ILDN (2) trajectory.
The phosphorylation of Thr-80 located at the turn region appears to have significant
effects on the peptide folding. β-hairpin formation was not observed in any of the pThr80 simulations (Figures 2.1C & 2.2C). Interestingly, these simulations all displayed
considerable bend content but failed to form a turn in the expected location (Figure 2.1C).
The averaged Cα-Cα atom pair distances (within 10 Å) were also plotted to identify
β-hairpin formation in the simulations (Figure 2.3). In these plots, the β-turn (77DEET80)
region, which the hairpin is approximately centered around, was indicated. For the
uncapped peptides, the Amber ff99SB-ILDN (1), Amber ff99SB*-ILDN, Amber ff99SB
(2), Amber ff99SB* (2), Amber ff03, Amber ff03*, GROMOS96 43a1p and
GROMOS96 53a6 (1 & 2) simulations, including those which used charge-groups,
appeared to form β-hairpins as evidenced by the cross-strand Cα-Cα contacts centered
around the β-turn (Figure 3.3A). Like the DSSP plots, this analysis also revealed clear
differences between the replicates of Amber ff99SB-ILDN, Amber ff99SB, and Amber
ff99SB* simulations. While Amber ff99SB-ILDN (2) displayed no signature of β-hairpin
structure, the hairpins formed in the Amber ff99SB (1) and Amber ff99SB* (1)
simulations were found in different regions compared to the replicas (Figure 2.3A). The
CHARMM27 simulations did not have cross-strand Cα-Cα contacts indicative of βhairpin structures, but showed regions of compactness in the turn segment (Figure 2.3A).
The OPLS-AA/L simulations without charge groups had some evident cross-strand
contacts, but the β-turn was shifted from the expected location (Figure 2.3A); while the
OPLS-AA/L simulation with default charge-groups did not appear to form a hairpin
(Figure 2.3A). Cα-Cα contacts in the capped peptide simulations were indicative of
hairpin structures. However, unlike the conformations observed with the GROMOS force
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fields, the β-hairpin in the Amber ff99SB-ILDN simulations were shifted from the
expected location (Figure 2.3B). None of the pThr-80 simulations had cross-strand
contacts evident of β-hairpin structures (Figure 2.3C). It is worthwhile to note that in both
GROMOS96 43a1p trajectories with Thr-80 phosphorylated there was evidence of close
contacts between the positively charged N-terminus and the negatively charged
phosphate group (Figure 2.3C). Since this may represent an unphysical interaction, we
performed an additional simulation with a capped version of the peptide (Table 2.1). In
this trajectory we still did not observe hairpin or turn formation and noticed similar close
contacts between the N-terminal region and phosphate group (data not shown).
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Figure 2.3 Cα-Cα atom pair distances.
Average Cα-Cα distances less than or equal to 10 Å during the last 0.1 µs of the
MD simulations. Distances equal to or greater than 10 Å are colored blue. The
black square indicates the β-turn (77DEET80) region. A) Uncapped peptide. B)
Capped peptide. C) pThr-80 peptide.

Comparison to experimental data
Next, we compared the results of our simulations to experimental data. To begin,
we assessed how many experimentally determined atomic contacts within the Nrf2 β-
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hairpin were found in our simulations. Even though the free state structure of the 16-mer
human Nrf2 peptide used in this study is not currently available, several atomic contacts
within the β-hairpin region of mouse Nrf2 have been determined by NMR (30). The
mouse Nrf2 contains the same β-hairpin sequence as the human version used in this
study, except with a single conservative amino acid change of L74F (Figure 2.4A). Given
that the human and mouse Nrf2 β-hairpin sequences are nearly identical, they are
expected to adopt similar structures.

Figure 2.4 Nrf2 β-hairpin sequence alignment and native contacts.
A) Sequence alignments between the human and mouse Nrf2 β-hairpin segments
were generated with ClustalW XXL (80). The Blosum scoring matrix (81) was
used and gap penalties were set at their default values. Opening and end gap
penalties were set to 10. Extending and separation gap penalties were set to 0.05.
B) Three NMR-derived cross-strand 1H, 1H NOEs determined by (30) mapped
onto a model Nrf2 β-hairpin backbone structure. C) Presence or absence of each
native contact for each force field. Time-averaged distances < 6 Å during the last
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0.1 µs of the simulations between hydrogen atom pairs matching those observed
by Tong et al. (30) were considered to be native contacts.

We compared the NMR-derived cross-strand 1H, 1H NOEs determined by (30) to
the corresponding time-averaged distances from our MD simulations. Time-averaged
distances < 6 Å between hydrogen atom pairs matching those observed in (30) were
considered to be native contacts. Because the united-atom GROMOS96 force fields used
in this study do not explicitly represent every hydrogen atom, we restricted our analysis
to backbone amide hydrogens, which were explicitly represented in all force fields. NOEs
between adjacent residues and those involving F74, were excluded from the analysis.
This reduced the number of experimentally determined native contacts used in this
analysis to three (Q75 HN:L84 HN, L76 HN:L84 HN and D77 HN:E82 HN). They are
depicted in Figure 2.4B.
The presence or absence of each of the three contacts is shown in Figure 2.4C.
For the uncapped peptides, the Amber ff99SB-ILDN (1), Amber ff99SB*-ILDN, Amber
ff99SB (2), Amber ff99SB* (2), Amber ff03, Amber ff03*, GROMOS96 43a1p and
GROMOS96 53a6 simulations, including those which used charge-groups, had at least 2
of the 3 native contacts (Figure 2.4C). Once again, there were differences between the
Amber replicas (Figure 2.4C). Notably, in the Amber ff99SB-ILDN (2), Amber ff99SB
(1) and Amber ff99SB* (1) simulations, only one or none of the native contacts were
present, while their replicas had all three (Figure 2.4C). The CHARMM27 and OPLSAA/L simulations had only 1 out of the 3 native contacts (Figure 2.4C). The capped
peptides were able to form all 3 native contacts, but differences between duplicates were
also evident. The Amber ff99SB-ILDN (1) simulation had all 3 contacts while its
duplicate had only 1 (Figure 2.4C). Native contacts were reduced in all pThr-80
simulations compared to their unphosphorylated counterparts (Figure 2.4C).
Interestingly, 2 of the 3 native contacts were still present in the GROMOS96 43a1p pThr80 trajectories (Figure 2.4C). In these simulations, while the two contacts in the β-sheet
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region of the hairpin were present, the contact in the turn region was missing (Figure
2.4C).
In addition to NMR-derived contacts, backbone and side chain hydrogen bonds
between Asp-77 and Thr-80 are present when Nrf2 is bound to Keap1 (PDB id: 2FLU)
(31). We previously found that hydrogen bonds between these residues may also exist in
the free state with high frequencies in simulations conducted with the GROMOS96 53a6
force field (9). Because hydrogen bonding between Asp-77 and Thr-80 may be correlated
with β-hairpin formation, we calculated the frequencies of hydrogen bonding between
these residues (Table 2.2). For the uncapped peptides, we observed high (> 0.68)
frequencies of Asp-77 to Thr-80 hydrogen bonding in the Amber ff99SB-ILDN (1),
Amber ff99SB*-ILDN, Amber ff99SB (2), Amber ff99SB* (2), Amber ff03*,
GROMOS96 43a1p and GROMOS96 53a6 (1 & 2) simulations, including those which
used charge-groups (Table 2.2). Like the aforementioned analyses, clear differences
between some replicas were observed (Table 2.2). Specifically, the Amber ff99SB-ILDN
(2), Amber ff99SB (1) and Amber ff99SB* (1) simulations had considerably less Asp-77
to Thr-80 hydrogen bonding compared to their duplicates (Table 2.2).

Table 2.2 Frequency of Asp-77 to Thr-80 hydrogen bondinga
Force field
Uncappedb Cappedc pThr-80d
Amber ff99SB-ILDN (1) 0.95
0.00
0.00
Amber ff99SB-ILDN (2) 0.27
0.00
Amber ff99SB*-ILDN
0.94
Amber ff99SB (1)
0.00
Amber ff99SB (2)
0.97
Amber ff99SB* (1)
0.00
Amber ff99SB* (2)
0.97
Amber ff03
0.00
Amber ff03*
0.86
GROMOS96 43a1p
0.69
0.91
0.00
e
(GROMOS96 43a1p)
0.94
0.00
GROMOS96 53a6 (1)
0.90
0.92
GROMOS96 53a6 (2)
0.93
(GROMOS96 53a6)
0.91
CHARMM27
0.32
0.00
CHARMM36
0.22
OPLS-AA/L
0.00
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(OPLS-AA/L)
0.00
OPLS-AA/L (TIP4P)
0.00
a
Frequencies of 1 or more hydrogen bonds during the last 0.1 µs of the trajectories.
Oxygen and nitrogen atoms were acceptors. Amine groups and the hydroxyl group
of Thr-80 were donors. Intra-residue hydrogen bonds were excluded from the
analysis. A hydrogen bond between a hydrogen donor (D-H) and a hydrogen
acceptor (A) was judged to be formed when the DA distance (r) was less than 3.2 Å
and the angle between the DA vector and the D-H bond (AD-H angle) was less than
35°.
b
Values for the peptides with unmodified N and C termini (NH3+ and COO-,
respectively).
c
Values for the peptides with capped N and C termini (ACE and NH2,
respectively).
d
Values for the peptides with residue Thr-80 phosphorylated.
e
Bracketed values indicate hydrogen bond frequencies for trajectories with default
GROMACS charge groups.
It is noteworthy that in the Amber ff03 simulation, no hydrogen bonding between
Asp-77 and Thr-80 was observed (Table 2.2). Because prior analysis showed that this
trajectory formed a hairpin with 3 native contacts (Figure 2.4A), the complete lack of
hydrogen bonding between these two residues was unexpected. Inspection of the
trajectory showed that the side chains of Leu-76 and Asp-77 were on opposite sides of
the hairpin compared to the other simulations (data not shown). Although Asp-77 was not
in an appropriate orientation to form hydrogen bonds with Thr-80, we found that the
frequency of forming 1 or more hydrogen bonds between Leu-76 and Thr-80 was 0.66 in
this trajectory. Low frequencies of Asp-77 to Thr-80 hydrogen bonding was found in the
CHARMM27 simulations (between 0.22 and 0.32) and was completely absent in the
OPLS-AA/L simulations (Table 2.2).
For the capped peptides, no hydrogen bonding between Asp-77 and Thr-80 was
observed in the Amber ff99SB-ILDN simulations, but was present in over 90% of the
structures in the last 0.1 µs of the GROMOS96 trajectories (Table 2.2). While the capped
Amber ff99SB-ILDN (1) simulation was found to have 3 native contacts (Figure 2.4C),
cluster analysis indicated that there was a short non-native helix before its β-turn region
(Figure 2.1B). Furthermore, the DSSP plot of this trajectory did not have a typical hairpin
signature (Figure 2.2B). These factors likely contributed to the lack of Asp-77 to Thr-80
hydrogen bonding in this trajectory (Table 2.2). The capped Amber ff99SB-ILDN (2)
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simulation had only 1 native contact (Figure 2.4C) and its β-turn was in a slightly
displaced from the expected location (Figure 2.3B); factors that likely contributed to the
lack of hydrogen bonding (Table 2.2). Hydrogen bonding between Asp-77 and Thr-80
was not observed in any of the pThr-80 simulations (Table 2.2).
We also compared the Nrf2 peptide structures from our simulations to that of the
Keap1-bound state (PDB id: 2FLU) (31). This comparison is interesting because the
ETGE motif of the disordered Nrf2 has been shown to have a tendency to form bound
state-like structure even in the absence of the target (9, 30, 31). Since the Nrf2 β-hairpin
does not adopt a well-defined in the free state (30), we restricted the RMSD calculations
to backbone atoms only.
RMSDs were calculated separately for the β-turn, 77DEET80 and β-hairpin,
72

AQLQLDEETGEFL84 regions. The RMSDs throughout the trajectories are plotted in

Figure 2.5 and average RMSD values over the last 0.1 µs are shown in Figure 2.6 and
summarized in Tables 2.3-2.5. For the uncapped peptides, the Amber ff99SB-ILDN (1),
Amber ff99SB*-ILDN, Amber ff99SB (2), Amber ff99SB* (2), Amber ff03, Amber
ff03*, GROMOS96 43a1p and GROMOS96 53a6 (1 & 2) simulations achieved average
RMSDs < 1 and < 3 Å to the bound state β-turn and hairpin, respectively, including
simulations which used charge-groups (Figure 2.6A). Again, there were some differences
between replicas. The Amber ff99SB-ILDN (2) simulation had a β-turn region with an
average RMSD < 1 Å, but when considering the full β-hairpin, the RMSD was larger
than 4.8 Å (Figure 2.6A). Also, the Amber ff99SB (1) and Amber ff99SB* (1)
simulations had substantially higher RMSDs compared to their duplicates (Figures 2.5A
and 2.6A). The CHARMM simulations did not lead to bound state like β-hairpin
(RMSDs > 4 Å), but had β-turn RMSDs below 1 Å (Figures 2.5A and 2.6A). The OPLSAA/L simulations had both β-turn and hairpin RMSDs greater than 1 Å and 3 Å,
respectively (Figures 2.5A and 2.6A), indicating significant deviations from the boundstate structure.
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Figure 2.5 Backbone RMSDs between the bound state and MD structures
throughout the trajectories.
RMSD values were calculated for the β-turn 4-mer, 77DEET80 (black) and βhairpin 13-mer, 72AQLQLDEETGEFL84 (red) by least squares fitting the
backbone atoms (N, Cα and C) from each frame to the corresponding atoms of
bound state reference structure (PDB id: 2FLU) (31). A) Uncapped peptide. B)
Capped peptide. C) pThr-80 peptide.
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Figure 2.6 Average backbone RMSDs between the bound state and MD structures.
Average RMSD values were calculated over the last 0.1 µs of the simulations for
the β-turn 4-mer, 77DEET80 (black) and β-hairpin 13-mer,
72

AQLQLDEETGEFL84 (red) by least squares fitting the backbone atoms (N, Cα

and C) from each frame to the corresponding atoms of bound state reference
structure (PDB id: 2FLU) (31). A) Uncapped peptide. B) Capped peptide. C)
pThr-80 peptide.
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Table 2.3 Average backbone RMSDs between the bound state structure and MD
structures of the uncapped peptidesa
Force field
Backboneb (Å) Backbone (Å) ±
± sdev β-turnc
sdev β-hairpind
Amber ff99SB-ILDN (1) 0.30 ± 0.10
2.74 ± 0.45
Amber ff99SB-ILDN (2) 0.77 ± 0.25
4.86 ± 1.14
Amber ff99SB*-ILDN
0.35 ± 0.08
2.41 ± 0.28
Amber ff99SB (1)
1.81 ± 0.19
6.10 ± 0.80
Amber ff99SB (2)
0.38 ± 0.13
2.53 ± 0.42
Amber ff99SB* (1)
1.86 ± 0.16
5.33 ± 0.14
Amber ff99SB* (2)
0.35 ± 0.09
2.32 ± 0.30
Amber ff03
0.77 ± 0.06
1.98 ± 0.24
Amber ff03*
0.46 ± 0.16
2.56 ± 0.39
GROMOS96 43a1p
0.50 ± 0.33
1.56 ± 0.43
(GROMOS96 43a1p)e
0.39 ± 0.09
2.88 ± 0.57
GROMOS96 53a6 (1)
0.25 ± 0.12
1.89 ± 0.41
GROMOS96 53a6 (2)
0.30 ± 0.12
2.32 ± 0.26
(GROMOS96 53a6)
0.32 ± 0.12
1.42 ± 0.56
CHARMM27
0.45 ± 0.21
4.45 ± 0.57
CHARMM36
0.39 ± 0.07
4.80 ± 0.71
OPLS-AA/L
1.84 ± 0.21
2.88 ± 0.87
(OPLS-AA/L)
1.33 ± 0.19
4.63 ± 0.57
OPLS-AA/L (TIP4P)
1.08 ± 0.11
3.48 ± 0.21
a
Average RMSDs were calculated over the last 0.1 µs of the trajectories.
b
Backbone atoms include N, Cα and C.
c
β-turn (77DEET80).
d
β-hairpin (72AQLQLDEETGEFL84).
e
Average RMSDs for trajectory with default GROMACS charge groups.

Table 2.4 Average RMSDs between the bound state conformation and MD
structures of the capped peptidesa
Force field
Backboneb (Å) Backbone (Å) ±
± sdev β-turnc sdev β-hairpind
Amber ff99SB-ILDN (1) 1.39 ± 0.13
2.67 ± 0.34
Amber ff99SB-ILDN (2) 1.66 ± 0.10
2.65 ± 0.38
GROMOS96 43a1p
0.32 ± 0.14
2.18 ± 0.31
GROMOS96 53a6
0.29 ± 0.11
2.23 ± 0.31
a
Average RMSDs were calculated over the last 0.1 µs of the trajectories.
b
Backbone atoms include N, Cα and C.
c
β-turn (77DEET80).
d
β-hairpin (72AQLQLDEETGEFL84).
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Table 2.5 Average RMSDs between the bound state conformation and MD
structures of the pThr-80 peptidesa
Force field
Backboneb (Å) Backbone (Å) ±
± sdev β-turnc sdev β-hairpind
Amber ff99SB-ILDN
1.85 ± 0.45
5.96 ± 1.19
GROMOS96 43a1p
2.01 ± 0.18
5.45 ± 0.17
(GROMOS96 43a1p)e
2.00 ± 0.18
5.04 ± 0.17
CHARMM27
1.89 ± 0.34
5.88 ± 0.93
a
Average RMSDs were calculated over the last 0.1 µs of the trajectories.
b
Backbone atoms include N, Cα and C.
c
β-turn (77DEET80).
d
β-hairpin (72AQLQLDEETGEFL84).
e
Average RMSDs for trajectory with default GROMACS charge groups.

For the capped peptides, both Amber ff99SB-ILDN simulations had average
RMSDs < 3 Å for the hairpin region, but their β-turns had RMSDs > 1 Å (Figures 2.5B
and 2.6B). In comparison, both GROMOS96 force fields had RMSDs of < 1 and < 3 Å
for the β-turn and hairpin, respectively (Figures 2.5B and 2.6B). These RMSDs were
similar to their uncapped versions (Figures 2.5A and 2.6A). It is worthwhile to note that
the capped GROMOS96 53a6 simulation converged to bound state like structure in <
0.05 µs, the fastest of all the simulations (Figure 2.5B). Among the simulations which
had bound state like RMSDs, the amount of time it took to adopt these conformations
varied between < 0.05 and ~ 0.9 µs, even for duplicates using the same force field
(Figures 2.5A and B). However, once a bound state like structure was formed, it tended
to remain stable. The β-turn and hairpin RMSDs were higher in all pThr-80 simulations
compared to those of the unphosphorylated peptides (Figures 2.5C and 2.6C).
The convergence of the dihedral angles from the trajectories to those from the
bound state structure was also assessed (PDB id: 2FLU) (31). The combined φ and ψ
angles from the simulations and bound state structure are shown in Figure 2.7 and the
average per-residue deviations are shown in Figure 2.8. For the uncapped peptides, the
GROMOS96 43a1p with charge groups and 53a6 force field simulations had the lowest φ
and ψ deviations from the bound state structure (Figure 2.8A). These simulations had
combined φ and ψ deviations of < 7º and < 17º per residue from the bound state in their
β-turn and hairpin regions, respectively (Figure 2.8A). The Amber ff99SB-ILDN (1) and
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CHARMM simulations had combined φ and ψ deviations of ~ 10º in their β-turns, but
deviated > 20º per residue when considering the entire hairpin (Figure 2.8A). For the
capped peptides, both GROMOS96 force fields had slightly lower deviations compared
to their uncapped counterparts and had considerably lower deviations than Amber
ff99SB-ILDN (Figure 2.8B). The β-turn and hairpin deviations were higher in all pThr80 simulations compared to those of the unphosphorylated peptides (Figure 2.8B).
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Figure 2.7 Comparison of the backbone dihedral angles from the bound state
structure and MD simulations.
The φ and ψ angles for residues 73QLQLDEETGEF83 were converted to radians
and the absolute values were summed and averaged. Black circles indicate the
values from the bound state crystal structure (PDB id: 2FLU) (31). Red squares
are the values over the last 0.1 µs of the simulations. A) Uncapped peptide. B)
Capped peptide. C) pThr-80 peptide.
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Figure 2.8 Average combined φ and ψ deviations per residue from the bound state
crystal structure.
Black bars are for the β-turn 4-mer, 77DEET80 and red bars are for the β-hairpin
13-mer, 72AQLQLDEETGEFL84. Data was analyzed over the last 0.1 µs of the
simulations. A) Uncapped peptide. B) Capped peptide. C) pThr-80 peptide.
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Secondary structure formation at elevated temperatures
Finally, we have performed MD simulations at elevated temperatures using a subset
of force fields, Amber ff99SB*-ILDN and ff03*, GROMOS96 53a6, CHARMM27, and
OPLS-AA/L, to identify secondary structure formation of the Neh2 peptide under these
conditions. Using elevated temperatures provides an additional test to examine possible
metastable states. The simulations were performed at 330, 350 and 370 K from both the
initial and final (after 1 µs) system configurations at 310 K. Again, we used DSSP
analysis to illustrate the evolution of secondary structures over the trajectories.
In the simulations starting from the initial (unfolded) system coordinates, hairpin
formation, at the expected location, was observed in the Amber ff03*, GROMOS96 53a6
(2), and capped GROMOS96 53a6 simulations at 330 K (Figure 9). β-hairpin structures
were also identified in the MD simulations using these force fields at 310 K as mentioned
above (Figure 2.1). Hairpin conformation, which was not observed in CHARMM27 (1)
at 310 K, was significantly populated in the trajectory at 330 K (Figure 2.9). At 350 K,
the Amber ff03*, GROMOS96 53a6 (2) and capped GROMOS96 53a6 simulations still
had hairpin signatures at some points in their trajectories, but β-hairpin structure was no
longer observed in the CHARMM27 (1) simulation (Figure 2.9). On the other hand, a
low population of hairpin conformation was observed in the 350 K OPLS-AA/L
trajectory (Figure 2.9). Significant population of β-hairpin structure remained even at 370
K in GROMOS96 53a6 (2) and capped GROMOS96 53a6 simulations (Figure 2.9), while
only transiently formed hairpin was observed in CHARMM27 (1). It is noteworthy that
rapid hairpin folding and high thermal stability were observed in the capped GROMOS96
53a6 simulations at all elevated temperatures (Figure 2.9).

60

Figure 2.9 Secondary structure propensity analysis of the elevated temperature
simulations from the initial system configurations.
Secondary structure content was assessed with the DSSP algorithm71: coil (white),
β-sheet (red), β-bridge (black), bend (green), turn (yellow), α-helix (blue) and 310
helix (grey). A) Uncapped peptide. B) Capped peptide.
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In the simulations starting from the final system coordinates, the Amber ff99SB*ILDN, Amber ff03*, GROMOS96 53a6 (2) and capped GROMOS96 53a6 trajectories,
all of which formed hairpins at 310 K, maintained hairpin signatures at 330 K over 0.2 µs
(Figure 10). On the other hand, the CHARMM27 (1) and OPLS-AA/L trajectories at 330
K were heavily biased by α-helical and bend conformations, respectively, similar to what
were observed at 310 K (Figure 2.10). When the temperature was increased to 350 K, the
hairpin signature in the Amber ff99SB*-ILDN trajectory disappeared shortly after ~ 0.1
µs, however the Amber ff03*, GROMOS96 53a6 (2) and capped GROMOS96 53a6
trajectories maintained their hairpins over the whole 0.2 µs period (Figure 2.10). The
CHARMM27 (1) simulation at 350 K lost its helical properties after about 0.15 µs and
appeared to form a hairpin shortly after (Figure 2.10). At 370 K, both the Amber
ff99SB*-ILDN and Amber ff03* trajectories lost their hairpin signatures after ~ 0.1 µs,
but the GROMOS96 53a6 (2) and capped GROMOS96 53a6 simulations still remained in
hairpin conformations throughout almost the whole trajectories (Figure 2.10). On the
other hand, the CHARMM27 (1) simulation at 370 K lost its helical property almost
immediately and a turn conformation was present in the expected location, but a distinct
hairpin signature was not observed (Figure 2.10). The OPLS-AA/L trajectories did not
have any clear hairpin signatures at any of the temperatures (Figure 2.10). Once again,
high thermal stability was observed in the GROMOS96 53a6 simulations (Figure 2.10).
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Figure 2.10 Secondary structure propensity analysis of the elevated temperature
simulations from the final (after 1µs) system configurations.
Secondary structure content was assessed with the DSSP algorithm71: coil (white),
β-sheet (red), β-bridge (black), bend (green), turn (yellow), α-helix (blue) and 310
helix (grey). A) Uncapped peptide. B) Capped peptide.
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2.5 Discussion and conclusions
We have examined the folding of a 16-mer polypeptide with 10 commonly used
biomolecular force fields. The peptide used in this study is derived from the Neh2
domain of Nrf2. Despite that Neh2 has been characterized as being intrinsically
disordered, the region encoded by the sequence of this peptide has been shown to contain
β-hairpin structure (30, 31, 72). Various criteria were used to assess β-hairpin formation
of this peptide and compare the results to experimental data. Although the simulations all
used the same, non-native, starting structure and were performed with identical
parameters, clear differences were observed between different force fields used and even
between replicate simulations with the same force field.
While no single type of analysis was sufficient to thoroughly assess and compare
β-hairpin formation, the DSSP plots were useful for visualizing potential hairpin
formation in this work. In addition, these analyses were also useful in identifying other
types of secondary structures. For example, DSSP plots of the CHARMM27 simulations
showed that the Nrf2 peptide did not fold into hairpins, but had tendencies to form short
α-helices (Figure 2.2A). This finding was not completely unexpected because CHARMM
force fields have been known to have a bias towards helical structures, even when
simulating the folding of all β proteins (3, 11-13, 73). In addition to CHARMM27, the
Amber ff03 force field has also been shown to overstabilize helical structures. LindorffLarsen et al. (44) observed that while both CHARMM27 and Amber ff03 could fold the
α-helical villin headpiece, proper folding of the β-sheet WW domain could not be
achieved even in simulations that were 10 times the experimentally determined folding
time in length. On the other hand, they found that the “helix-coil-balanced” Amber ff03*
and recently developed CHARMM22* variants could achieve proper folding of both
villin and the WW domain (8, 57).
The DSSP plots for the OPLS-AA/L force field simulations also were not
indicative of hairpins, but showed considerable amounts of ‘bend’ content. This aligns
with the finding of Cao et al. (74) that this force field did not produce the expected β-
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hairpin structure of the H1 peptide. Interestingly, simulations of the H1 peptide
performed with GROMOS96 43a1 yielded a β-hairpin structure consistent with
experimental data (74). It is difficult to determine why the OPLS-AA/L simulations did
not form a native-like hairpin structure in our simulations. It is possible that, in general,
longer trajectories may be needed for convergence due to the rugged energy landscape
and different barriers in these systems (75, 76). The weak hairpin signature observed in
the DSSP plot of the OPLS-AA/L trajectory at 350 K supports this notion. Alternatively,
there may be incompatibilities between our peptide sequence and OPLS-AA/L, such as
high amounts of exposed hydrophobic content (74).
The Cα-Cα contacts plots also illustrated β-hairpin formation and helped to
identify non-native hairpins. For example, these plots showed that the β-turn in the
capped peptide Amber ff99SB-ILDN (2) simulation was slightly displaced from its
expected location (Figure 2.2B). This likely explains the lack of Asp-77 to Thr-80
hydrogen bonding in this simulation (Table 2.2). Together, our findings from the DSSP
and Cα-Cα contact analysis, suggested that the uncapped Amber ff99SB-ILDN (1), Amber
ff99SB*-ILDN, Amber ff99SB (2), Amber ff99SB* (2), Amber ff03, Amber ff03*,
GROMOS96 43a1p, GROMOS96 53a6 (1 & 2) and capped GROMOS96 43a1p and
53a6 simulations formed native-like β-hairpins.
Interestingly, the simulations that formed β-hairpins, as judged by DSSP and CαCα contact analysis, also exhibited experimentally determined native contacts present in
the free state of Nrf2. Furthermore, we observed that the presence or absence of native
contacts was correlated with the frequency of Asp-77 to Thr-80 hydrogen bonding to
some extent. Interactions between these residues are thought to be important for the
hairpin structure (9, 31). Most of the simulations of the uncapped and unphosphorylated
peptides that had two or more native contacts also had high frequencies of Asp-77 to Thr80 hydrogen bonding. On the other hand, when 1 or 0 native contacts were present, there
was usually less hydrogen bonding. One exception was the Amber ff03 simulation, which
had all 3 native contacts, but lacked hydrogen bonding between Asp-77 to Thr-80. Figure
2.5 shows that in this simulation, Leu-76 and Asp-77 had large backbone dihedral angle
deviations from the bound state structure, which could possibly explain the lower
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hydrogen bonding with Thr-80. It is possible that alternate hydrogen bonds between Leu76 and Thr-80 may have compensated. The evident positive correlation between native
contact formation and a high frequency of Asp-77 to Thr-80 hydrogen bonding in our
simulations supports prior suggestions that these interactions are vital for the hairpin
structure (9, 31).
We also found that the simulations that formed β-hairpins converged upon
conformations that were similar to the structure of Nrf2 bound to Keap1 (PDB id: 2FLU)
(31). It is common for disordered proteins, like Nrf2, to contain preformed structural
elements in their binding regions (9, 30, 77-79). Indeed, NMR data and our prior MD
simulations indicated that Nrf2 adopts a hairpin structure in the free-state, which is high
resemblance to its Keap1 bound form (PDB id: 2FLU) (9, 31). Therefore, it was expected
that simulations with 2-3 free state native contacts also had low RMSDs to the bound
state structure. The GROMOS96 simulations clearly had the lowest β-turn and hairpin
RMSDs of all the simulations. These simulations also had very low dihedral angle
deviations from the bound state structure.
In general, the simulations that used charge-groups or peptide capping groups
were not largely different from their uncapped counterparts with single atom chargegroups. When studying peptides from the interior of a protein sequence, it is common to
add capping groups to the ends. This neutralizes the unphysical charges introduced by the
free N- and C-termini, which can potentially disrupt the native structure. However, we
did not find that the uncapped termini had a detrimental effect on hairpin folding in our
current simulations. The GROMOS96 force field simulations employing default chargegroups or peptide capping groups were highly consistent, in all aspects, to their uncapped
counterparts. On the other hand, in both capped Amber ff99SB-ILDN replicates, the
peptide folded into structures that were moderately different from their uncapped
counterparts. It was difficult to determine the cause of this behavior and it could simply
be a convergence issue.
The finding that none of the simulations where Thr-80 was phosphorylated
formed β-hairpins was not surprising. Experimental data has shown that phosphorylation
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of this residue can severely impair binding of Nrf2 to Keap1, likely due to a disruption of
β-turn formation (31). Our pThr-80 simulations were consistent with this proposition and
also suggest that β-turn disruption strongly impairs hairpin formation.
The evident differences between duplicate simulations in this work highlight the
importance of replica simulations when performing MD simulations of folding. Even
though all duplicate simulations here used identical starting structures and parameters, the
assignment of different initial atom velocities led the simulations to follow different
pathways. As a result, duplicate simulations did not always converge upon folded
structures even with microsecond long trajectories. In this work, we have conducted
simulations at elevated temperatures using a subset of force fields in order to gain
insights into the temperature-dependence and metastability of conformational sampling.
The results show that with the GROMOS96 53a6 force field, the Neh2 peptide continued
to fold into β-hairpin conformation and remained stable even at higher temperatures. This
is quite different from what was observed for Amber ff99SB*-ILDN as the hairpin
structure becomes less stable under this force field when the temperature increases.
Although native-like conformation was not observed in the microsecond long
CHARMM27 (1) simulation at 310 K, the peptide quickly folded into a β-hairpin
structure at 330 K. Therefore, the lack of conformational convergence at lower
temperature may simply be due to insufficient sampling time. However, further increase
in temperature (i.e. 350 and 370 K) again led to the disappearance of β-hairpin structure
in the CHARMM27 (1) simulations. The results here also show that although long
simulation times are necessary, it is important to have alternative methods of sampling
conformations, such as replica-exchange and related methods (82-84).
Finally, this and other recent comparative studies (44, 45, 85) show the
importance of using different criteria for assessing the properties of different force fields.
In addition to more reliable simulations, such studies provide invaluable information
about the collective non-additive properties of amino acids that are helpful in interpreting
experiments.
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2.6 Supplemental information
Two videos are available on YouTube (too large for direct inclusion):
Video 1: http://www.youtube.com/watch?v=AtDOJnVNC18&feature=channel&list=UL.
The first and last 10 ns of the Amber ff99SB-ILDN (1), Amber ff99SB*-ILDN, Amber
ff99SB (2), Amber ff03, Amber ff03* GROMOS96 43a1p, GROMOS96 53a6 (2),
CHARMM27 (2) and OPLS-AA/L trajectories (without terminal capping or charge
groups). For clarity, water, ions and hydrogens are not shown and rotation and translation
of the peptide has been removed. Secondary structures were colored as follows in VMD:
yellow - β-sheet (arrows indicate chain direction), purple - alpha helix, blue - 310 helix,
white - coil.
Video 2: at http://www.youtube.com/watch?v=HtRbtQ12eOI&feature=channel&list=UL.
0-400 ns of the Amber ff99SB* (2) trajectory. For clarity, water, ions and hydrogens are
not shown and rotation and translation of the peptide has been removed. Secondary
structures were colored as follows in VMD: yellow - β-sheet (arrows indicate chain
direction), purple - alpha helix, blue - 310 helix, white - coil.
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3.1 Abstract
Intrinsically disordered proteins (IDPs) are abundant in cells and have central
roles in protein-protein interaction networks. Interactions between the IDP Prothymosin
alpha (ProTα) and the Neh2 domain of Nuclear factor erythroid 2-related factor 2 (Nrf2),
with a common binding partner, Kelch-like ECH-associated protein 1 (Keap1), are
essential for regulating cellular response to oxidative stress. Misregulation of this
pathway can lead to neurodegenerative diseases, premature aging and cancer. In order to
understand the mechanisms these two disordered proteins employ to bind to Keap1, we
performed extensive 0.5-1.0 microsecond atomistic molecular dynamics (MD)
simulations and isothermal titration calorimetry experiments to investigate the
structure/dynamics of free-state ProTα and Neh2 and their thermodynamics of bindings.
The results show that in their free states, both ProTα and Neh2 have propensities to form
bound-state-like β-turn structures but to different extents. We also found that, for both
proteins, residues outside the Keap1-binding motifs may play important roles in
stabilizing the bound-state-like structures. Based on our findings, we propose that the
binding of disordered ProTα and Neh2 to Keap1 occurs synergistically via preformed
structural elements (PSEs) and coupled folding and binding, with a heavy bias towards
PSEs, particularly for Neh2. Our results provide insights into the molecular mechanisms
Neh2 and ProTα bind to Keap1, information that is useful for developing therapeutics to
enhance the oxidative stress response.
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3.2 Introduction
IDPs are a class of proteins that are biologically functional despite lacking welldefined structures (1-5). They are abundant in nature: 25-30% of eukaryotic proteins are
predicted to be at least partially disordered, while up to 70% of signaling proteins may
contain intrinsically disordered regions (6, 7). Compared to globular proteins, the amino
acid compositions of IDPs are usually biased towards charged, polar and structurebreaking residues, such as glycine and proline (3, 8, 9). As a result, in the absence of
binding partners, these proteins generally lack structured hydrophobic cores and display
high conformational flexibility (3, 5).
Despite their dynamic nature, IDPs seldom adopt completely random coil
conformations (10-13). In fact, many IDPs are found to possess considerable
conformational propensities along their sequences (14-20). These transiently structured
regions frequently act as molecular recognition features for target binding (16-18, 21,
22). Interestingly, interactions with different partners can also cause a disordered region
to adopt distinct conformations (2, 18, 21-23). For example, the same region of the
intrinsically disordered C-terminus of p53 can adopt either a helix or a ß-strand structure
depending on the target it interacts with (23). These unique structural properties empower
many IDPs to act as hubs in protein-protein interaction networks through low-affinity but
yet highly specific binding (4, 21, 24-26). Therefore, it is not a surprise that IDPs are
frequently associated with human diseases, in particular cancer and neurodegenerative
diseases (27-29).
Even though IDPs are involved in crucial biological functions, the mechanisms by
which they interact with targets are not well understood. Recent studies have shown that
some IDPs undergo large conformational changes upon target binding (4, 30-32), while
others have preformed structural elements (PSEs) that resemble the bound state
conformations in a significant population of conformers in the ensemble (16, 33-35). It is
noteworthy that these two mechanisms are not always independent; in many cases, the
binding of IDPs to their targets involves a combination of both (36). Knowledge of the
detailed mechanisms that IDPs employ to bind to their targets is critical for understanding
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how this class of proteins function. More importantly, it will also aid in the development
of therapeutic agents targeting these types of interactions (37, 38).
While X-ray crystallography is commonly used to determine protein structures
with atomic-level accuracy, the dynamic nature of IDPs makes acquiring diffracting
crystals of these proteins in free states extremely challenging (2). Nuclear magnetic
resonance (NMR) spectroscopy has become the primary technique for the structural
characterization of this class of proteins (39, 40). Despite the fact that NMR can yield a
wealth of data, there are limitations. For an IDP undergoing fast conformational exchange
on the NMR timescale, collected data are averaged over the entire ensemble of
conformations sampled by the protein. Therefore, unlike for folded proteins, it is
inappropriate to determine a single conformation to represent the disordered state. To
circumvent this problem, molecular dynamics (MD) simulations have been used to
complement the experimental techniques in order to establish better models for
describing the dynamic nature of interconverting disordered state ensembles and, more
importantly, the mechanisms by which IDPs interact with targets. For instance, MD
simulations have been performed on both the bound and apo phosphorylated forms of
intrinsically disordered kinase-inducible domain (KID) to investigate the molecular
mechanism by which pKID interacts with KIX in signal transduction (41). Wu et al. have
combined NMR spectroscopy and MD simulations to identify the structural
reorganization of alpha-synuclein at low pH (42).
The objective of this work is to understand the molecular mechanisms that the
disordered ProTα and Neh2 domain of Nrf2 use to bind Keap1 in the oxidative stress
response pathway. Exposure to toxic reactive electrophiles from the environment as well
as those generated by our own metabolism can disrupt the cellular functions, resulting in
neurodegenerative diseases, cancer and aging (43). Nrf2 is a key transcription factor for
genes responsive to oxidative stress (44, 45). The protein consists of six highly
homologous regions (Neh1-6 domains). The Neh2 domain, which is located at the Nterminus of Nrf2, plays a regulatory role by interacting with an ubiquitously expressed
inhibitor, Keap1 (45). Under homeostatic conditions, the Neh2 domain of Nrf2 binds to
the Kelch domains of the monomeric units of a Keap1 dimer via a high affinity ETGE
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motif and a lower affinity DLG motif (with Kd values of ~8 nM and ~0.5 µM),
respectively (46). When both motifs are bound to a Keap1 dimer, Neh2 is (poly)
ubiquitinated and subsequently degraded by the proteosome (45-48). When the cells are
under oxidative stress conditions, the interaction of Keap1 and Nrf2 is disrupted, leading
to the upregulation of Nrf2-mediated gene expression.
Recent studies have shown that ProTα can compete with Nrf2 for binding to
Keap1, resulting in the upregulation of Nrf2-targeted cytoprotective genes (49, 50).
ProTα is ubiquitously expressed in a wide variety of human tissues and besides the
regulatory role it plays in the expression of oxidative stress response genes, the protein
has also been found to be involved in other cellular processes such as cell proliferation,
chromatin remodeling, transcriptional regulation and apoptosis (51-53). The Keap1binding motif of ProTα (-NEENGE-) shares a similar sequence with that of the Neh2 (DEETGE-). Crystal structures of ProTα and Neh2 peptides bound to the Kelch domain of
Keap1 further reveal that these two proteins bind to the same site on the Kelch domain
and form similar β-turn conformations (46, 50) (Figure 3.1). The Kelch domain adopts a
six-bladed ß-propeller structure with each blade composed of four anti-parallel ß-strands
(46, 50). Both ProTα and Neh2 bind to the positively charged face of the ß-propeller
where the inter-blade loops are located and the electrostatic interactions are crucial for
the stability of the complexes (46, 50). Interestingly, despite the high sequence identity
and structural similarity of the binding motifs, ProTα seems to have a lower binding
affinity to Keap1 (see result below) compared to Neh2 (only the ETGE motif is
considered) (46, 49).
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Figure 3.1 Crystal structures of ProTα and Neh2 peptides bound to the Kelch
domain of Keap1.
A) Cartoon B-Spline representations of the ProTα-Keap1 and Neh2-Keap1 crystal
structures (PDB ids: 2Z32 and 1X2R respectively (50, 55). Residues Asn-41 to
Glu-48 of ProTα and Leu-76 to Leu-84 of Neh2 (red) are shown bound to the
Kelch domain of Keap1 (grey). B) Licorice representations of the i to i+3 residues
of the β-turns from the crystal structures (41Asn-Glu-Glu-Asn44 and 77Asp-GluGlu-Thr80, of ProTα and Neh2 respectively). C) Overlay of the ProTα (white) and
Neh2 (grey) β-turns.

Atomistic microsecond scale MD simulations were used to investigate the
molecular mechanisms by which the intrinsically disordered ProTα and Neh2 interact
with Keap1. In particular, we focused on whether their XEEXGE motifs bind to Kelch
domain through coupled folding and binding, PSEs or a combination of both
mechanisms. Our results show that in their free states, both the Keap1-binding motifs of
ProTα and Neh2 display intrinsic propensities to form bound-state-like β-turns, and that
the residues outside of the motifs may also contribute to the stability of the structural
elements. We found that the Keap1-binding motif of Neh2 adopted a β-turn conformation
that more closely resembled its bound-state structure than that of ProTα. Based on these
results, we propose that binding occurs synergistically via a combination of PSEs and
coupled folding and binding with a heavy bias towards PSEs, especially for Neh2. The
better understanding of the binding mechanisms may provide insight into developing of
therapeutics that can be used to promote cellular response to oxidative stress.

3.3 Materials and methods
Starting structures
The free state structure and dynamics of ProTα and Neh2 were investigated using
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atomistic MD simulations. All starting structures were generated using the
Crystallography & NMR System (CNS) software package (54). Briefly, extended
structures were first generated based on the amino acid sequences of ProTα and Neh2.
Each structure subsequently underwent a simulated annealing simulation using default
CNS parameters from the anneal.inp script (without any restraints) (54). By using this
procedure, we generated structures of peptides with identical sequences and lengths to
those used to generate the crystal structures of mouse ProTα and Neh2 bound to Keap1
(PDB ids: 2Z32 and 1X2R respectively) (50, 55), the full-length mouse ProTα protein
and a 32-mer mouse Neh2 peptide, as well as their human homologs. Table 1 summarizes
the amino acid sequences used in the MD simulations and the lengths of the trajectories.
Peptides with longer sequences (full-length ProTα protein and the 32-mer Neh2 peptide)
were simulated to determine if residues outside of the Keap1 binding motif might be
important for binding, while human sequences were simulated for cross-species
comparison. To focus on the ETGE binding motif, the 32-mer Neh2 peptides instead of
the full-length proteins were simulated in order to exclude the N-terminus DLG motif and
the central helical region, which is not involved in Keap1 binding (46). To avoid biasing
the sampling towards native-like conformations, conformers from the annealing
simulations that did not resemble their bound-states were chosen as starting structures
(Figure S1). The underlined residues in Table 1 comprise the Keap1-binding β-turns of
ProTα and Neh2, determined from the crystal structures (50, 55), and are referred to as
positions i through i+3 in this work (Figure 1).

MD simulations
All simulations were performed using GROMACS (GROningen MAchine for
Chemical Simulations) version 4 (56), with the GROMOS96 53a6 united atom force-field
parameter set (57, 58). This force field has been shown to be reliable in simulating
proteins, including β-peptide folding (59). Protonation states of ionizable residues were
chosen based on their most probable state at pH 7. The amino and carboxyl terminals of
all systems were capped with NH3+ and COO- groups respectively. The starting structures
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were solvated in simple point charge (SPC) water (60), followed by the addition of
sodium (Na+) and chloride (Cl-) ions to make the system charge neutral and bring the salt
concentration to 0.1 M. The 16-mer ProTα and the 9-mer Neh2 systems (Table 3.1)
contained between 9950 and 5926 water molecules and 43 to 26 molecules of salt,
respectively. The full-length ProTα and the 32-mer Neh2 systems (Table 3.1) contained
between 68146 and 16887 water molecules and 293 to 67 molecules of salt, respectively.
The GROMOS parameterization of Na+ and Cl- was used, which has been shown to work
well with SPC water (61). MD simulations were performed at constant temperature,
pressure and number of particles (NPT ensemble). Protein and non-protein atoms were
coupled to their own temperature baths, which were kept constant at 310 K using the
weak coupling algorithm (62). Pressure was maintained isotropically at 1 bar using the
Berendsen barostat (62). Prior to the production runs, the energy of each system was
minimized using the steepest descents method. This was followed by 2 ps of positionrestrained dynamics with all non-hydrogen atoms restrained with a 1000 kJ mol-1 force
constant. The timestep was set to 2 fs. Initial atom velocities were taken from a
Maxwellian distribution at 310 K. All bond lengths were constrained using the LINCS
algorithm (63). Cut-off of 1.0 nm was used for Lennard-Jones interactions and the real
part of the long-range electrostatic interactions, which were calculated using the ParticleMesh Ewald (PME) method (64). 0.12 nm grid-spacing was used for PME. It is important
to treat electrostatic interactions with accurate methods, such as PME, to avoid potential
serious artifacts (65, 66). It has been shown that choosing simulation parameters,
including thermostat and electrostatic treatment, is a subtle issue and that the choice of
charge-groups may lead to unphysical effects (67). Baumketner et al. (68, 69) also
reported that charge-group based truncation with reaction-field electrostatics may cause
artificial repulsions between charged residues, identified as the microscopic reason
behind artificial unfolding of protein in some simulations. Here, charge-groups were
chosen to be small to avoid artifacts (67). Periodic boundary conditions were applied in
all directions. This simulation protocol has been successfully applied in a number of our
previous protein and membrane simulations (67, 70, 71). Simulations of the shorter
peptide systems took ~1-2 weeks each using 32 cores, while the larger systems each took
~3-7 weeks using 64 cores. The cumulative simulation time for all of the trajectories was

86

~231, 000 CPU hours.
Table 3.1 Amino acid sequences of the simulated molecules and trajectory lengths.
System
Sequence
Simulation time (µs)
39
54
16-mer
AQNEENGEQEADNEVD
1.0
ProTα
peptide
(mouse)
76
9-mer Neh2
LDEETGEFL84
1.0
peptide
(mouse)
1
Full-length
MSDAAVDTSSEITTKDLKEKKEVVEEAE 0.5
ProTα
NGRDAPANGNAQNEENGEQEADNEVDEE
(mouse)
EEEGGEEEEEEEEGDGEEEDGDEDEEAEA
PTGKRVAEDDEDDDVDTKKQKTEEDD111
32-mer Neh2 69AFFAQFQLDEETGEFLPIQPAQHIQTDTS 0.5
peptide
GSA100
(mouse)
1
Full-length
MSDAAVDTSSEITTKDLKEKKEVVEEAE 0.5
ProTα
NGRDAPANGNANEENGEQEADNEVDEEE
(human
EEGGEEEEEEEEGDGEEEDGDEDEEAESA
isoform 2)
TGKRAAEDDEDDDVDTKKQKTDEDD110
32-mer Neh2 69AFFAQLQLDEETGEFLPIQPAQHIQSETS 0.5
peptide
GSA100
(human
isoform 1)
Residues i through i+3 of the β-turn regions of the ProTα and Neh2 sequences,
determined from the crystal structures (50, 55) are underlined.

Simulation analysis
To determine whether the binding motifs of ProTα and Neh2 have tendencies to
adopt bound-state-like structures in their free states, coordinates from the MD trajectories
were compared with the corresponding PDB crystal structures (PDB ids: 2Z32 and 1X2R
respectively) (50, 55). Distance-based root-mean-square deviations (RMSD) were
computed between structures at time t of the trajectory and the bound state reference
determined from the crystal structure using the equation (56):
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where rij(t) and rij(0) are the distances between atoms i and j at time t of the trajectory and
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the same pair of atoms in the bound-state structure, respectively.
The Cαi-Cαi+3 distances were calculated to determine if Keap1-binding β-turns of
ProTα and Neh2 were formed during the simulations. To be defined as a β-turn, the CαiCαi+3 distance must be less than 7 Å (72). Residue specific dynamics of the β-turns were
also probed by analyzing the circular variance (C.V.) of the φ and ψ dihedral angles over
time. The C.V. is defined as (73):

CV = 1" R /m

(2)

where m is the number of structures included in the analysis, and R is calculated using the
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The value of C.V. ranges between 0 and 1. Lower values represent tighter clustering
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about the mean and higher values are indicative of greater φ and ψ variability.
Hydrogen bonds were analyzed as follows: A hydrogen bond between a donor (DH) and an acceptor (A) was considered to be formed when the DA distance was less than
3.2 Å and the angle between the DA vector and the D-H bond (AD-H angle) was less
than 35° (74, 75). Visualization of the structures was done using VMD (76) and Chimera
(77).

Isothermal titration calorimetry (ITC) experiments
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The Kelch domain (residues 324-612) of mouse Keap1 was expressed in
Escherichia coli BL21 (DE3) grown in minimal M9 medium. The N-terminally Histagged protein was purified by affinity chromatography using Ni Sepharose™ 6 Fast
Flow beads (Amersham Biosciences). The tag was then cleaved by incubation with Histagged tobacco etch virus (TEV) protease overnight at 25 ºC. The protein product was
purified by passing the mixture through Ni Sepharose™ 6 Fast Flow beads (Amersham
Biosciences).
ITC experiments were performed on a VP-ITC system (MicroCal) at 25 ºC. The
Kelch domain was dialyzed against 50 mM phosphate buffer at pH 7, containing 100 mM
NaCl and 1 mM DTT. Mouse ProTα (Ala-39 to Asp-54) and Neh2 (Leu-76 to Leu-84)
peptides (GenScript) were also dissolved in the same buffer. All samples were filtered
and degassed before the ITC experiments. Typically, 5 µL aliquots of 0.5 mM ProTα or
Neh2 peptide were titrated to the sample cell containing 1.4 mL of 0.05 mM Kelch at 4minute intervals. Heat changes after saturation were used to account for the heat of
dilution. The binding stoichiometries (n), enthalpy changes (∆H), binding constants (Ka),
Gibbs free energy changes (∆G) and entropy changes (∆S) were calculated using the
titration data.

3.4 Results and discussion
MD simulations were used to study the free-state structure and dynamics of
ProTα and the Neh2 domain of Nrf2. The crystal structures revealed that the NEENGE
and DEETGE motifs of ProTα and Neh2, respectively, bind to same site on the Cterminal Kelch domain of Keap1 (50, 55) (Figure 3.1). In particular, both the segments
NEEN and DEET of ProTα and Neh2 occupied positions i through i+3 of their respective
β-turns and adopted highly similar structures in their bound states (Figure 3.1). We
compared the structures of free-state ProTα and Neh2 peptides from the MD simulations
to their corresponding bound-state conformations (50, 55) in order to determine whether
ProTα and Neh2 interact with Keap1 via PSEs or coupled folding and binding
mechanisms. MD simulations on the full-length ProTα protein and a 32-mer Neh2
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peptide were also performed to determine if the residues outside the binding motifs play a
role in binding. Finally, contributing factors to the β-turn propensities of ProTα and Neh2
were investigated through circular variance, Cα-Cα contact, and hydrogen-bond analyses.

Comparison of the free and bound-state structures
We first determined the average distance-based RMSD values (Eq. 1) between the
free-state MD structures of ProTα and Neh2 peptides and their corresponding Keap1
bound-state conformations (Table 3.2). To focus on the turn structure that is crucial for
the Keap1 binding, only the four residues that are involved in the β-turn formation
(NEEN and DEET of ProTα and Neh2, respectively) were included in the following
calculations. The all-atom RMSD values plotted over the trajectories reveal that the βturn segment in the ProTα peptide sampled conformations with ~3 Å RMSD from the
bound-state structure for the majority of the trajectory, and infrequently adopted lower
RMSD (i.e. < 1.0 Å) bound-state like conformations (Figure 3.2A). In contrast, the 9mer Neh2 peptide underwent conformational change between structures with ~1.0 Å and
~2.5 Å all-atom RMSD throughout the trajectory and adopted bound-state like
conformations at multiple periods of time (Figure 3.2A; Video S3.1).

Table 3.2 Average distance-based RMSD values between the bound-state
conformation and the MD structures.
System
Cα (Å) ± sdev
Backbonea (Å) ± sdev All-atom (Å) ± sdev
16-mer ProTα peptide 1.17 ± 0.48
1.13 ± 0.40
2.47 ± 0.62
9-mer Neh2 peptide
1.02 ± 0.66
1.03 ± 0.59
1.73 ± 0.68
b
Full-length ProTα
0.34 ± 0.12
0.44 ± 0.12
1.82 ± 0.25
32-mer Neh2 peptideb 0.18 ± 0.08
0.26 ± 0.07
0.85 ± 0.12
a
Backbone atoms include N, Cα and C.
b
The last 0.1 µs of the trajectory was used in the RMSD calculations.
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Figure 3.2 All-atom RMSD values between the MD and crystal structures.
The RMSD values were computed by subtracting the all-atom distance matrix at
time t of the MD trajectories from the reference distance matrix determined from
the crystal structures of the ProTα and Neh2 peptides bound to Keap1 (PDB ids:
2Z32 and 1X2R respectively) (50, 55). The distance matrices consisted of
residues i through i+3 of the β-turn regions of the ProTα and Neh2 peptides
determined from the crystal structures (50, 55).

Next, we determined if defined β-turns were formed by the free-state peptides. A
good indicator of β-turn formation is that the distance between the Cα atoms of residues i
and i+3 (Cαi-Cαi+3) is less than 7 Å (72). Based on this criterion, ~28% of the structures
from the 16-mer ProTα peptide trajectory adopted a β-turn conformation in that particular
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segment of the sequence, compared to ~53% of the structures from the 9-mer Neh2
trajectory (Figure 3.3A). The same data set was also plotted in terms of deviation from
their corresponding Cαi-Cαi+3 values in the crystal structure (Figure 3.3B). The ProTα
peptide had a single distribution of conformations, with an average Cαi-Cαi+3 deviation of
~2.2 Å from its bound state value (Figure 3.3B). In contrast, the Cαi-Cαi+3 distance
deviations for the Neh2 peptide showed that significant populations of structures had
deviations of <1.0 Å and >3.0 Å (Figure 3.3B). This finding was consistent with the
RMSD data, which showed that the 9-mer Neh2 peptide transitioned between ~1 Å and
~2.5 Å all-atom RMSD throughout the trajectory (Figure 3.2A). Importantly, the RMSD
data and Cαi-Cαi+3 distance distribution of the 9-mer Neh2 indicated that the free-state
conformational ensemble of this peptide consists of both structures that closely resemble
the bound-state β-turn conformation and ones that are comparably extended in that region
(Video S1).
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Figure 3.3 Cαi-Cαi+3 distances and their deviations from their crystal structure
distances.
Panels B and D show the absolute deviations of Cαi-Cαi+3 distances from the
corresponding distances in the crystal structures. Data were collected over the full
1.0 µs trajectories for the crystal structure peptides and the last 0.1 µs for the fulllength ProTα and 32-mer Neh2. Deviations were calculated for Cαi-Cαi+3 pairs
from the β-turns, determined from the crystal structures (50, 55), by subtraction of
the i to i+3 distance at time t of the trajectory from the fixed distance of the
corresponding atom pair from the crystal structures (PDB ids: 2Z32 and 1X2R)
for ProTα and Neh2 respectively) (50, 55).

The above findings also indicate that during the 1-µs simulations, both the 16-mer
ProTα and the 9-mer Neh2 peptides displayed intrinsic propensities of forming boundstate-like β-turn structures in the absence of Keap1. We realized that in the absence of
Keap1, the peptides might not be long enough to form stable structures. To assess the
contributions of residues outside the binding motifs in stabilizing the ß-turn
conformation, MD simulations of the full-length ProTα protein and a 32-mer Neh2
peptide were performed. Structural resemblance to their Keap1-bound states was gauged
by the same parameters as above.
Figure 3.2B shows the distance-based all-atom RMSD values between the MD
structures and the corresponding bound-state crystal structures of full-length ProTα and
the 32-mer Neh2 peptide over 0.5-µs trajectories. Like above, the analyses focused on the
four residues that are involved in the β-turn formation. Interestingly, both the full-length
ProTα protein and the 32-mer Neh2 peptide achieved lower and more stable all-atom
RMSDs than their shorter counterparts (Figure 3.2). Specifically, the full-length ProTα
converged to an all-atom RMSD of ~1 Å after a short period of simulation time despite
having a starting structure with an RMSD ~2.6 Å (Figure S3.1). The values of RMSD
fluctuated between ~0.75-3.75 Å in the first 0.18 µs and then stabilized at an all-atom
RMSD around 2 Å for the remainder of the trajectory (Figure 3.2B). The 32-mer Neh2
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peptide converged to an all-atom RMSD of less than 1 Å in about 0.13 µs and remained
stable around that value for the rest of the trajectory (Figure 3.2B; Video S3.2). It is
worth mentioning that the bound-state-like β-turn conformations formed by the fulllength ProTα and the 32-mer Neh2 peptide closely resembled the ones adopted by their
shorter peptide counterparts (Figure S3.2).
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Figure S3.1 Overlays of the starting structure (grey) and crystal structure (pink) βturns.
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Residues i through i+3 of the β-turns from the starting structures, generated in
CNS (54), were superimposed onto the corresponding residues from their bound
state crystal structures. The RMSD values were computed by subtracting the allatom distance matrix of the starting structures from the reference distance matrix
determined from the crystal structures of the ProTα and Neh2 peptides bound to
Keap1 (PDB ids: 2Z32 and 1X2R respectively) (50, 55). The distance matrices
consisted of residues i through i+3 of the β-turn regions of the ProTα and Neh2
peptides determined from the crystal structures (50,55). The starting structures for
human ProTα and Neh2 were compared to the mouse structures (PDB ids: 2Z32
and 1X2R) (50, 55) as their bound-state references. Hydrogen atoms were added
for clarity.

Figure S3.2 Overlays of the β-turn structures from the 16-mer ProTα and 9-mer
Neh2 MD simulations (white) with those from the longer sequence simulations
(pink).
The RMSD values were computed by subtracting the all-atom distance matrices.
The distance matrices consisted of residues i through i+3 of the β-turn regions of
the ProTα and Neh2 peptides determined from the crystal structures (50, 55).
Centroid structures from the shorter peptide simulations with lowest RMSDs to
the bound state (820-830 ns and 630-640 ns from the ProTα and Neh2
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simulations, respectively) were superimposed onto the corresponding centroid
structures from the last 100 ns of the longer sequence simulations.

The Cαi-Cαi+3 distances were also calculated to appraise the formation of β-turn
structure during the simulations. The results show that during the last 0.1 µs of the fulllength ProTα trajectory, ~66% of the structures have the binding motif in β-turn
conformations (Cαi-Cαi+3 < 7 Å), compared to ~94% of the 32-mer Neh2 peptide
structures (Figure 3.3C). It is noteworthy that both systems showed considerably smaller
deviations from their bound-state Cαi-Cαi+3 distances compared to their shorter
counterparts (Figure 3.3D).
The superpositions of the cluster centroids of β-turn-forming residues from the MD
simulations with their corresponding crystal structure atoms in Figure 3.4 further
illustrate the structural similarities between the free and bound states for both ProTα and
the Neh2 domain. The average distance-based RMSD values between the bound-state
conformation and the MD structures were summarized in Table 3.2. Although both
ProTα and Neh2 had average Cα and backbone RMSDs below 0.5 Å, the RMSDs and
standard deviations increase considerably when all atoms were considered. It is clear that
the side chains were not all in their bound state-like conformations. Figure S3 shows the
distributions of side chain torsion angles in the NEEN and DEET motifs of ProTα and
Neh2, respectively. The results suggest that although the backbones of these two proteins
have strong propensity of forming ß-turn structure, the side chains within the turns are
not restricted in torsion angle samplings. However, it is worthwhile to note that Thr-80 of
Neh2 showed a clear preference for adopting a χ1 angle that closely resembled its bound
state value (Figure S3.3). This is discussed further in the following section.
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Figure 3.4 Overlay of the free and bound-state β-turns.
Residues i through i+3 of the β-turns from the full-length ProTα and the 32-mer
Neh2 MD structures were superimposed onto the corresponding residues from
their bound state crystal structures. Cluster centroids from the last 0.1 µs of the
MD simulations (grey) were superimposed onto the corresponding Cα atoms from
the crystal structures (pink) of ProTα and Neh2 bound to Keap1 (PDB ids: 2Z32
and 1X2R respectively) (50, 55). The single linkage clustering algorithm was
used with a cutoff that included all structures from the last 0.1 µs. Hydrogens
were added to the crystal structures for clarity. RMSD values were computed by
subtracting the Cα, backbone or all-atom distance matrix of the centroid structures
from the reference distance matrix determined from the crystal structures of the
ProTα and Neh2 peptides bound to Keap1 (PDB ids: 2Z32 and 1X2R
respectively) (50, 55).
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Figure S3.3 χ1 and χ2 angles from the MD and bound-state structures.
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Plots of the sidechain χ1 and χ2 angles for residues i to i+3 of the β-turns are
shown. Red dots indicate the angles from the last 0.1 µs of the full-length ProTα
and 32-mer Neh2 trajectories. Black dots indicate the angles from the crystal
structures (PDB ids: 2Z32 and 1X2R) for ProTα and Neh2 respectively) (50, 55).

Contributing factors to the β-turn propensities of ProTα and Neh2
To determine residue-specific convergences of amino acids in the torsion angle
space, backbone dihedral angles of the Keap1-binding β-turns from the MD trajectories
were compared to their corresponding bound-state values. Since ProTα and Neh2
peptides bind to the same site on the Kelch domain of Keap1 and adopt structurally
similar β-turns (Figure 3.1), their bound-state φ and ψ angles are comparable as expected
(Figure 3.5). MD simulations show that, in their free states, both ProTα and Neh2 had
preferences of sampling dihedral angles around their bound-state values (Figure 3.5).
Circular variance (C.V.) measurements were used to quantify the spread of φ and ψ
angles over the last 0.1 µs of the trajectories. Both ProTα and Neh2 had similar C.V. (Eq.
2) values for residues i to i+2, while ProTα displayed a slightly lower circular variance
for residue i+3 compared to that of Neh2 (Figure 3.5). Snapshots over the last 0.1 µs of
the trajectories illustrate that the β-turns of Neh2 and ProTα had limited backbone
flexibilities (Figure 3.5).
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Figure 3.5 Ramachandran plots for residues i to i+3 of the ß-turns from the MD and
crystal structures.
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Red dots indicate the φ and ψ pair from the last 0.1 µs of the full-length ProTα
and the 32-mer Neh2 trajectories. Blue circles indicate the angles of the starting
structures. Green circles indicate the φ and ψ angle pair from the crystal structures
(PDB ids: 2Z32 and 1X2R) (50, 55). Circular variance (C.V.) values and overlaid
licorice representation snapshots from the last 0.1 µs of the simulations illustrate
backbone mobility within the β-turns of ProTα and Neh2. Average circular
variance values were calculated over the last 0.1 µs of the full-length ProTα and
the 32-mer Neh2 peptide MD trajectories using the method described by
MacArthur & Thornton (73).

Contacts between Cα-Cα atom pairs during the last 0.1 µs of the simulations were
also examined. The contact plots and structures from the MD simulations show that the
β-turns formed by ProTα and Neh2 at their Keap1-binding sites stretched out in both
directions to form antiparallel β-sheets (Figure 3.6). This finding was in good agreement
with previous NMR results, which suggest that residual structures may exist in regions
surrounding the Keap1-binding motifs of disordered ProTα and Neh2 (46, 78).
Interestingly, Neh2 has relatively higher 1H-15N heteronuclear NOE values in its Keap1binding region, indicating a less dynamic free-state (46). Furthermore, chemical shift
index values indicative of β-strand structure and the observance of 1H, 1H NOEs between
the adjacent strands also evidence that residues on either side of the ETGE motif of Neh2
form a short β-sheet (46). Tong et al. suggested that interactions between the
hydrophobic residues (Phe-74, Leu-76, Phe-83, and Pro-85) located on the β-strands may
stabilize the antiparallel β-sheet structure (46). This proposal is supported by the ITC data
showing that a long Neh2 segment containing the ETGE motif bound to the Kelch
domain of Keap1 with higher affinity than the 9-mer peptide used in the current study
(Kd≈8 nM vs Kd≈182 nM) (46). Similarly, Lo et al. (79) demonstrated that human Nrf2derived 14-mer (LQLDEETGEFLPIQ) or 16-mer (AFFAQLQLDEETGEFL) peptides
could compete with full-length Nrf2 for binding to Keap1 much better than a 10-mer
peptide (LDEETGEFLP). Their ITC measurements showed that the human 16-mer Nrf2
peptide binds to the Kelch domain of Keap1 with Kd≈20 nM, an affinity similar to that of
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the mouse homolog (79).

Figure 3.6 Cα-Cα contacts in the MD structures.
A) Average Cα-Cα distances over the last 0.1 µs of the full-length ProTα and 32mer Neh2 MD trajectories. Distances equal to or greater than 10 Å are colored
dark red and distances equal to or less than 2 Å are colored dark blue. The CαiCαi+3 atoms of the β-turns are indicated by the black boxes. B) Cartoon B-Spline
representations colored by residue type of ther Keap1 binding regions of fulllength ProTα and 32-mer Neh2 cluster centroids from the last 0.1 µs of the MD
simulations. The single linkage clustering algorithm was used with a cutoff that
included all structures from the last 0.1 µs. Residues comprising the XEEXGE
Keap1-binding motifs are labeled. Directionality is indicated with the N and C
labels.
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In this work, we have measured the binding affinities of mouse 16-mer ProTα and
9-mer Neh2 peptides to the Kelch domain using ITC (Table 3.3; Figure S3.4). The large
and negative entropy changes of 16-mer ProTα and 9-mer Neh2 peptides upon binding to
Keap1 (Table 3.3) clearly reflect the significant reduction in conformational entropy of
the peptides due to the disorder-to-order transition upon binding. Even though the 16-mer
ProTα and the 9-mer Neh2 peptides have similar binding affinity to the Kelch domain,
the former interacts more weakly with Keap1 compared to the Neh2 peptide with the
same length (79). This observation is in good agreement with the lower propensity of the
ß-turn formation in ProTα that is critical for the binding revealed by our MD simulations.
It is noteworthy that unlike Neh2, ProTα lacks comparable hydrophobic content in the
region surrounding the Keap1-binding motifs (Table 3.1). The deficiency in hydrophobic
interactions may also account for the lower binding affinity between ProTα and Keap1.

Table 3.3 Thermodynamic parameters for the binding of ProTα and Neh2 peptides
to the Kelch domain of Keap1.
Peptide
na
Ka b
∆Hb
T∆Sb
∆Gb
6
-1
(10 M )
(kcal/mol)
(kcal/mol) (kcal/mol)
16-mer ProTα peptide 1.03 2.4 ± 0.1
-18.9 ± 0.1
-10.20
-8.70 ± 0.02
9-mer Neh2 peptide
1.02 3.7 ± 0.1
-19.0 ± 0.1
-10.05
-8.95 ± 0.02
a
Binding stoichiometry
b
Ka is the binding constant. ∆H, ∆S and ∆G are the change in enthalpy, entropy and
Gibbs free energy upon binding (at temperature T=298 K), respectively.
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Figure S3.4 Isothermal titration calorimetry (ITC) measurements.
Panels A and B correspond to titrations of 16-mer ProTα and 9-mer Neh2 peptide
to the mouse Kelch domain of Keap1, respectively. (Upper) The raw data of two
ITC experiments each performed at 25° C. (Lower) The integrated heat changes,
corrected for the heat of dilution, and the fitted curve assuming single-site
binding.

Hydrogen bond analysis was conducted to help explain why the β-turns of ProTα
and Neh2 converged to their bound state structures to different extents. Inspection of the
MD structures from the last 0.1 µs of the simulations reveal that ProTα and Neh2 had
different occurrence frequencies of hydrogen bonds within their Keap1-binding β-turns
(Table 3.4). ProTα had at least one hydrogen bond present in only 14.3% of the
structures, compared to a frequency of 98.6% for Neh2 (Table 3.4). The main differences
arose from increased i to i+3 and, to a lesser extent, i to i+2 intra-turn hydrogen bonding
in Neh2 compared to ProTα. For instance, hydrogen bonding between the side chains of
Asp-77 and Thr-80 was observed in ~80% of the Neh2 structures, while the
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corresponding side chain hydrogen bonding between Asn-41 and Asn-44 of ProTα was
not observed in the MD trajectory (Table 3.4). The involvement of Thr-80 in intra-turn
hydrogen bonds may explain why its χ1 angle closely resembled its bound state value
(Figure S3). Furthermore, hydrogen bonding between the side chain of Asn-41 and the
main chain of Asn-44 was observed in only 6.7% of the ProTα conformations, while, in
the Neh2 trajectory, over 77.5% of the conformations were found to have hydrogen
bonding between the side chain of Asp-77 and the main chain of Thr-80 (Table 3.4). In
addition, the side chain of Asp-77 and the main chain of Glu-79 in Neh2 also form
hydrogen bond more frequently compared to the corresponding residues in ProTα (55%
vs 0.4%) (Table 3.4). The result of this analysis suggested that the greater number and
more frequent intra-turn hydrogen bonds formed by Neh2, particularly between the i and
i+3 residues, may explain why it adopts more stable bound-state-like structure than
ProTα. Interestingly, this finding qualitatively agrees with the difference in the residuespecific turn potentials for the β-turns of ProTα and Neh2. Using a table of overall turn
potentials for each amino acid determined by Hutchinson & Thornton (80), the turn
potentials for residues in the i to i+3 positions were summed. The NEEN and DEET
sequences of Neh2 and ProTα had turn potentials of 4.87 and 5.03 respectively. The
lower value for ProTα compared to Neh2 arose partly due to asparagine being slightly
disfavored in position i compared to aspartic acid, but mainly because threonine was
considerably more favored in position i+3 than asparagine.
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Table 3.4 Frequencies of intra-turn hydrogen bond formations.
Atom involved
Full-length ProTαa 32-mer Neh2a
b
mc i to mc i+2
0.196%
mc i to mc i+3
3.844%
mc i to sc i+3
27.808%
mc i+2 to sc i+3 0.284%
0.204%
c
sc i to mc i+2
0.396%
55.368%
sc i to mc i+3
6.696%
77.524%
sc i+1 to mc i+2
0.428%
sc i to sc i+3
80.212%
sc i+2 to sc i+3
7.316%
0.572%
Intra-turn total
14.348%
98.644%
a
Each frame from the last 0.1 µs of the mouse full-length ProTα and 32-mer Neh2
trajectories were used for the hydrogen bond calculations (25,000 structures). A
hydrogen bond between a hydrogen donor (D-H) and a hydrogen acceptor (A) was
judged to be formed when the DA distance (r) was less than 3.2 Å and the angle
between the DA vector and the D-H bond (AD-H angle) was less than 35°. For
clarity, only hydrogen bonds occur in more than 0.1% of the structures are listed
and intra-residue hydrogen bonds are excluded.
b
mc – main chain atoms
c
sc – side chain atoms

As shown in Table 3.4, a large fraction of the intra-turn hydrogen bonds formed by
Neh2 involve Thr-80. Studies reveal that mutating Thr-80 of Neh2 to alanine disrupts the
interaction between these two proteins, making Nrf2 resistant to Keap1 mediated
degradation. In contrast, a T80S mutant, which has the side chain hydroxyl group
retained, behaved similarly to the wild type (79). Interestingly, the phosphorylation of
Thr-80 has also been shown to severely decrease binding of Neh2 to Keap1 (79). The
authors suggested that the negative charge introduced by the phosphorylation may disrupt
the β-turn formation, preventing Neh2 from adopting a complementary structure to the
binding site of Keap1 (79).
The attenuation of Keap1 binding when Thr-80 is mutated to alanine is likely due
to the disruption of the β-turn structure. This idea is reinforced by our findings, which
showed that the side chain of this residue is involved in the majority of intra-turn
hydrogen bonds in the free state (Table 3.4). Moreover, residue-specific turn potential
calculation also indicates that when the DEET sequence of Nrf2 is mutated to DEEA, the
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turn potential falls below that of the ProTα sequence to 4.72. Therefore, Thr-80 may act
as a function switch, allowing Nrf2 activity to be regulated efficiently by phosphorylation
(79, 81).

Comparison of the mouse and human simulations
Finally, MD simulations were performed on the human homologs of full-length
ProTα and the 32-mer Neh2 peptide (Table 3.1). The sequence alignments (Figure S3.5)
indicate that there is a large percentage of sequence identity between the human and
mouse versions of ProTα and Neh2. The human isoform 2 of ProTα used in this study
contains 110 residues, which is shorter than the corresponding mouse sequence by one
amino acid. The deletion site is located near the Keap1 binding region, immediately
before the NEEN sequence. Besides the deletion, the human and mouse ProTα sequences
are differ in only 5 other positions (Figure S3.5). For the 32-mer Neh2, there are three
substitutions in the human sequence; one of them is located three residues upstream of
the DEET ß-turn. The MD simulations of human ProTα and Neh2 therefore serve as
pseudo duplicates of the mouse trajectories owing to the high sequence identities between
the human and mouse versions of these two proteins. Moreover, the single-residue
changes (deletion in ProTα and substitution in Neh2) close to the ß-turn sequences also
allowed us to gauge the effects of mutations on the simulations.
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Figure S3.5 Sequence alignments of the mouse and human full-length ProTα and 32mer Neh2 constructs generated using ClustalW XXL.
The Blosum scoring matrix was used and gap penalties were set at their default
values. Opening and end gap penalties were set to 10. Extending and separation
gap penalties were set to 0.05.

The structure of a 16-mer human Neh2 peptide bound to human Keap1 (PDB id:
2FLU) (79) was compared to the structure of mouse Neh2-Keap1. Average distancebased RMSD calculations show that the residues comprising the β-turns in human and
mouse Neh2 peptides adopt almost identical structures, with a backbone RMSD less than
0.1 Å in the bound-states (55, 79). For ProTα, the crystal structure of human ProTαKeap1 was not currently available. Therefore, for consistency, in the following
calculations, we continued to use the mouse structures (PDB ids: 2Z32 and 1X2R) (50,
55) as the bound-state references for the human MD data.
Due to the intrinsically disordered nature of ProTα and Neh2, the initial structures
used for the simulations are not well-defined. To avoid the potential bias of
conformational sampling, starting structures used in the MD simulations of human ProTα
and Neh2 were different from that used for the mouse. Considering the residues
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comprising the β-turns, the all-atom RMSDs between starting structures for the human
and mouse sequences were 2.41 Å and 2.48 Å for the full-length ProTα proteins and the
32-mer Neh2 peptides, respectively.
Like the mouse versions, the β-turns of the human full-length ProTα and the 32-mer
Neh2 peptide also converged to bound-state-like structures by the end of the trajectories
(Figure S3.6). In the last 0.1 µs of the trajectories, both ProTα and Neh2 had Cαi-Cαi+3
distance deviations around 1 Å from their mouse bound-state distances, with Neh2
having slightly closer Cαi-Cαi+3 contacts (Figure S3.7). Interestingly, the 32-mer human
Neh2 peptide adopted structures with about the same all-atom RMSDs to the bound-state
conformation after a similar amount of simulation time compared to the mouse version
(Figure S3.6 and Figure 3.2B). Meanwhile, the human ProTα was able to adopt structures
with a lower all-atom RMSD to its bound state compared to its mouse counterpart (Figure
S3.6 and Figure 3.2B).

Figure S3.6 All-atom RMSD values between the MD and crystal structures.
The RMSD values were computed by subtracting the all-atom distance matrix at
time t of the MD trajectories from the reference distance matrix determined from
the crystal structures of the ProTα and Neh2 peptides bound to Keap1 (PDB ids:
2Z32 and 1X2R respectively) (50, 55). The distance matrices consisted of
residues i through i+3 of the β-turn regions of the ProTα and Neh2 peptides
determined from the crystal structures (50, 55).
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Figure S3.7 Cαi-Cαi+3 distances and their deviations from their crystal structure
distances.
Panels A and B show the Cαi-Cαi+3 distances and the deviations from the
corresponding distances in the crystal structures respectively. Data was collected
over the last 0.1 µs of the full-length human ProTα and human 32-mer Neh2
trajectories. Deviations were calculated for Cαi-Cαi+3 pairs from the β-turns,
determined from the mouse crystal structures (50, 55), by subtraction of the i to
i+3 distance at time t of the trajectory from the fixed distance of the
corresponding atom pair from the crystal structures (PDB ids: 2Z32 and 1X2R)
for ProTα and Neh2 respectively) (50, 55).
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The hydrogen bond analysis showed that, like the mouse homolog, human ProTα
formed i to i+3 hydrogen bonds less frequently compared to Neh2 (Table S3.1). For
instance, hydrogen bonding between the side chains of Asn-40 and Asn-43 was observed
in 24.2% of the ProTα structures compared to 63.7% for the corresponding Asp-77 and
Thr-80 pair in Neh2 (Table S3.1). Furthermore, hydrogen bonding between the side chain
of Asn-40 and the main chain of Asn-43 was observed in 61.3% of the ProTα
conformations compared to 74.5% for the corresponding Asp-77 and Thr-80 pair in Neh2
(Table S3.1). The results from the human systems reinforce the notion that i to i+3
hydrogen bonding between Asp-77 and Thr-80 of Neh2 might be more preferable than
the corresponding Asn pair in ProTα.

Table S3.1 Frequencies of intra-turn hydrogen bond formations
Atoms involved Full-length ProTαa
32-mer Neh2a
mc i to mc i+2
85.124%
0.16%
mc i to mc i+3
1.744%
mc i to sc i+3
15.884%
mc i+1 to sc i
1.708%
mc i+1 to sc i+2
0.56%
sc i to mc i+2
6.828%
49.164%
sc i to mc i+3
61.272%
74.504%
sc i+1 to mc i+2
0.328%
sc i+2 to mc i+3 0.112%
sc i to sc i+3
24.172%
63.74%
sc i+2 to sc i+3
0.14%
0.536%
Intra-turn total
96.844%
95.248%
a
Each frame from the last 0.1 µs of the human full-length ProTα and 32-mer Neh2
trajectories were used for the hydrogen bond calculations (25 000 structures). A
hydrogen bond between a hydrogen donor (D-H) and a hydrogen acceptor (A) was
judged to be formed when the DA distance (r) was less than 3.2 Å and the angle
between the DA vector and the D-H bond (AD-H angle) was less than 35°. For
clarity, only hydrogen bonds occur in more than 0.1% of the structures are listed
and intra-residue hydrogen bonds are excluded.
b
mc – main chain atoms
c
sc – side chain atoms

Unlike the high similarities between the simulations of the mouse and the human
Neh2, the intra-turn hydrogen bonding patterns of the human and mouse versions of
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ProTα were less consistent (Tables 3.4 and S3.1). Higher occurrences of hydrogen
bonding between the main chains of i and i+2 residues, as well as between the side chain
and main chain of i and i+3 were found in human ProTα. We speculate that the
discrepancies reflect lower simulation convergence due to the less restricted
conformation sampling of free-state ProTα (78). However, the influence of starting
structures and sequence differences cannot be ruled out. Further experimental studies are
required to validate these findings.

3.5 Conclusion
In this work we have investigated how ProTα and Neh2 interact with a common
binding partner, the Kelch domain of Keap1 using 0.5-1.0 µs MD simulations. Our main
findings are that the XEEXGE Keap1 binding motifs of ProTα and Neh2 in their free
states possess propensities to form bound-state-like structure to different extents. Neh2
was found to form a defined β-turn more frequently than ProTα and had lower RMSD to
its bound state conformation. This may be attributed to a larger number of and more
stable intra-turn hydrogen bonds. In particular, hydrogen bonding between Asp-77 and
Thr-80 of Neh2 might be more preferable than the corresponding Asn pair in ProTα.
However, we cannot rule out that other factors, such as the lack of comparable
hydrophobic content surrounding the Keap1 binding region of ProTα. This may also
contribute to the more dynamic nature of ProTα and its lower propensity for adopting
bound-state-like conformations.
Addressing whether ProTα and Neh2 bind to Keap1 through PSEs, coupled
folding and binding or a combination of both mechanisms was challenging. To conclude
that binding occurs via PSEs, the free and bound state conformations would have to be
highly similar or identical. The definition of being highly similar can be ambiguous,
while restricting the definition to identical structures seems too stringent. In any proteinprotein interaction there are likely to be a certain amount of structural changes upon
binding. In this case, the backbone atoms of the β-turns overlay well with the crystal
structure backbones, especially for Neh2. However, the side chain orientations of some
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residues show considerable differences. It is clear that both mechanisms are at work to
different extents. Because our data shows that the Keap1 binding regions of ProTα and
Neh2 tend to form β-turns that have an obvious resemblance to their bound state
conformations, we propose that binding occurs synergistically via a combination of PSEs
and coupled folding and binding with a heavy bias towards PSEs, especially for Neh2.
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4.2 Abstract
In the protein interactome, there are a small number of proteins with high
connectivity. These proteins are commonly referred to as hubs, and are essential for
interactome functionality and integrity. By combining experimental and computational
approaches, we identified the Kelch domain of Keap1 as a crucial hub for binding
intrinsically disordered proteins (IDPs) in oxidative stress response and apoptosis. Keap1
regulates transcriptional activity of nuclear factor erythroid 2-related factor 2 (NRF2), a
master regulator of cytoprotective gene activation in the oxidative stress response
pathway. Disorder predictions suggest that the majority of proteins that interact with the
Kelch hub are intrinsically disordered in their binding regions. These targets share similar
binding motifs, but have a wide range of binding affinities, spanning more than 2 orders
of magnitude. Using nuclear magnetic resonance spectroscopy and molecular dynamic
simulations, the major factors that govern the binding affinity and specificity of different
disordered targets to the Kelch hub were determined. Good correlations (r2 > 0.75)
between the binding free-energy and protein dynamics and hydrophobicity were found.
The results indicate that the binding affinity of different disordered targets to the Kelch
hub is largely determined by the extent of preformed bound-state like conformation in
their free-state structures. Based on the knowledge acquired, we have designed a highbinding affinity peptide that can specifically disrupt the Keap1-NRF2 interaction and has
the potential for therapeutic applications. Overall, the work demonstrates a simple yet
effective methodology for structurally characterizing IDP-protein interactions.
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4.3 Introduction
Protein-protein interactions are the foundation upon which cells carry out their
functions. Characterizing the interaction network is crucial for determining the functions
of individual proteins, and identifying signaling pathways and their interconnections (16). Some proteins have much higher connectivity relative to the others. These proteins are
referred to as hubs (1, 7-11). It is common for a protein to interact with a few targets but
hubs, which may have tens to hundreds of network connections, are rare in comparison
(6, 7, 12). Their ability to interact with numerous partners is thought to be essential for
network functionality and stability. Because of the critical roles they play, disruption of
hub interactions in the human protein interaction network are frequently associated with
diseases (5, 13, 14).
The structural plasticity of IDPs is a crucial feature allowing them to interact with
numerous different partners (15-19). Therefore, these proteins are frequently found to
function as hubs. Interestingly, there are also examples of ordered hubs that interact
almost exclusively with disordered partners (15, 18, 20-22). In contrast to protein-protein
interactions between globular proteins, which usually involve larger interaction surfaces
that are discontinuous in sequence, IDPs typically bind to ordered hubs using short (~6
residues) consecutive stretches of amino acid residues called linear motifs (LMs) (23-27).
For example, the 14-3-3 family is one of the most studied hubs for IDPs. These are ~30
kDa dimeric proteins that adopt rigid structures capable of binding hundreds of ligands,
which together may comprise 0.6% of the human proteome (18, 20, 22, 28-30). These
interactions are involved in important cellular functions such as catalysis, regulation and
localization (22, 29, 30). It is estimated that over 90% of the 14-3-3 binding partners are
completely or partially disordered (20, 22). Binding is governed by phosphoserine and
phosphothreonine containing motifs on the partners. Several distinct consensus motifs
(modes), with varying binding affinities, have been discovered across the broad spectrum
of 14-3-3 ligands (28, 29). In addition to phosphorylation of 14-3-3 binding motifs, the
presence of structurally constrained anchor residues outside of the motifs are thought to
play important roles in the stability and specificity of the interactions (31). Another
established hub with a preference for binding disordered partners is the N-terminal β-
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propeller domain (TD) domain of clathrin. Interactions between this hub and several
disordered partners, including amphiphysins, AP180 and SNX9 have been demonstrated
(32, 33). Using NMR, AP180 was found to be largely unstructured in free and clathrin
bound states. Residues comprising the two clathrin binding motifs of AP180 had limited
β-turn structures in their free and bound states and are more restricted in dynamics
relative to their surrounding regions (33). Binding partners that remain dynamic in their
free and bound states have been described to form ‘fuzzy’ complexes. Such complexes
are thought to be important where specific, yet reversible binding is required (34-36).
Because LMs along an IDP sequence often represent potential target binding
motifs, there have been considerable efforts towards identifying them (19, 23, 24, 37).
The majority of work has been to detect motifs from sequences. Linear motifs often have
distinct sequence characteristics compared to their surroundings, with the primary
difference being an increased hydrophobic content (38), which may promote local
structure formations. Such preformed structural elements often resemble their bound state
conformations (39-42). A major hindrance in accurately detecting LMs with preformed
structures or conformational propensity is a lack of free state structure data. Such
information would provide unique insights into the relationships between sequence and
structure, which could be used to verify and improve bioinformatics predictions of LMs.
Another impeding factor in identifying, characterizing and comparing LMs is
inconsistency in methods. For instance, to determine binding affinities and bound state
structures, peptides containing the LM are frequently used. This is reasonable for IDPs
because binding is typically a local event. However, because different binding partners
for a given hub are typically discovered by different groups, there is often a lack of
consistency in peptide lengths, alignments of LMs, organisms, buffers, methods, etc,
which can be problematic if one wants to compare all binding partners simultaneously.
While there are clear benefits of combining experimental data and predictive methods to
predict and characterize LMs, variability in methods, experimental techniques can make
it difficult to perform fair comparisons.
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In this study, we have used bioinformatics tools for disorder prediction,
isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy,
and molecular dynamic (MD) simulations to systematically characterize the interactions
between Kelch-like ECH-associated protein 1 (Keap1), an ordered hub protein, and all of
its known (to date) disordered partners that bind to the Kelch domain of the protein
(Figure 4.1A). Keap1/NRF2 pathway is essential for regulating the cellular response to
oxidative stress (43, 44). The Kelch domain is a ~32 kDa β-propeller located near the Cterminus of Keap1. To date, 9 different proteins have been shown to interact with it and
most of them share similar ‘GE’-containing motifs (Figure 4.1A). Scrutinizing the
mechanisms they employ to interact with the Kelch domain is essential for understanding
their functions. It will also provide insight into how the Kelch domain tasks as a hub for
disordered proteins in the oxidative stress response, and possibly other biological
processes. Our study illustrates that by using a systematic approach based on a
combination of experimental and computational methods, one can obtain unique insights
into factors regulating the affinities and specificities of interactions of disordered partners
with ordered hub proteins. Our approach should be generally applicable to investigate the
binding mechanisms of other systems involving disordered LMs.
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Figure 4.1 Sequence analysis of the Kelch domain interacting proteins.
Sequence analysis of the Kelch domain interacting proteins. A) Manual sequence
alignment and sequence logos of the site 1- and site 2-type regions of the Kelch
domain binding proteins (91-93). B) Residue type fractions of the sequences. A,
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F, I, L, M, P, V and W are hydrophobic; C, G, N, Q, S and T are polar; D and E
are acidic; K, H and R are basic

4.4 Materials and methods
Expression and purification of the human Kelch domain
The Kelch domain of human Keap1 (residues 321-609), subcloned into the pET15b
expression vector (from Dr. Mark Hannink, University of Missouri-Columbia), was
expressed as an N-terminally His-tagged protein in Escherichia coli BL21 (DE3) and
grown in minimal M9 medium. Protein expression was induced by addition of 0.5 mM
IPTG at 18ºC for 24 h. The protein was purified from the crude cell lysate by affinity
chromatography using Ni Sepharose™ 6 Fast Flow beads (Amersham Biosciences). The
His-tag was then cleaved by incubation with human α-thrombin (Haematologic
Technologies Inc.) overnight at 4ºC. The Kelch domain was purified from the cleavage
mixture using a HiLoad Superdex-75 size-exclusion column (GE Healthcare) equilibrated
with 50 mM sodium phosphate buffer, 100 mM NaCl, 1 mM DTT at pH 7.

Kelch domain interacting peptides
Peptides from the various site 1-type Kelch domain interacting proteins (Figure
4.1A) were synthesized (Tufts peptide synthesis). The sequences were manually aligned
at their Kelch domain binding motifs, and extended on either side, up to 20 residues
(Figure 4.1A). Because the sequences were from the interior regions of their respective
proteins, acetyl and NH2 groups were added on their N- and C-termini, respectively.
IKKβ peptide was excluded from this study because its Kelch domain interacting region
is located in a structured region of the protein (65). A WTX peptide with S286
phosphorylated was also synthesized. Phosphorylation of this residue has been
demonstrated to occur in vivo (45). Two peptides were synthesized for PTMA, one for
each isoform. The only difference between the two isoforms (in the full length proteins)
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is the absence of E40 in isoform 2 (Figure 4.1A); therefore, the PTMA isoform 2 peptide
was only 19 residues long. The peptides were dialyzed into 50 mM sodium phosphate
buffer at pH 7 containing 100 mM NaCl and 1 mM DTT before use.

Isothermal titration calorimetry (ITC) experiments
ITC experiments were carried out on a VP-ITC instrument (MicroCal) at 25ºC. The
protein and peptide samples were dialyzed into a buffer containing 50 mM sodium
phosphate, 100 mM NaCl, 1 mM DTT at pH 7 and degassed before the experiments. ~40
µM Kelch was added to the 1.4 mL sample cell and subjected to stepwise titration with 5
µL aliquots of ~500 µM peptide. The equilibration period between each injection was
300 seconds. The association constant (Ka), molar binding stoichiometry (n) and the
binding enthalpy (∆H), entropy (∆S) and Gibbs free energy (∆G) were determined by
fitting the binding isotherm to a single-binding-site model with Origin7 software
(MicroCal). The heat changes after saturation were averaged and used to correct for the
heats of dilution. All ITC experiments were performed in duplicate.

NMR spectroscopy
NMR experiments were performed on a 600 MHz Varian INOVA spectrometer
(UWO Biomolecular NMR Facility). The peptide samples were prepared at a
concentration of ~3 mM in a buffer containing 50 mM sodium phosphate, 100 mM NaCl,
1 mM DTT at pH 7.0. All samples contained 10% D2O and trace 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) for 1H chemical shift referencing. The experiments were
conducted at either 25 or 10ºC. Two-dimensional 1H-1H TOCSY and NOESY spectra
were collected with spectral widths of 8000 Hz in both dimensions. WATERGATE
solvent suppression was employed (82). TOCSY spectra were recorded with a 50 ms spin
lock time. NOESY spectra were collected with a mixing time of 200 ms. The TOCSY
and NOESY experiments were acquired using 4096 points with 256 increments.
Sequential assignments for each peptide were obtained using the TOCSY and NOESY
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spectra along with a natural abundance 1H-15N HSQC spectrum. All NMR data was
processed with NMRPipe (83).

MD simulations
The amino acid sequences of all simulated peptides were the same as those used
in the ITC experiments (Figure 4.1A and Table 4.1). We used the Crystallography &
NMR System (CNS) (84) to generate an extended structure from each sequence.
Simulated annealing was performed on each extended structure and resulting
conformations that did not resemble the Neh2 domain site 1 region bound to the Kelch
domain (PDB id: 2FLU) were used as starting structures (51). The N- and C-terminus of
each structure was capped with acetyl (ACE) and NH2 groups, respectively, using
chimera (85). For the WTX peptide with S286 phosphorylated (WTX pS286), a dianionic
phosphate group (PO42-) was modeled onto S286 of the non-phosphorylated WTX
peptide structure.
The MD simulations were performed using GROMACS (GROningen MAchine
for Chemical Simulations) version 4.5 (86). All chemical species were represented by the
GROMOS96 53a6 force field (87, 88), except in the WTX pS286 peptide simulation,
where the GROMOS96 43a1p (89) force field was used. The starting structures were
solvated in cubic boxes of linear size 6 nm with periodic boundary conditions applied in
all directions. The SPC (simple point charge) water model was used (90). Protonation
states of all ionizable residues were chosen based on their most probable state at pH 7.
Histidine residues were protonated on ND1 only. Each system was neutralized and
brought to an ionic strength of 0.1 M with sodium (Na+) and chloride (Cl-) ions. The
simulations were performed using similar protocols as described in (39). System
coordinates were written out at 4 ps intervals and each simulation was run for at least 1
µs, for a cumulative simulation time of 15 µs. The systems are summarized in Table 4.1.
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Table 4.1 Summary of the MD simulations.
Protein
Sequence
NRF2 site 1 Ac-FAQLQLDEETGEFLPIQPAQ-NH2
PGAM5
Ac-INVRKRNVESGEEELASKLD-NH2
p62
Ac-LSSKEVDPSTGELQSLQMPE-NH2
WTX
Ac-SLEEPHSPETGEKVVAGEVN-NH2
WTX pS286 Ac-SLEEPHpSPETGEKVVAGEVN-NH2
FAC1
Ac-SAKAADDPENGERESHTPVS-NH2
PALB2
Ac-HIKTHLDEETGEKTSITLDV-NH2
PTMA
Ac-ANGNAENEENGEQEADNEVD-NH2
isoform 1
PTMA
Ac-ANGNANEENGEQEADNEVD-NH2
isoform 2
IKKβ
Ac-NVIRWHNQETGEQIAIKQCR-NH2
NRF2 site 2 Ac-MDLIDILWRQDIDLGVSREV-NH2
BCL2
Ac-LNRHLHTWIQDNGGWDAFVE-NH2
NRF2 site 1 Ac-FAQLQLDPETGEFLPIQPAQ-NH2
E78P

Water & ions
7007, 17 Na+, 13 Cl7019, 14 Na+, 13 Cl7012, 16 Na+, 13 Cl7017, 17 Na+, 13 Cl7010, 19 Na+, 13 Cl7024, 16 Na+, 13 Cl7019, 16 Na+, 13 Cl7020, 21 Na+, 13 Cl7022, 20 Na+, 13 Cl7005, 13 Na+, 14 Cl7008, 16 Na+, 13 Cl7001, 15 Na+, 13 Cl7013, 16 Na+, 13 Cl-

4.5 Results and discussion
We have used a multidisciplinary approach involving bioinformatics, ITC, NMR
and MD simulations to compare the sequences, binding parameters and free state
structures of all Kelch domain interacting proteins identified to date. The study builds
upon the findings from numerous investigations of Kelch domain interacting proteins (43,
45-59). While these protein-protein interactions have been identified, they have not all
been thoroughly characterized and compared. Our study provides new insights into the
relationship between sequence and structure in governing the binding affinity of the
different targets to the hub protein Keap1. The findings will be useful in delineating the
binding mechanisms of the different proteins – crucial information for understanding
their biological roles. Importantly, our approach is generally applicable for investigations
of the binding mechanisms of other systems involving disordered proteins.

Kelch domain interacting proteins are predominantly disordered
The Neh2 domain of NRF2 is responsible for mediating the interaction with the
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Kelch domain of Keap1. Structural studies have shown that Neh2 is intrinsically
disordered (57, 58). It has high and low affinity ‘ETGE’ and ‘DLG’ containing Kelch
domain binding regions, respectively, which will be referred to as sites 1 and 2,
respectively hereafter (57, 58). These sites are located on separate ends of the ~100
residue Neh2 domain, connected by a segment with high helical propensity (57). When
both sites are bound to two separate Kelch domains, NRF2 is ubiquitinated, which targets
it for proteasomal degradation (58). When only site 1 is bound, NRF2 avoids the
degradation pathway and can promote expression of its target genes (58).

Several proteins have been shown to disrupt the low affinity site 2-Kelch domain
interaction, allowing NRF2 to promote cytoprotective gene expression. These proteins
include PGAM5, p62, WTX and PALB2 (45, 48, 50, 52). In addition, FAC1 (56), PTMA
(54, 60), IKKβ (47, 49) and BCL2 (53) can also bind to the Kelch domain. PTMA is a
highly disordered protein that functions as a vehicle for shuttling Keap1 into the nucleus
(60-62). The purposes of the other protein-protein interactions are currently under
intensive investigations (44, 63). Most of the Kelch domain interacting proteins contain
sequences resembling the site 1 sequence of the Neh2 domain (Figure 4.1A) and will be
referred to as site 1-type proteins hereafter. The one exception is BCL2, which contains a
site 2-type sequence and will be referred to as a site 2-type protein (Figure 4.1A).
Although not included in this study, because it does not appear to be directly linked to the
oxidative stress response or apoptosis, myosin-VIIa has also been shown to interact with
Kelch (64). It is worthwhile to mention that the region of human myosin-VIIa capable of
binding Kelch includes a site 1 type sequence 1635LDHDTGE1641.

Structural information of only a few of the Kelch domain interacting proteins is
currently available. Crystal structures of PTMA and p62 peptides in complex with the
Kelch domain show that their site 1-type motifs bind to the same region as the NRF2 site
1 region and form similar β-hairpin structures in their bound states (48, 51, 54, 55). In its
unbound state, the NRF2 site 1 region contains a short β-sheet structure, which is thought

133

to contribute to its higher binding affinity compared to the site 2 region (39, 40, 57). Our
previous MD simulations showed that, in their free states, the NRF2 site 1 region and the
site 1-type region of PTMA formed β-hairpin structures that resembled the bound state
structure to different extents, with NRF2 forming a more defined hairpin that had a closer
resemblance to its bound state structure compared to PTMA (40). Although the structure
of a p62 peptide bound to the Kelch domain has been determined (48), its free state
structure has not been examined and it is not known if it may also contain residual
structure in its Kelch domain interacting region. Additionally, a homology structure of
the IKKβ kinase domain, in the absence of the Kelch domain, illustrates that its site 1type motif also adopts a β-hairpin conformation (65).

Based on the amino acids sequences of the various proteins (Figure 4.1A), we
found that intrinsic disorder in the Kelch domain binding regions of the site 1-type
binders may be a common attribute. NRF2 site 1 and PALB2 had PONDR-FIT (66)
disorder tendencies of 0.50 or higher, while p62, WTX, FAC1 and PTMA had tendencies
>0.70 (Figure S4.1). Furthermore, p62, WTX, FAC1 and PTMA are predicted to have
long stretches of disorder around their binding regions (Figure S4.1). PGAM5 and IKKβ
were the only site 1-type proteins with predicted disorder tendencies <0.5 (Figure S4.1).
The binding region of PGAM5 (Figure 4.1A) had an average PONDR-FIT score of 0.36,
but scored 0.59 when the metaPrDOS predictor was used (67). PONDR-FIT predicted
that the N-terminal portion of PGAM5 is largely disordered, while the C-terminal is
structured (Figure S4.1), suggesting that the Kelch domain binding region of PGAM5 is
located on the border of a disordered region and structured domain. This notion is
supported by the X-ray crystal structure of the C-terminal PGAM5 domain (PDB id:
3MXO), beginning at D90 (Figure 4.1A). The binding region of IKKβ is predicted to be
in a structured part of the protein (Figure S4.1), which is consistent with the homology
model (65) that illustrates that it is a well-folded protein (Figure 4.2). The site 2-type
binders were predicted to have disorder tendencies of 0.40 for NRF2 and 0.07 for BCL2
(Figure S4.1). The predicted low disorder tendency of BCL2 was not surprising because
its binding region is found in a well-folded part of the protein (68) (Figure 4.2). We also
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used the MoRFpred server (69) to identify if the Kelch domain interacting regions of the
various proteins are predicted to contain molecular recognition features (MoRFs). NRF2
site 1, PTMA and NRF2 site 2 were the only partners that were predicted to contain
MoRFs at their binding sites (Figure S4.1). However, it is noteworthy that these two
proteins were included in the training dataset of MoRFpred (69). Data presented
throughout this work may be useful for further improving this predictive tool. Overall,
the results suggest that while both intrinsically disordered and well-folded polypeptide
segments are able to bind to the same interaction surface of the Kelch domain, the
majority of the partners (identified to date) are disordered.
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Figure S4.1 Disorder and MoRF predictions of the Kelch domain interacting
proteins.
The disorder predictions were performed with PONDR-FIT (66). Arrows indicate
the locations of the Kelch domain binding regions (Figure 4.1A). Blue lines
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indicate predicted MoRFs (>3 residues) by the MoRFpred web server (69). The
gene of FAC1 encodes part of a larger protein called bromodomain PHD finger
transcription factor (BPTF). For the FAC1 plot, the prediction of the entire BPTF
protein is shown. The residues 1-810 of FAC1 correspond to residues 140-939 of
BPTF (97).

Sequence and structure comparison of the Kelch domain interacting proteins
To help assess factors that dictate the binding affinity and specificity to the Kelch
domain, we performed an analysis of the amino acid sequences and available structures
of the Kelch domain interacting proteins. The site 1-type proteins have sequence identity
in a 6-residue stretch corresponding to the ‘DEETGE’ of NRF2 site 1 (Figure 4.1A).
These residues comprise the Kelch domain binding interface (51) and will be referred to
as positions i - i+5. G and E always occupy positions i+4 and i+5, respectively (Figure
4.1A). E is found at i+2 in all of the proteins, except p62, which contains an S at this
position (Figure 4.1A). The other positions are more variable (Figure 4.1A). In order of
highest to lowest occurrence frequencies, D/N or S is found at position i, E, P or V/Q at
i+1 and T, N or S at i+3 (Figure 4.1A). Outside of this 6-residue stretch, there are no
clear sequence similarities between the different site 1-type proteins (Figure 4.1A).
Furthermore, there is no obvious sequence consensus between the site 1- and 2-type
Kelch binding proteins (Figure 4.1A). The two site 2-type proteins have a short, 4residue, ‘WXQD’ consensus region. BCL2 contains the sequence ‘WIQD’, which bears
similarity to the ‘WRQD’ sequence of NRF2 site 2 (Figure 4.1A). Like the site 1-type
proteins, these two proteins do not share apparent sequence consensus outside of this
short motif (Figure 4.1A).
Next, we compared the residue type fractions of the sequences (Figure 4.1B). The
hydrophobic content amongst the site 1-type binders varied considerably between 2050% (Figure 4.1B). NRF2 site 1 had the highest fraction of hydrophobic residues,
followed by p62/WTX, PGAM5/FAC1/IKKβ, PALB2 and PTMA (Figure 4.1B). Polar
content in the site 1-type binders was more consistent, with a range of 25-40% (Figure
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4.1B). PTMA, p62 and IKKβ had the highest fraction of polar content, followed by
NRF2/WTX/FAC1/PALB2 and PGAM5 (Figure 4.1B). Acidic content fell into a range
of 10-25% for all proteins, except PTMA, which had a considerably higher fraction of
40% (Figure 4.1B). Basic content varied between 0% in NRF2 and PTMA to 20% in
PGAM5, PALB2 and IKKβ (Figure 4.1B). The site 2-type sequences of NRF2 and BCL2
had similar amounts of hydrophobic content between 40-45% (Figure 4.1B). BCL2 had
considerably more polar and less acidic content compared to the NRF2 site 2 sequence
(Figure 4.1B). Basic content was similar for both 20-mer sequences (Figure 4.1B).
We also compared the available structures of the Kelch domain binding proteins.
Aside from IKKβ, for which a homology model structure exists (65), the free-state
structures of the site 1 type Kelch domain binding proteins are otherwise not known.
However, structures of NRF2 site 1 and 2, p62 and PTMA peptides bound to the Kelch
domain have been determined (48, 54, 55, 59). In their bound states, the PTMA and p62
peptides both adopt β-hairpin structures with low rmsd (< 0.3 Å Cα rmsds for 8 atom
pairs) to the NRF2 site 1 peptide bound to the Kelch domain (48, 54, 55) (Figure 4.2).
The bound state structures of these peptides also reveal that they assume similar
sidechain conformations (Figure 4.2). In its free state, the Kelch domain binding region
of IKKβ (Figure 4.1A) also forms a β-hairpin that has considerable resemblance (~0.5 Å
Cα rmsd for 8 atom pairs) to the bound state structure of the NRF2 site 1 peptide (Figure
4.2). Furthermore, the bound state structures of the NRF2 site 1, p62 and PTMA peptides
and the free state structure of IKKβ have similar backbone and sidechain χ1 dihedral
angles in their binding interface residues (Table S1). When comparing the site 2-type
binders, it was clear that in its free state, the ‘WIQD’ sequence of BCL2 (PDB id: 1G5M)
(68) has considerable structural resemblance (<0.5 Å Cα rmsd for 4 atom pairs) to the
‘WRQD’ sequence of the NRF2 site 2 peptide bound to Kelch (PDB id: 2DYH) (59)
(Figure 4.2). These residues appear to adopt a ‘turn’ conformation and share similar
backbone, but not χ1, dihedral angles (Figure 4.2 and Table S1). Intriguingly, although
the site 1- and 2-type Kelch domain interacting proteins do not have obvious sequence
similarities, the residues that are largely buried in the Kelch domain binding interface (EE
in NRF2 site 1 and PTMA, PS in p62, QE in IKKβ and QD in NRF2 site 2 and BCL2)
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have similar φ and ψ angles (Table S1).

Figure 4.2 Structure comparisons of the Kelch domain binding proteins.
A) Superposition of NRF2 site 1 and PTMA peptides bound to the Kelch domain
(PDB ids: 1X2R and 2Z32, respectively) (54, 55). The structures of the Kelch
domain are not shown for clarity. B) Superposition of NRF2 site 1 and p62
peptides bound to the Kelch domain (not shown) (PDB ids: 1X2R and 3ADE,
respectively) (48, 55). C) Superposition of an NRF2 site 1 peptide bound to the
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Kelch domain (not shown) (PDB id: 1X2R) (55) and the free state IKKβ
homology model structure (PMDB id: 76858) (65). D) Superposition of an NRF2
site 2 peptide bound to the Kelch domain (not shown) (PDB id: 2DYH) (59) and
the free state BCL2 structure (PDB id: 1G5M) (68).

Table S1 Dihedral angles of the Kelch domain binding interface residues.
Protein
Residue
φº
ψº
χ1º
a
NRF2 site 1
D77
-70.8
110.0
-170.8
E78
-63.8
-21.8
-144.1
E79
-82.0
-31.4
-72.8
T80
-117.2
-21.2
66.0
G81
85.3
-5.7
E82
-71.8
146.8
-67.0
p62b
D349
-87.3
109.3
-179.9
P350
-47.7
-39.0
-26.0
S351
-72.9
-31.1
-173.2
T352
-121.8
-22.0
61.5
G353
84.7
4.7
E354
-76.0
143.1
-80.5
c
PTMA
N41
-67.8
115.6
-174.6
E42
-70.1
-16.1
-80.4
E43
-77.7
-39.9
-68.1
N44
-126.4
-2.9
61.4
G45
78.1
0.3
E46
-74.8
152.8
-51.2
IKKβd
N34
-94.8
134.7
-168.9
Q35
-91.5
-22.0
-83.2
E36
-81.7
-36.7
-60.4
T37
-102.5
-26.4
62.1
G38
80.8
10.6
E39
-59.7
133.1
-166.9
NRF2 site 2e
W24
nag
nag
nag
R25
-67.9
-16.5
58.5
Q26
D27
BCL2f
W188
I189
Q190
D191
a
PDB id: 1X2R(55).
b
PDB id: 3ADE(48).
c
PDB id: 2Z32(54).

-77.6
-76.5
-63.7
-46.5
-66.8
-64.5

-24.6
-17.3
-40.2
-59.0
-30.2
-45.5

49.0
-88.4
-179.6
-81.2
-76.1
-150.4
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Protein model database (PMDB) id: 76858(65).
PDB id: 2DYH(59).
f
PDB id: 1G5M(68).
g
Atom positions needed to calculate the angle were not resolved in the structure.
e

Binding parameters of the Kelch domain interacting proteins
Using ITC, we determined the thermodynamic parameters of binding (Table 4.2)
for peptides from the binding regions (Figure 4.1A) of all of the known (to date) site 1type Kelch domain interacting proteins with high disorder tendencies. ITC thermograms
and an additional set of binding parameters from duplicate experiments are available
(Figure S4.2 and Table S4.2). Binding parameters have been previously reported for
NRF2 (40, 57, 58), p62 (48) and PTMA isoform 2 (40). To our knowledge, parameters
for PGAM5, WTX, WTX pS286, FAC1, PALB2 and PTMA isoform 1 have not been
reported. Here, we determined the binding parameters for these proteins as well as the
ones that have been previously reported. The reason for repeating the previously
documented measurements was to insure that a systematic comparison with equal length
peptides, same buffer conditions, protein/peptide concentrations, was performed.
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Table 4.2 Thermodynamic parameters for the binding of the peptides to the human
Kelch domaina
nb
Kd c
∆Hc
T∆Sc
∆Gc
-6
Protein
(10 M)
(kcal/mol)
(kcal/mol) (kcal/mol)
NRF2 site 1
1.08 0.023 ± 0.002 -16.96 ± 0.046 -6.559
-10.40 ± 0.03
PGAM5
1.07 0.23 ± 0.010 -19.12 ± 0.056 -10.048
-9.07 ± 0.03
p62
0.97 1.3 ± 0.021
-18.38 ± 0.067 -10.345
-8.04 ± 0.03
WTX
1.04 0.25 ± 0.017 -18.04 ± 0.087 -9.034
-9.01 ± 0.04
WTX pS286
0.98 1.5 ± 0.140
-10.83 ± 0.143 -2.880
-7.95 ± 0.10
FAC1
0.99 1.1 ± 0.047
-15.11 ± 0.076 -6.976
-8.13 ± 0.04
PALB2
1.01 0.087 ± 0.007 -19.29 ± 0.109 -9.660
-9.63 ± 0.05
PTMA iso 1
1.07 11.6 ± 0.230 -14.74 ± 0.120 -8.020
-6.72 ± 0.05
PTMA iso 2
1.05 2.62 ± 0.052 -17.29 ± 0.064 -9.690
-7.60 ± 0.03
a
The peptide sequences are shown in Figure 4.1A and Table 4.1.
b
Binding stoichiometry.
c
Kd is the dissociation constant. ∆H, ∆S and ∆G are the change in enthalpy, entropy
and Gibbs free energy upon binding at T=298.15 K, respectively.
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Figure S4.2 ITC thermograms.
Filtered and degassed aliquots of ~40 µM Kelch containing 50 mM sodium
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phosphate, 100 mM NaCl, 1 mM DTT at pH 7 was added to the 1.4 mL sample
cell and subjected to stepwise titration with 5 µL aliquots of ~500 µM peptide.
The equilibration period between each injection was 300 seconds. The association
constant (Ka), molar binding stoichiometry (n) and the binding enthalpy (∆H),
entropy (∆S) and Gibbs free energy (∆G) were determined by fitting the binding
isotherm to a single-binding-site model with Origin7 software (MicroCal). The
heat changes after saturation were averaged and used to correct for the heats of
dilution. All ITC experiments were performed in duplicate. ITC experiments
were carried out on a VP-ITC instrument (MicroCal) at 25ºC. The protein and
peptide samples were dialyzed into a buffer containing 50 mM sodium phosphate,
100 mM NaCl, 1 mM DTT at pH 7 and degassed before the experiments.

Table S4.2. Duplicate set of peptide to the human Kelch domain thermodynamic
binding parametersa
Protein
nb
Kd c
∆Hc
T∆Sc
∆Gc
-6
(10 M)
(kcal/mol)
(kcal/mol) (kcal/mol)
NRF2 site 1
1.08 0.024 ± 0.002 -17.56 ± 0.046 -7.185
-10.38 ± 0.03
PGAM5
1.08 0.18 ± 0.010 -19.78 ± 0.066 -10.584
-9.20 ± 0.03
p62
0.99 1.7 ± 0.038
-18.27 ± 0.088 -10.375
-7.90 ± 0.04
WTX
1.04 0.27 ± 0.020 -18.15 ± 0.094 -9.183
-8.97 ± 0.05
WTX pS286
0.99 1.6 ± 0.16
-10.39 ± 0.136 -2.480
-7.91 ± 0.10
FAC1
0.96 0.98 ± 0.069 -15.41 ± 0.124 -7.215
-8.20 ± 0.07
PALB2
0.96 0.13 ± 0.02
-19.30 ± 0.123 -9.869
-9.43 ± 0.06
PTMA iso 1
1.09 13.4 ± 0.32
-14.32 ± 0.153 -7.662
-6.66 ± 0.07
PTMA iso 2
1.04 2.93 ± 0.078 -17.53 ± 0.093 -10.077
-7.45 ± 0.04
a
The peptide sequences are shown in Figure 4.1A and Table 4.1.
b
Binding stoichiometry.
c
Kd is the dissociation constant. ∆H, ∆S and ∆G are the change in enthalpy, entropy
and Gibbs free energy upon binding at T=298.15 K, respectively.

A large variation in the binding affinity (Kd ranging from ~12 µM to 23 nM) was
observed for different disordered Kelch domain interacting proteins. Out of all the
peptides, the NRF2 site 1 peptide had the highest affinity for the Kelch domain (23 ± 2
nM), followed by PALB2 (87 ± 7 nM), PGAM5 (230 ± 10 nM), WTX (250 ± 17 nM),
FAC1 (1 100 ± 47 nM), p62 (1 300 ± 21 nM), WTX pS286 (1 500 ± 140 nM), PTMA
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isoform 2 (2 620 ± 52 nM) and PTMA isoform 1 (11 600 ± 230 nM). The Kd of the
NRF2 site 1-Kelch domain interaction has been measured at 20 nM for a 16-mer peptide,
which was consistent with our value of 23 ± 2 nM (51). It is interesting that PALB2,
which contains the same ‘LDEETGE’ sequence as NRF2 site 1, was ~4-fold weaker. It
has been demonstrated that PALB2 can compete with NRF2 for Kelch domain binding,
and as a result, the authors proposed that PALB2 may have a similar, or higher affinity
(52). Our ITC data showed that while the PALB2 peptide interacted with the Kelch
domain slightly more favorably enthalpically than the NRF2 site 1 peptide, it lost
considerable entropy upon binding. Our sequence analysis illustrates that, compared to
NRF2 site 1, PALB2 has considerably less hydrophobic content in its binding region,
which may allow for more conformational freedom. This could possibly explain why
PALB2 loses considerable entropy upon binding, resulting in a weaker interaction. The
affinity of the p62 peptide for the Kelch domain was 1300 ± 21 nM, which was on par
with the reported value of 1851 ± 103 for a (mouse) fragment containing residues 168391 (48). The high similarity between these measurements indicates that regions distant
from the binding motif may not participate in the interaction. The relatively weak affinity
of the p62-Kelch domain interaction may be attributed to the lacking of an E in the i+2
position of p62 (Figure 4.1A). The other binding partners all contain an E at this position
and structures of NRF2 site 1 and PTMA peptides in complex with Kelch show that this
residue forms favorable electrostatic interactions with a basic surface of Kelch (51, 54,
55). Although this suggests that the lower affinity of the p62 peptide would be primarily
due to a less favorable enthalpic component of binding, p62 actually had a more
favorable ∆H of binding compared to most of the other peptides, including NRF2.
Because this could be due to number of possibilities, such as favorable intra-peptide
interactions occurring upon binding, further experiments are necessary to determine the
thermodynamic contributions of the E in position i+2. The unphosphorylated WTX
peptide interacted comparably to PGAM5; however, upon phosphorylation of S286,
binding was substantially decreased by ~6-fold (Table 4.2). The significant effect of
WTX phosphorylation on its binding affinity parallels the effect of phosphorylation of
residue T80 (position i+3) in NRF2, both of which occur in vivo (45, 51, 70). The ~5 fold
lower affinity of PTMA isoform 1 compared to isoform 2 (Table 4.2) was intriguing. The
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two isoforms have nearly identical sequences, with the major difference being a deletion
of E at position i-1 in isoform 2 (Figure 4.1A). The contributing factor(s) for this
difference are not clear, but we speculate that having amino acids with the same charge
(E41 and E48) somewhat close to each other in a β-turn conformation is unfavorable.
Similarly, the D589 and E597 pair in FAC1 would also be in close proximity, assuming a
β-turn conformation is adopted.
There were some obvious trends in the ITC data, which led us to group the
different proteins based on their binding affinities. These groupings may be helpful in
deciphering the relationships between binding affinity and the biological functions of the
various protein-protein interactions. Tier 1 consists of NRF2 only, which has a Kd of ~20
nM. NRF2 is known as the master regulator of the cellular oxidative stress response
pathway (71-73). Tier 2 consists of PALB2, PGAM5 and WTX, which have Kd’s in the
~100-200 nM range. The proteins have been shown to promote NRF2-mediated
cytoprotective gene expression, by presumably, disrupting the low affinity site 2-Kelch
domain interaction. Based on their affinities, these proteins should be able to easily
disrupt this interaction, which has a Kd of ~1 µM (57). A third tier of proteins, consisting
of FAC1, p62 and PTMA have dissociation constants > 1000 nM. PTMA contains a
nuclear localization signal, and is thought to function as a vehicle for shuttling Keap1
into the nucleus. The transient nature of its shuttling role may explain its lower affinity. It
should be noted that while the proteins discussed here interact with the Kelch domain of
Keap1, the purpose of many of the interactions are not well established. The binding
parameters reported here and hypothesis presented in several recent review articles may
give insights into their possible roles (44, 63).

Free state structures of Kelch domain interacting peptides
NMR and MD simulations were used to assess the free state solution structures of
the various Kelch domain interacting peptides. These experiments were crucial for
assessing the relationships between peptide conformation in the free and bound states.
We previously found evidence that, in their free states, the NRF2 site 1 region and the
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site 1-type region of PTMA adopt β-hairpin conformations that resemble the bound state
structures to different extents, with NRF2 forming a more defined hairpin that has a
closer resemblance to its bound state structure compared to PTMA (40). The chemical
shift assignments and assigned 1H-15N HSQC spectra for each peptide are available
(Table S4.3 and Figure S4.3). The small 1Hα chemical shifts deviations from their
random coil values, and narrow range of 1H peak dispersions (~1 ppm) suggest that the
peptides are largely disordered in solution (Table S4.3 and Figure S4.3). The main
purpose of assigning the 1H resonances was to assess the solution structures of the
various peptides using NOESY experiments. In Figure 4.3, lines mapped onto the peptide
sequences, are used to illustrate any NOESY cross-peaks between protons >2 residues
apart. Using this criterion, the NRF2 site 1 peptide had the largest number of cross-peaks
of all the peptides (Figure 4.3). Several of the NRF2 site 1 peptide cross-peaks were
between residues comprising the β-turn motif that forms the binding interface with the
Kelch domain (Figure 4.3). The corresponding region in many of the other peptides also
contained NOESY cross-peaks (Figure 4.3). In particular, cross-peaks between residues
in the i and i+3 positions of the regions corresponding to the β-turn motif of the NRF2
site 1 peptide were usually observed (Figure 4.3). In addition to contacts within the βturn, the NRF2 site 1 peptide also contained cross-peaks between hydrophobic residues
on either side of the turn, suggestive of a hairpin structure (Figure 4.3). The p62 and
WTX peptides also had detectable NOESY cross-peaks between residues outside of their
binding motifs indicative of hairpin structures (Figure 4.3). Although NOESY crosspeaks between residues > 2 residues apart were not found for the FAC1, PALB2 and
PTMA peptides, the presence of such contacts cannot be ruled out. Incomplete resonance
assignments and overcrowding made analysis of these spectra challenging.
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Figure 4.3 Peptide NOESY connections.
The NMR experiments were performed at 25ºC with a 3 mM peptide sample in 50
mM sodium phosphate pH 7, 100 mM NaCl, 1 mM DTT and trace DSS for
chemical shift referencing. Lines mapped onto the peptide sequences are used to
illustrate any NOESY cross-peaks between protons > 2 residues apart.
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Table S4.3. Chemical shifts assignments of the peptides.
NRF2 site 1 peptide, Ac-FAQLQLDEETGEFLPIQPAQ-NH2
Residue NH
HN
Hα
Hβ
F
125.931
8.175
4.540
2.977, 3.119
A
125.300
8.269
4.272
1.328
Q
119.427
8.217
4.298
1.968, 2.084
L

123.158

8.165

4.423

1.621

Q

121.318

8.596

4.449

1.977, 2.058

L

124.973

8.388

4.209

D
E
E
T
G

123.342
123.292
120.166
111.394
111.218

8.515
8.571
8.439
8.022
8.426

2.560, 2.846
1.967, 2.056
1.923, 2.090
4.275

E
F
L

119.788
120.922
125.787

7.931
8.426
8.296

4.589
4.102
4.283
4.383
3.810,
3.999
4.258
4.667
4.664
4.463

2.004, 2.258

P

1.786, 1.925
2.960, 3.009
1.575

I

121.300

8.154

4.099

1.783

Q
P

125.711

8.450

4.275
4.368

1.984, 1.213
2.314, 2.021

A
124.333
8.439
4.253
1.401
Q
119.821
8.337
4.275
1.984, 2.123
PGAM5 peptide, Ac-INVRKRNVESGEEELASKLD-NH2
Residue NH
HN
Hα
Hβ
I
125.561
8.145
4.121
1.826
N
V
R

120.831
120.437
123.436

8.599
7.962
8.342

4.695
4.077
4.338

2.763, 2.873
2.082
1.748, 1.824

K

122.556

8.393

4.342

1.743, 1.812

R

124.816

8.340

4.305

1.744, 1.825

N
V

128.837
120.166

8.550
8.133

4.717
4.123

2.746, 2.831
2.113

Others
Hδ: 7.261
Hγ: 2.346, Hε:
6.867, 7.548
Hγ: 1.490, Hδ:
0.825
Hγ: 2.315, Hε:
6.850, 7.563
Hγ: 1.456, 1.495,
Hδ: 0.661, 0.749
Hγ: 2.384
Hγ: 1.211
Hγ: 2.071, 2.150
Hδ: 7.185
Hγ: 1.529, Hδ:
0.886
Hγ: 1.863, Hδ:
3.616, 3.741
Hγ: 1.166, Hδ:
0.875
Hγ: 2.371
Hγ: 1.908, Hδ:
3.676, 3.811
Hγ: 2.371
Others
Hγ: 1.461, 1.196,
Hδ: 0.867
Hδ: 6.901, 7.599
Hγ: 0.912
Hγ: 1.624, Hδ:
3.008
Hγ: 1.586, Hδ:
1.627
Hγ: 1.626, Hδ:
3.182, Hε: 7.249
Hδ: 6.928, 7.638
Hγ: 0.924
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E
S
G

121.718
116.273
111.198

8.548
8.328
8.484

E
E
E
La
A
S
K

120.511
122.556
121.693
123.053
124.157
114.277
123.147

8.263
8.393
8.564
8.224
8.226
8.133
8.198

4.318
4.442
3.971,
4.012
4.283
4.246
4.233
4.285
4.279
4.397
4.286

1.956, 2.087
3.869. 3.927

Hγ: 2.282

1.928, 2.054
1.957, 2.033
1.960, 2.020
1.592, 1.665
1.416
3.862, 3.889
1.782, 1.883

Hγ: 2.247
Hγ: 2.233, 2.271
Hγ: 2.275
Hδ: 0.904, 0.955
Hγ: 1.446, Hε:
3.266

La
D
121.151
8.213
4.546
2.654
a
L15 and L19 have similar HN shifts. A set of ambiguous shifts for both residues is
reported in the L15 row.
p62 peptide, Ac-LSSKEVDPSTGELQSLQMPE-NH2
Residue NH
HN
Hα
Hβ
Others
L
123.822
8.182
4.368
1.624
Hδ: 0.856, 0.898
S
116.678
8.286
4.419
3.852, 3.877
S
115.561
8.572
4.458
3.910, 3.945
K
127.719
8.272
4.334
1.746, 1.840
Hγ: 1.423, Hε:
3.155
E
121.822
8.335
4.322
1.918, 2.044
Hγ: 2.255
V
120.783
8.116
4.093
1.990
Hγ: 0.895
D
126.005
8.481
4.878
2.552, 2.864
P
4.435
2.034, 2.323
Hδ: 3.685, 3.827
S
117.812
8.337
4.458
3.924, 3.990
T
114.054
7.960
4.348
4.309
Hγ: 1.226
G
110.677
8.323
3.931,
3.995
E
120.549
8.181
4.297
1.918, 2.041
Hγ: 2.220, 2.258
L
122.936
8.337
4.324
1.659
Hγ: 1.579, Hδ:
0.863
Q
123.326
8.391
4.294
1.964, 2.104
Hγ: 2.372
S
116.546
8.415
4.510
3.876, 3.911
L
122.695
8.285
4.332
1.603, 1.655
Hδ: 0.882, 0.906
Q
120.946
8.269
4.312
1.963, 2.073
Hγ: 2.348
M
121.310
8.403
4.347
Hγ: 2.562, 2.635
P
4.412
1.926
Hδ: 3.687, 3.812
E
121.692
8.545
4.204
1.965, 2.031
Hγ: 2.292
WTX peptide, Ac-SLEEPHSPETGEKVVAGEVN-NH2
Residue NH
HN
Hα
Hβ
Others
S
121.319
8.303
4.426
3.832, 3.859
L
124.232
8.428
4.398
1.627
Hδ: 0.868, 0.911
E
123.677
8.338
4.273
1.877, 2.016
Hγ: 2.267
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E
P

121.578

8.298

4.253
4.380

1.889, 2.028
1.992, 2.257

H
S
P

119.526
119.102

8.506
8.430

4.671
4.291
4.433

3.148, 3.162
3.832, 3.869
2.026, 2.307

E
T
G
E
K

121.066
114.070
111.053
120.807
122.843

4.323
4.353
3.988
4.346
4.342

1.963, 2.084
4.293

8.597
8.167
8.377
8.259
8.403

1.922, 2.026
1.779

V
122.843
8.207
4.091
2.019
V
125.563
8.337
4.104
2.027
A
128.821
8.455
4.331
1.392
G
108.444
8.350
3.948
E
na
8.109
4.286
1.793, 1.931
V
121.436
8.286
4.088
2.080
N
122.584
8.531
4.762
2.747, 2.821
WTX pS286 peptide, Ac-SLEEPHpSPETGEKVVAGEVN-NH2
Residue NH
HN
Hα
Hβ
S
120.426
8.262
4.429
3.831, 3.866
L
123.907
8.423
4.375
1.627
E
123.341
8.319
4.267
1.916, 2.021
E
120.465
8.265
4.301
1.895, 2.026
P
4.535
2.013, 2.272
H

118.983

8.501

4.688

3.194, 3.250

pS
P

120.027

9.068

4.340
4.420

4.014, 4.080
2.016, 2.292

E
T
G
E
K

121.388
114.342
110.618
120.443
122.448

8.672
8.228
8.410
8.240
8.358

4.334
4.349
3.983
4.352
4.328

2.005, 2.086
4.270

V
V
A
G
E
V
N

122.419
125.197
128.434
108.126
na
121.073
122.276

8.190
8.320
8.449
8.333
8.073
8.269
8.515

4.088
4.086
4.315
3.944
4.243
4.105
4.688

2.022
2.084
1.396

1.927
1.750, 1.799

1.792, 1.923
2.041
2.761, 2.835

Hγ: 2.238
Hγ: 1.838, Hδ:
3.680, 3.776
Hδ: 7.165
Hγ: 1.944, Hδ:
3.757
Hγ: 2.299
Hγ: 1.212
Hγ: 2.224
Hγ: 1.412, Hδ:
1.742, Hε: 2.987
Hγ: 0.885, 0.921
Hγ: 0.922
Hγ: 2.145, 2.233
Hγ: 0.931
Hδ: 6.924, 7.602
Others
Hδ: 0.860, 0.917
Hγ: 2.243
Hγ: 2.249
Hγ: 1.871, Hδ:
3.677, 3.839
Hδ: 7.198, Hε:
8.644
Hγ: 1.899, Hδ:
3.656, 3.843
Hγ: 2.321
Hγ: 1.206
Hγ: 2.230
Hγ: 1.432, Hε:
2.761
Hγ: 0.903, 0.939
Hγ: 0.931
Hγ: 2.151
Hγ: 0.932, 0.914
Hδ: 6.893, 7.575
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FAC1 peptide, Ac-SAKAADDPENGERESHTPVS-NH2
Residue NH
HN
Hα
Hβ
a
S
na
8.289
4.425
3.841, 3.871
Ab
126.315
8.408
4.313
1.403
K
121.013
8.232
4.291
1.737, 1.811
A
A
D
D
P

118.438
121.669

8.173
8.054

4.556
4.853
4.383

2.591, 2.641
2.549, 2.747
2.025, 2.301
1.957, 2.063
2.796, 2.861

E
N
G

119.725
118.715
109.298

8.525
8.199
8.316

E
R

120.685
123.285

8.252
8.316

4.227
4.712
3.955,
3.982
4.296
4.298

E
S
H
T
P

121.568

8.408

4.269

1.935, 2.009

118.816
120.584

8.095
8.320

4.664
4.330
4.462

3.429
4.246
2.049, 2.321

1.954, 2.045
1.781, 1.859

Others
Hγ: 1.435, Hδ:
1.681

Hγ: 1.961, Hδ:
3.799
Hγ: 2.233, 2.278
Hδ: 6.912, 7.675
Hγ: 2.240, 2.268
Hγ: 1.639, Hδ:
3.188, Hε: 7.178
Hγ: 2.243
Hγ: 1.382
Hγ: 1.914, Hδ:
3.719, 3.867
Hγ: 0.968

V
121.694
8.304
4.120
2.113
S
a
S1, S15 and S20 have similar HN and Hβ shifts. A set of ambiguous shifts for all
three residues is reported in the S1 row.
b
A2, A4 and A5 have similar NH, HN and Hβ shifts. A set of ambiguous shifts for all
three residues is reported in the A2 row.
PALB2 peptide, Ac-HIKTHLDEETGEKTSITLDV-NH2
Residue NH
HN
Hα
Hβ
Others
H
I
125.362
8.281
4.105
1.812
Hγ: 1.190, Hδ:
0.899
K
122.602
8.463
4.346
1.783, 1.863
Hγ: 1.467, Hδ:
1.680
T
H
L
D
E
E
T
G
111.026
8.373
3.975
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E
120.835
8.269
4.270
1.936, 2.055
Hγ: 2.263
K
T
S
I
T
L
D
V
120.188
8.018
4.125
2.164
Hγ: 0.935
PTMA isoform 1 peptide, Ac-ANGNAENEENGEQEADNEVD-NH2
Residue NH
HN
Hα
Hβ
Others
A
N
G
N
A
E
N
E
E
N
G
E
Q
E
A
D
N
E
V
120.786
8.149
4.096
2.100
Hγ: 0.923
D
PTMA isoform 2 peptide, Ac-ANGNANEENGEQEADNEVD-NH2
Residue NH
HN
Hα
Hβ
Others
A
N
G
N
A
N
E
E
N
G
E
Q
E
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A
D
N
E
V
120.727
8.144
4.073
2.092
Hγ: 0.928
D
NRF2 site 1 E78P peptide, Ac-FAQLQLDPETGEFLPIQPAQ-NH2
Residue NH
HN
Hα
Hβ
Others
F
126.184
8.286
4.541
2.954, 3.108
Hδ: 7.250
A
125.466
8.363
4.264
1.328
Q
119.515
8.313
4.273
1.967, 2.095
Hγ: 2.358
L
123.128
8.247
4.499
1.614, 1.835
Hγ: 1.426, Hδ:
0.780
Q
121.109
8.820
4.506
1.981, 2.062
Hγ: 2.327
L
124.962
8.492
4.198
1.353
Hγ: 1.268, Hδ:
0.624, 0.545
D
125.926
8.769
4.850
2.533, 3.025
P
4.381
2.019, 2.311
Hγ: 1.918, Hδ:
3.674, 3.830
E
117.769
8.444
4.273
2.117
Hγ: 2.226, 2.299
T
108.789
7.855
4.424
4.303
Hγ: 1.197
G
111.154
8.508
3.732.
4.047
E
119.124
7.817
4.286
1.787, 1.986
Hγ: 2.116, 2.205
F
120.586
8.625
4.716
2.932, 2.971
Hδ: 7.159
L
125.899
8.508
4.699
Hγ: 1.560, 1.601,
Hδ: 0.922
P
4.277
2.042, 2.309
Hδ: 3.889, 4.018
I
121.789
8.284
4.088
1.770
Hγ: 1.159, Hδ:
0.873
Q
126.173
8.599
4.607
1.920, 2.096
Hγ: 2.400
P
4.511
2.273
Hγ: 1.856, Hδ:
3.653, 3.798
A
124.693
8.570
4.266
1.401
Q
120.176
8.469
4.277
1.987, 2.123
Hγ: 2.383
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Figure S4.3 Assigned
connections.

1

H-15N HSQC spectra of the peptides and NOESY
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The NMR experiments were performed at 25ºC with a 3 mM peptide sample in 50
mM sodium phosphate buffer at pH 7, 100 mM NaCl, 1 mM DTT and trace DSS
for chemical shift referencing. Lines mapped onto the peptide sequences are used to
illustrate any NOESY cross-peaks between protons > 2 residues apart.

Microsecond atomistic MD simulations were performed on the Kelch domain
interaction peptides (Table 4.1) to investigate their free-state conformational propensities.
To compare to the NMR result obtained, the 1/r6 averaged C"i # C"i+3 distances were
calculated (Figure 4.4). The results clearly show that the regions of compactness
identified in the NOESY experiments were also found in MD simulations of the peptide
!
in the free states (The 1/r6 averaged distance matrices and final structures from the
simulations are shown in Figure S4.4). Secondary structure assignments throughout the
MD trajectories were also conducted (Figure S4.5). The NRF2 site 1, PGAM5, p62,
FAC1, PALB2 and IKKβ peptides showed evidence of cross-strand contacts, which
propagated away from their turn regions, and also had final structures with hairpin-like
conformations (Figures 4.4 and S4.4). Several of these peptides had intra-turn contacts.
Specifically, contacts between residues in position i, i+2 and i+3 were frequently
observed (Figure S4.4). The NRF2 site 1 peptide also had contacts between hydrophobic
residues on adjacent strands (Figure S4.4). The PGAM5 peptide showed evidence of
cross-strand contacts from the N77 to E82 and E84 sidechains (Figures S4.4 and 4.1A).
There was also indication of cross-strand contacts between the oppositely charged K344
and E352 sidechains of the p62 peptide (Figure S4.4 and 4.1A). The WTX peptide
adopted a turn/bend conformation at the expected location, and had i to i+2 contacts, but
did not have cross-strand contacts indicative of a hairpin (Figure S4.4). The WTX pS286
peptide had a turn at the expected location, and some evidence of cross-strand contacts,
slightly offset from the turn location (Figure S4.4). In this peptide, obvious contacts
between the pS286 sidechain phosphate group and a lysine residue on the opposite side of
the turn were observed (Figure S4.4 and 4.1A). In our previous MD simulations, we
found that phosphorylation of T80 in an NRF2 peptide severely inhibited formation of
the expected β-hairpin structure (39). In the current MD simulations of WTX, it appeared
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that S286 phosphorylation may actually enhance free state structure formation. This is
supported by our ITC data (Table 4.2), which revealed that the WTX pS286 peptide had
the smallest entropy change upon binding. However, this peptide interacted with the
Kelch domain the least favorably enthalpically, which suggests that the peptide
conformation induced by phosphorylation is not ideal for binding. Indeed, our MD
simulations show that the β-turn adopted by this peptide is distorted due to interactions
between the pS286 residue and a lysine on the opposite side of the turn (Figure S4.4).
Both PTMA peptides did not show clear evidence of turn or hairpin formation in the
expected location; however, the secondary structure analysis (Figure S4.5) showed these
features occurred transiently throughout the trajectories. Despite the site 2-type peptide
trajectories being extended to 2 µs, their ‘WXQD’ motifs rarely formed ‘turn’ structures
that resembled the NRF2 site 2 bound state structure, or the BCL2 free state structure
(data not shown). These trajectories were not analyzed further.

Figure 4.4 Cαi-Cαi+3 1/r6 averaged distances from the MD simulations.
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The 1/r6 averaged distances were calculated using the g_rmsdist tool in
GROMACS 4.5 (86) over the last 0.5 µs of the trajectories.
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Figure S4.4 1/r6 averaged distances and final structures from the MD simulations.
The NMR averaged 1/r6 distances between all atoms pairs (atom index) were
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calculated using the g_rmsdist tool in GROMACS 4.5(86) over the last 0.5 µs of
the trajectories. Final (t=1.0 µs) structures of the peptides rendered with VMD
(94). The potential turn forming regions (Figure 4.1A) are boxed and possible turn
stabilizing contacts are indicated.
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Figure S4.5 Evolution of secondary structures throughout the MD simulations.
The DSSP algorithm (98) was used for secondary structure assignments: coil
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(white), β-sheet (red), β-bridge (black), bend (green), turn (yellow), α-helix (blue)
and 310 helix (grey).

The NMR and MD results suggest that a larger fraction of hydrophobic residues
in the NRF2 peptide may act to stabilize the free state peptide conformation, lowering the
entropy difference between the free and bound states, leading to higher binding affinity.
While the peptides from the other Kelch domain interacting proteins lack comparable
hydrophobic content, our NMR and MD data suggest that like NRF2, interactions
between residues within their β-turns are likely to play important roles in stabilizing their
free states. This idea is supported by various studies, which together clearly demonstrate
that mutating residues within and surrounding the binding regions to amino acids with
different characteristics usually decrease Kelch domain binding (45, 48, 50, 52). In
addition to intra-turn contacts, we found that interactions between oppositely charged
sidechains surrounding the turn might act to stabilize the free state conformations of the
PGAM5, p62, WTX pS286 and possibly some of the other peptides (Figure S4.4).
Overall, the analysis of the free states reveal that several, if not all, of the Kelch domain
binding peptides analyzed in this study contain β-turn resembling LMs at their binding
sites. These structures likely have some resemblance to their bound state conformations.
It is anticipated that preformed structures are important features in regulating the binding
affinities and other thermodynamic parameters of the different interactions.

A higher affinity Kelch domain interacting peptide
The findings from our analysis of the site 1-type proteins were used to create a
peptide with a higher affinity for the Kelch domain than any of the natural peptides
(identified to date). This peptide aided our interpretation and understanding of the
thermodynamics of interaction with the Kelch domain and, possibly even more
importantly, may be a potential therapeutic agent (74). Because the data presented here
and in our previous work (40) points to a positive correlation between residual structure,
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resembling the bound state conformation, in the free state and increased binding affinity,
our peptide design aimed to further define the free state structure of the NRF2 site 1
peptide. By further restricting the bound state like conformation of this peptide, the
entropic cost of binding may be reduced, potentially increasing binding affinity.
Therefore, our attempt at designing a higher affinity peptide focused on reducing free
state entropy.
NMR and MD data indicated that β-turn formation at the Kelch domain binding
sites is a common feature of the various peptides, therefore, we aimed to increase the turn
propensity of this region. The likely sites of turn formation in the site 1-type binders are
the ‘DEET’-like regions (Figure 4.1A) (40). For the site 2-type binders, the β-turn
forming region is not as firmly established, however, the residues ‘WRQD’ appear to
adopt a turn conformation in the bound state (59) (Figure 4.2). Using a table of turn
potentials (75), we calculated the residue-specific and overall turn potentials of the
‘DEET’-like regions of the various proteins (Table 4.3). The protein with the highest turn
potential was p62, followed by FAC1, WTX, NRF2 site 1/PALB2, PTMA, IKKβ and
PGAM5 (Table 4.3). The high turn potentials of p62, FAC1 and WTX result primarily
from their sequences containing proline at position i+1 (Table 4.3). The site 2-type Kelch
domain interacting proteins had lower turn propensities than the site 1 binders and NRF2
site 2 had a slightly lower turn potential than BCL2 (Table 4.3).
Table 4.3 Turn potentials of the Kelch domain binding proteinsa.
Protein
i
i+1
i+2
i+3
Total
NRF2 site 1
D(1.56)
E(1.35) E(0.92) T(1.20) 5.03
NRF2 site 1 E78P D(1.56)
P(2.45) E(0.92) T(1.20) 6.13
PGAM5
N(1.54)
V(0.70) E(0.92) S(1.03) 4.19
p62
D(1.56)
P(2.45) S(1.06) T(1.20) 6.27
WTX
S(1.29)
P(2.45) E(0.92) T(1.20) 5.86
FAC1
D(1.56)
P(2.45) E(0.92) N(1.06) 5.99
PALB2
D(1.56)
E(1.35) E(0.92) T(1.20) 5.03
PTMA
N(1.54)
E(1.35) E(0.92) N(1.06) 4.87
IKKβ
N(1.54)
Q(0.94) E(0.92) T(1.20) 4.60
NRF2 site 2
W(0.62) R(0.93) Q(0.92) D(0.99) 3.46
BCL2
W(0.62) I(0.61) Q(0.92) D(0.99) 3.14
a
Turn potentials are from (75).
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Based upon the turn potential analysis, we made a single point mutation, E78P, to
the natural, 20-mer NRF2 site 1 peptide (Figure 4.1A) and used ITC to assess its binding
affinity to the Kelch domain. This mutation increases the turn potential to 6.13 (Table
4.3), possibly enriching the population of molecules with defined structure in solution
(75). Our ITC measurements reveal that the E78P mutation indeed increases the binding
affinity of the peptide (6.90 ± 1.07 nM) compared to the natural sequence by 3-4 fold
(Tables 4.2 and 4.4). This increase in binding affinity arises primarily due to a decreased
entropic cost of binding (Tables 4.2 and 4.4). The T∆S value is increased by ~1 kcal/mol,
while the ∆H increased marginally (0.2 kcal/mol) compared to the natural peptide (Tables
4.2 and 4.4). The ITC thermogram for this measurement and an additional set of
thermodynamic parameters from a duplicate experiment are available (Figure S4.6 and
Table S4.4).

Table 4.4 Thermodynamic parameters for the binding of the E78P to the human
Kelch domaina
Protein
nb
Kd c
∆Hc
T∆Sc
∆Gc
(10-9 M)
(kcal/mol)
(kcal/mol) (kcal/mol)
NRF2 site 1 E78P 0.994 6.90 ± 1.07 -16.76 ± 0.05 -5.635
-11.12 ± 0.03
a
The peptide sequences are shown in Table 4.1.
b
Binding stoichiometry.
c
Kd is the dissociation constant. ∆H, ∆S and ∆G are the change in enthalpy, entropy
and Gibbs free energy upon binding at T=298.15 K, respectively.
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Figure S4.6 ITC thermogram for the NRF2 site 1 E78P peptide.
Filtered and degassed aliquots of ~40 µM Kelch containing 50 mM sodium
phosphate, 100 mM NaCl, 1 mM DTT at pH 7 was added to the 1.4 mL sample cell
and subjected to stepwise titration with 5 µL aliquots of ~500 µM peptide. The
equilibration period between each injection was 300 seconds. The association
constant (Ka), molar binding stoichiometry (n) and the binding enthalpy (∆H),
entropy (∆S) and Gibbs free energy (∆G) were determined by fitting the binding
isotherm to a single-binding-site model with Origin7 software (MicroCal). The heat
changes after saturation were averaged and used to correct for the heats of dilution.
All ITC experiments were performed in duplicate. ITC experiments were carried
out on a VP-ITC instrument (MicroCal) at 25ºC. The protein and peptide samples
were dialyzed into a buffer containing 50 mM sodium phosphate, 100 mM NaCl, 1
mM DTT at pH 7 and degassed before the experiments.
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Table S4.4: Duplicate set of NRF2 E78P peptide to the human Kelch domain
thermodynamic binding parameters
Protein
nb
Kd c
∆Hc
T∆Sc
∆Gc
-9
(10 M)
(kcal/mol)
(kcal/mol) (kcal/mol)
NRF2 site 1 E78P 1.04 5.95 ± 0.24 -16.65 ± 0.064 -5.367
- 11.28 ± 0.04
a
The peptide sequences are shown in Table 4.1.
b
Binding stoichiometry.
c
Kd is the dissociation constant. ∆H, ∆S and ∆G are the change in enthalpy, entropy
and Gibbs free energy upon binding at T=298.15 K, respectively.

NMR experiments and MD simulations were used to examine the free state
structures of the E78P peptide. The chemical shifts assignments are available (Table
S4.3). The assigned 1H-15N HSQC spectrum, NOESY contacts between protons >2
residues apart, 1/r6 averaged distances, extracted from the MD simulation, and final MD
structures are shown in Figure 4.5. The data confirms that the E78P peptide is able to
adopt a hairpin structure with similar cross-strand contacts as the natural peptide (Figure
4.5). Overall, these findings provide new insights into the interplay between entropy and
enthalpy in regulating interactions between IDPs and targets. Such information is useful
for understanding how LMs can be regulated in IDPs in general, and provides guidance
for making additional modifications the LM region of NRF2 in order to further increase
its Kelch domain binding affinity.
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Figure 4.5 Assigned 1H-15N HSQC spectrum, NOESY connections, 1/r6 averaged
distances and final structure from the MD simulations of the E78P peptide.
The NMR experiments were performed at 10ºC with a 3 mM peptide sample in 50
mM sodium phosphate pH 7, 100 mM NaCl, 1 mM DTT and trace DSS for
chemical shift referencing. Lines mapped onto the peptide sequences are used to
illustrate any NOESY cross-peaks between protons > 2 residues apart. The
averaged 1/r6 distances were calculated using the g_rmsdist tool in GROMACS
4.5 (86) over the last 0.5 µs of the trajectory. The final (t=1.0 µs) structure of the
peptide was rendered with VMD (94).

The development of higher affinity Kelch domain ligands, which can compete with
NRF2, is an area of active research. Several NRF2 inducers (eg. bardoxolone methyl) are
currently in development or clinical trials for the treatment of chronic kidney disease,
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diabetes, cancer prevention, multiple sclerosis and oxidative tissue damage (76-80).
However, to our knowledge, none of these compounds disrupt the NRF2-Kelch domain
interaction directly. Instead, data suggests that these triterpenoids prevent NRF2
ubiquitination by reacting with specific thiol groups on the surface of Keap1 (76).
Interestingly, these NRF2 inducers may actually promote interaction of NRF2 with
Keap1 (76). While compounds such as bardoxolone methyl have shown positive clinical
results, it is conceivable that such electrophilic compounds could covalently bind to
cysteines of off-target proteins. Compounds, such as our E78P peptide, which directly
and specifically bind to the NRF2 binding site on the Kelch domain through non-covalent
interactions can be an alternative therapeutic agents. Head-to-tail cyclization or
attachment of our E78P peptide to a cell-penetration peptide may further improve this
peptide as a drug candidate (81).

Binding affinity correlations
Because all experiments and simulations were conducted with the same conditions
for each peptide, we were able to assess correlations between the affinities of binding and
various physical properties (Figure 4.6). We found that there was a good correlation (r2 =
0.77) between Kyte Doolittle hydropathy index (higher values indicates more
hydrophobic content in the sequence) and the free energy difference (ΔG) of binding
(Figure 4.6A). The two main outliers in this correlation were the p62 and WTX pS286
peptides. For p62, this deviation is probably due to the lack of an E in position i+2. If an
E was present at this position, the 6-mer motif of p62 gets converted to that of our NRF2
E78P peptide and would be expected to increase its binding affinity substantially to a
level comparable the Tier 2 binders. The overestimated affinity of the WTX pS286
peptide was understandable considering the Kyte Doolittle scale does not include values
for phosphorylated amino acids. Although phosphoserine was assigned the maximum
negative value on the scale (-4.5), equivalent to arginine, a more negative value is
probably appropriate.
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Figure 4.6 Correlations between ∆G’s of binding and hydropathy, disorderness, and
circular variances.
∆G values were determined by ITC (Table 4.2) and plotted against Kyte Doolittle
hydropathy indexes (A), average circular variances (B), combined circular
variances and Kyte Doolittle indexes (C), and PONDR-FIT disorder predictions
(D) of the peptides (Figure 4.1). Kyte Doolittle hydropathy index values were
obtained from (95). For the WTX pS286 peptide, phosphoserine was assigned the
maximum hydrophilic value on the scale (-4.5). The circular variances were
calculated over the last 0.5 µs of the MD trajectories, using the method described
by (96). Disorder predictions were performed on the full-length sequences and the
average values for the segments in Figure 4.1A were plotted. For the WTX pS286
peptide, phosphoserine was changed to glutamic acid.
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Circular variance values, a measure of backbone dynamics, extracted from the MD
simulations, were also well correlated (r2 = 0.75) with the ΔG of binding (Figure 4.6B).
The trend clearly illustrates that lower free state dynamics corresponds to a higher
binding affinity. By combining hydropathy indices with circular variances (Figure 4.6C),
the correlation was moderately improved (r2 = 0.81). The binding affinities were
correlated to a lesser extent (r2 = 0.50) to the PONDR-FIT disorder tendencies (Figure
4.6D). The major outlier here was PGAM5, with an average disorder probability of 0.36
for the 20-mer region of its sequence (Figure 4.6D). However, another disorder predictor,
metaPrDOS (67) yielded a disorder probability of 0.59, which improves the correlation
considerably r2 = 0.70 (data not shown).
By establishing important parameters that are well correlated with the ΔG’s of
binding, it may be possible to identify novel LMs capable of binding Kelch and to assess
their possible interaction strengths. One potential partner is the DNA replication licensing
factor MCM3, which was found to have a physical interaction (by two hybrid methods)
with Keap1 in Fruit fly (6). Although the function of this interaction is not known and
experimental studies are required to confirm this interaction in humans, the human
MCM3 sequence does harbor a site 1 type sequence,
379

TAAVTTDQETGERRLEAGAM398. This peptide has a hydropathy index of -13 and

an MD simulation of this sequence did indeed form a hairpin conformation at the
expected location and had an average C.V. value of 0.18. These diagnostics place it in the
realm of the Tier 2 binders, but this needs to be experimentally verified.

4.6 Conclusions
Our findings suggest that intrinsic disorder coupled with a preformed β-turn
resembling LM located at the binding site is a common feature among many of the Kelch
domain interacting proteins. The LMs are differentially stabilized by intra-turn contacts
and interactions between residues in close proximity to the binding region. The extent of
turn stabilization is likely an important factor in modulating binding affinity. We found
that the hydropathic indices and circular variance measurements of the peptides were well
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correlated with the measured free energy difference of binding. These parameters may be
useful for prediction the affinities of other possible Kelch domain interactions. Based on
this knowledge, we have selectively mutated the turn region of the NRF2 site 1 peptide
(E78P) to increase its binding affinity. The increase in affinity resulted from a lower
entropic cost of binding, possibly due to a reduction in the conformational freedom of the
free state. Importantly, this modified higher affinity peptide may have potential
therapeutic applications. This work illustrates a simple, yet effective methodology for
structurally characterizing LMs in the context of target binding. The results should also
be useful for determining the biological roles of the various Kelch domain interactions
and development of specific NRF2 inducers.
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5.1 Abstract
Keap1 is a multi-domain protein that functions as an inhibitor of the transcription
factor Nrf2 in the cellular response to oxidative stress. Under normal conditions, Keap1
binds to Nrf2 via its C-terminal Kelch domain and the interaction ultimately leads to the
ubiquitin-dependent degradation of Nrf2. It has been proposed that designing molecules
to selectively disrupt the Keap1-Nrf2 interaction can be a potential therapeutic approach
for enhancing the expression of cytoprotective genes. Here, we reported the 1H, 13C, and
15

N backbone chemical shift assignments of the Kelch domain of mouse Keap1. Further,

unlabeled Nrf2 peptide containing the Kelch-binding motif was added to the 15N-labeled
Kelch sample. 1H-15N HSQC spectra of the protein in the absence and presence of an
equimolar concentration of the Nrf2 peptide were presented. A significant number of
resonance signals were shifted upon addition of the peptide, confirming the proteinpeptide interaction. The results here will not just facilitate the further studies of the
binding between Keap1 and Nrf2, it will also be valuable for probing interactions
between the Kelch domain and small molecules, as well as a growing list of protein
targets that have been identified recently.

Keywords
Oxidative stress response; Keap1; Kelch domain; Nrf2; protein-protein interaction
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5.2 Biological context
Keap1 (Kelch-like ECH-associated Protein 1) is a 70-kDa protein that is rich in
cysteine. It functions as the repressor of Nrf2 (nuclear factor E2-related factor 2), the key
transcription factor that coordinates the cellular responses to oxidative stress. Keap1 is
composed of three domains (1). The N-terminal BTB (Broad-Complex, Tramtrack and
Bric-a-Brac) domain mediates the protein dimerization and is also responsible for the
binding to the Cul3-dependent E3 ubiquitin ligase complex (1). The BTB domain is
linked to the C-terminal Kelch domain by the intervening region (IVR), where cysteines
that are pivotal for the Keap1 functions as chemical sensor are located (1). The Cterminal Kelch domain is responsible for target recognition. It directly interacts with the
ETGE and DLG motifs present in the N-terminal Neh2 domain of Nrf2 (2-4). Under
unstressed conditions, Keap1 binds to Nrf2 and targets this transcription factor for
degradation (5).
The 32-kDa Kelch domain adopts a six-bladed β-propeller conformation and the
structures in complex with peptides derived from Nrf2 that contain the binding motifs
have been determined by X-ray crystallography (6-8). Due to the critical roles Keap1 and
Nrf2 play in the oxidative stress response mechanism, disrupting their interaction has
been proposed as a potential strategy to enhance the expression of cytoprotective genes.
The backbone resonance assignments obtained here will facilitate the screening of
inhibitors that can disrupt the Keap1-Nrf2 interaction. In addition to Nrf2, several novel
targets of the Kelch domain of Keap1 have been identified recently. These include FAC1
(9), PGAM5 (10), WTX (11, 12), prothymosin α (13), p62 (14) and PALB2 (15). The
assignments reported here will also serve as important starting points for studying the
interaction of Keap1 with these proteins.

5.3 Methods and experiments
Sample preparation
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The mouse Keap1 cDNA (GenBank# BC055732) was purchased from the
American Type Culture Collection (ATCC) and the Kelch domain (residues 324-612)
was cloned into the expression vector pDEST17 (Invitrogen). The TEV cleavage
recognition sequence, ‘ENLYFQG’, was introduced between the histidine tag and insert.
This vector was transformed into E. coli BL21(DE3). 15N, 13C and 2H labeled protein was
produced by growing E. coli in deuterated M9 media. Cells adapted in 70% D2O were
used to inoculate 1L of M9 prepared in 100% D2O. The cells were then grown at 37ºC
and overexpression was induced at an OD600 of 0.6 with 0.5 mM IPTG. After a 60-hour
induction, the cells were centrifuged and the pellets were frozen. The N-terminally Histagged protein was purified by affinity chromatography using Ni Sepharose™ 6 Fast
Flow beads (Amersham Biosciences). The tag was cleaved by incubation with His-tagged
tobacco etch virus (TEV) protease overnight at 25 ºC and the protein product was
purified by passing the mixture through Ni Sepharose™ 6 Fast Flow beads (Amersham
Biosciences). For NMR experiments, the purified protein was dialyzed against 50 mM
sodium phosphate at pH 7 containing 50 mM NaCl and 1 mM DTT. The samples were
then concentrated to ~0.3 mM. All samples contained 10% D2O and 1 mM 2,2-dimethyl2-sila-pentane-5-sulfonic acid (DSS) as 1H and 13C chemical shift references.

Sequential assignment experiments
NMR experiments for the backbone resonance assignment were conducted at
25ºC on Varian INOVA 800 MHz (NANUC) and Bruker Avance 800 MHz (Singapore)
spectrometers equipped with cryogenic probes. Sequential assignments were obtained
from 1H-15N TROSY-HSQC, HNCA, HN(CO)CA, HNCACB, HN(CO)CACB and 15NNOESY-HSQC spectra. The data was processed with NMRPipe (16) and analyzed using
CARA (17).

Ligand binding experiment
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To demonstrate the binding of the Kelch domain to a mouse Nrf2 peptide (Ac72

AQFQLDEETGEFLP85-NH2; ordered from NEOpeptide), 1H-15N HSQC spectra of

15

N-labeled Kelch domain (~ 200 µM) were collected on a Varian Inova 600 MHz

spectrometer with cryogenic probe (UWO Biomolecular NMR Facility) at 25ºC in the
absence and presence of equimolar concentration of the Nrf2 peptide.

5.4 Assignments and data deposition
The 1H-15N TROSY-HSQC of the Kelch domain of Keap1 (Figure 5.1a) had well
dispersed peaks for a protein of this size. We were able to assign 91.3% of the 1HN and
15

N resonances of non-proline residues, 90.7% of all 13Cα and 90% all 13Cβ resonances.

Repetitive sequences of the β-propeller structure (Figure 5.1b) made it difficult to obtain
a higher percentage of resonance assignments. The 1H, 15N and 13C α/β chemical shifts of
the backbone resonances have been deposited in the BioMagResBank
(http://www.bmrb.wisc.edu), under BMRB accession number 18353.
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Figure 5.1 1H-15N TROSY-HSQC spectrum and backbone resonance assignment of
the 2H/13C/15N labeled Kelch domain of mouse Keap1.
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a 1H-15N TROSY-HSQC spectrum and backbone resonance assignment of the
2

H/13C/15N labeled Kelch domain of mouse Keap1. The figure was generated

using Sparky (21). b Protein sequence of the Kelch domain with unassigned
resonances colored red and regions with high sequence identities boxed. The
starting ‘G’ was a non-native residue from the TEV recognition sequence that
remained after cleavage.

Figure 5.2 shows the residue-specific secondary structure propensity (SSP) scores
determined using the program SSP on the basis of the assigned 13C α/β chemical shifts
(18). The result strongly indicates that the protein has an all-β fold (Figure 5.2). This is in
good agreement with the crystal structure of the Kelch domain (PDB id: 1X2J), which
shows that the protein adopts a six-bladed β-propeller conformation (7). The SSP scores
we obtained here are also consistent with the DSSP analysis (19) and the secondary
structure plot (20) of the crystal structure (7).
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Figure 5.2 Secondary structure propensity (SSP) scores and DSSP analysis of the
mouse Kelch domain of Keap1.
SSP scores were calculated based upon the 13C α/β chemical shifts (18). The
crystal structure of the mouse Kelch domain (PDB id: 1X2J) (7) was used for the
DSSP analysis (19) and generation of the secondary structure cartoon diagram
(20).

The overlay of the 1H-15N HSQC spectra of the Kelch domain in the absence and
presence of an equimolar concentration of the 14-mer Nrf2 peptide is shown in Figure
5.3a. A significant number of resonance signals are shifted upon addition of the peptide
(Figure 3a). To quantify the magnitude of peak shifts, combined chemical shift changes
(Δω = |Δ15N| + |Δ1HN|) were calculated, where |Δ15N| + |Δ1HN| are the absolute values of
resonance frequency change (in Hz) in the 15N and 1H dimensions, respectively. Figure
5.3b shows that many of the traceable assigned residues with Δω > 50 Hz (in descending
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order: G378, N504, G364, G477, G600, G570, G571, G417, G524, G379 and S431) are
residues that comprise, or are in close proximity, to the binding interface as identified in
the crystal structure (7).

Figure 5.3 Overlay of 1H-15N HSQC spectra in the absence (black) and presence
(pink) of an equimolar concentration of the Nrf2
a Overlay of 1H-15N HSQC spectra in the absence (black) and presence (pink) of
an equimolar concentration of the Nrf2 peptide (Ac-72AQFQLDEETGEFLP85-
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NH2). b Crystal structure of the mouse Kelch domain of Keap1 (grey) in complex
with an Nrf2 peptide (red) (PDB id: 1X2R) (7). Residues with traceable assigned
resonances are colored based on their combined absolute proton and nitrogen
resonance frequency changes (Hz) upon ligand binding (yellow <25 Hz, orange
25-50 Hz and pink >50 Hz).
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6.1

Abstract
Inside cells, the concentration of macromolecules can reach up to 400 g/L. In such

crowded environments, proteins are expected to behave differently than in vitro. It has
been shown that the stability and the folding rate of a globular protein can be altered by
the excluded volume effect produced by a high density of macromolecules. However,
macromolecular crowding effects on intrinsically disordered proteins (IDPs) are less
explored. These proteins can be extremely dynamic and potentially sample a wide
ensemble of conformations under non-denaturing conditions. The dynamic properties of
IDPs are intimately related to the timescale of conformational exchange within the
ensemble, which govern target recognition and how these proteins function. In this work,
we investigated the macromolecular crowding effects on the dynamics of several IDPs by
measuring the NMR spin relaxation parameters of three disordered proteins (ProTα, TC1,
and α-synuclein) with different extents of residual structures. To aid the interpretation of
experimental results, we also performed an MD simulation of ProTα. Based on the MD
analysis, a simple model to correlate the observed changes in relaxation rates to the
alteration in protein motions under crowding conditions was proposed. Our results show
that 1) IDPs remain at least partially disordered despite the presence of high
concentration of other macromolecules, 2) the crowded environment has differential
effects on the conformational propensity of distinct regions of an IDP, which may lead to
selective stabilization of certain target-binding motifs, and 3) the segmental motions of
IDPs on the nanosecond timescale are retained under crowded conditions. These findings
strongly suggest that IDPs function as dynamic structural ensembles in cellular
environments.
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6.2

Introduction
Macromolecular crowding and confinement can have significant impacts on the

behaviors of proteins in cellular environments. Inside of cells, the concentration of
macromolecules can reach up to 400 g/L (1, 2). The cumulative excluded volume from all
macromolecules inside of cells is commonly referred to as macromolecular crowding (3,
4). The large volume occupied by macromolecules in the cellular environment exerts
nonspecific forces on surrounding molecules (3). It is well documented that these forces
can have significant effects on the behaviors of proteins (5-7).
Experimental studies have demonstrated that molecular crowding can affect protein
structure and function. For example, at low pH, cytochrome c adopts an unfolded form.
When the crowding agent dextran is added to the sample, the protein transitions into a
near-native molten globule state (8). Crowding has also been shown to enhance the
activity of phosphoglycerate kinase (PGK) in vitro. At a mild concentration of Ficoll 70
(100 g/L), the enzymatic activity of PGK was found to increase by more than 10 fold
(after the viscosity effect was taken into account), possibility due to the large-scale of
conformational changes induced by the crowders (9). In another study, Stagg et al. (10)
investigated effects of crowding on the structure and stability of both the native and
denatured states of Flavodoxin. Interestingly, their experimental and computer simulation
results indicate that the presence of a high concentration of Ficoll 70 in solution increased
the thermal stability and secondary structure content of the native-state ensemble, but had
relatively minor effects on the denatured state (10).
The crowded environment in cells also alters the diffusional behavior of proteins,
and thus their rates of folding, association with other molecules and intracellular transport
(11, 12). A recent work by Leduc et al. (13) suggested that different motor proteins, such
as kinesins, process distinct molecular properties in order to operate effectively in the
crowded cellular environments. Macromolecular crowding has also been proposed to be
one of the possible factors that regulate the phosphorylation of ERK kinase in cells. Aoki
et al. (14) demonstrated that under crowded conditions, the phosphorylation of ERK
could switch from the distributive to processive mode. Further, experimental and
molecular simulation studies suggested that crowding plays a key role in human diseases
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that are related to protein aggregation and fibril formation (15-17). For instance, the
amyloid formation of human and bovine prion proteins are significantly enhanced even at
mild concentration (150-200 g/L) of Ficoll 70. Intriguingly, the amyloid formation of
rabbit prion protein is inhibited by crowding agents (17, 18).
The effects of macromolecular crowding on the structure and dynamics of IDPs, on
the other hand, are less explored. These proteins lack stable tertiary structures and can be
very flexible under non-denaturing conditions. The functions of IDPs are intimately
related to their dynamics (19). It has been proposed that proteins with disordered regions
have larger capture radius for targets, therefore, enhancing the binding rates by the socalled “fly-casting” mechanism (20). Flexibility of IDPs also governs the affinity of
target recognition. The high entropic cost of disorder-to-order transition upon binding
needs to be compensated by specific interactions formed in the interface with target.
Therefore, IDPs frequently associate with binding partners through low affinity but
highly specific interactions, which are important for their functions in signal transduction
and cell cycle control (21, 22). Another important link between protein flexibility and
function is the rate of inter-conversion between conformers. An IDP exists as an
ensemble of conformers in equilibrium (23-25). Different structures in the ensemble can
participate in the interactions with distinct targets; therefore, the rate of exchange
between conformers can have significant impact on the protein function (26, 27). Further,
recent studies show that some IDPs employ multiple linear motifs to engage in a dynamic
equilibrium with a target, resulting in ultra-sensitivity of binding (28-30). Undoubtedly,
protein flexibility plays a critical role in this polyvalent mode of binding (29).
There are several studies of macromolecular crowding effects on the structure of
IDPs. The results, however, are not conclusive. For instance, FlgM is disordered in dilute
buffer solutions, but gains structure in its C-terminal half when studied in cells or in
solutions with high concentration of glucose (31). On the other hand, Flaugh and Lumb
reported that neither the disordered C-terminal activation domain of c-Fos nor the kinaseinhibition domain of p27Kip1 undergo any significantly conformational change in the
presence of dextran or Ficoll (32). By using small-angle neutron scattering techniques,
Johansen et al. (33) demonstrated that the disordered N protein of bacteriophage λ adopts
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more compact conformations even in the presence of relatively low concentration of
crowding agents (~65 g/L of BPTI protein). A recent work by Tompa and co-worker
(34), however, shows that molecular crowding caused only minor structural changes to
three IDPs (α-casein, MAP2c and p21Cip1). The authors suggested that retaining
dynamics under crowded conditions is a functional requirement of IDPs.
Further experimental studies of the macromolecular crowding effects on IDPs are
important for increasing our understanding of how these proteins behave in cellular
environments. These studies will also facilitate the development of computational models
that can be used to explain and predict the behaviors these proteins under crowded
conditions (5, 34, 35). We focus on assessing the effects of macromolecular crowding on
the dynamics of IDPs in residue-specific manner using NMR spin relaxation experiments.
Three IDPs with different extents of residual structure under dilute buffer conditions were
studied. Further, by using one of the IDPs (ProTα) as a representative case, based on an
MD simulation, we proposed a model to correlate the observed changes in relaxation
rates to the possible alteration in protein motions under crowding conditions. ProTα is a
ubiquitously expressed, highly acidic IDP that is involved in multiple biological functions
(36-38). Our recent studies demonstrated that ProTα is largely disordered with minimal
residual structure present under non-denaturing conditions (39, 40). Although ProTα
adopts an extended structure, it can convert to more compact conformations in the
presence of zinc ions (40). Another IDP used in this study is Thyroid Cancer 1 (TC-1),
which was first found to be overexpressed in thyroid cancer (41, 42). TC-1 is a basic
protein and is a positive regulator of the Wnt/β-catenin signaling pathway (42-44). It
competes with β-catenin on binding to Chibby (Cby) and therefore inhibits the
antagonistic action of Cby on β-catenin mediated transcription (44, 45). Even though TC1 is classified as an IDP, structural characterization shows that while the N-terminal half
of the protein is largely unstructured, high helical propensity is present in the C-terminal
part (42, 46). α-synuclein, a well-studied IDP that has been found to be the main
structural component of Lewy body fibrils found in patients with Parkinson’s disease
(47), was also included in this study to add additional depth to our approach. α-synuclein
is natively disordered in its soluble form, but is able to self-associate to form insoluble
aggregates that have considerable structure (47). In-cell NMR experiments have shown
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that the periplasmic environment in Escherichia coli prevents α-synuclein from
undergoing a conformational change that is detected in dilute buffer conditions,
indicating that the crowding acts to keep α-synuclein disordered (48). In addition to the
IDPs mentioned above, we also assessed the crowding effect on a well-studied globular
protein, Ubiquitin, for comparison. By performing NMR relaxation measurements on
these proteins we aim to determine how the dynamics of IDPs with different structural
characteristics can be affected by macromolecular crowding.

6.3

Materials and methods

Protein expression and purification
15

Uniformly N labeled ProTα (human isoform 2), TC-1 (human) and α-synuclein
(human isoform 1) were expressed in Escherichia coli BL21 (DE3) cells grown in
15

minimal M9 medium containing NH4Cl (Cambridge Isotope Laboratories) as the sole
15

13

13

nitrogen source. N/ C labeled TC-1 was expressed as above except with C6-Dglucose (Isotec) as the sole carbon source. ProTα was purified using the method
described by Yi et al. (39). The N-terminally His tagged TC-1 protein was extracted from
inclusion bodies using 6 M guanidine hydrochloride and purified by affinity
chromatography using Ni Sepharose™ 6 Fast Flow beads (Amersham Biosciences) (46).
The plasmid carrying the α-synuclein cDNA was kindly supplied by Dr. Pielak at the
University of North Carolina-Chapel Hill. The protein was purified by osmotic shock,
using a procedure similar to the one reported by Shevchik et al. (49), followed by boiling
and cooling steps similar to (39). The protein was then precipitated out of solution with
15

60% saturated solution of ammonium sulfate. Lyophilized N labeled human Ubiquitin
was kindly supplied by Dr. Gary Shaw’s lab at the University of Western Ontario.

NMR spectroscopy
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All NMR experiments were performed at 25 ºC on a Varian Inova 600 MHz
spectrometer (UWO Biomolecular NMR Facility) with an xyz-gradient triple resonance
probe. The experiments were performed in the presence and absence of 160 g/L, and
several used 400 g/L, Ficoll 70 (Sigma) or Dextran 70 (Sigma). Each NMR sample
contained 10% D2O and trace sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS,
Sigma) for chemical shift referencing. Data was processed with NMRPipe (50) and
spectra were visualized with NMRViewJ (51).
1

H-15N HSQC spectra were collected using 0.2 mM 15N-labeled ProTα, TC-1 and

α-synuclein samples and 1 mM Ubiquitin samples in the presence or absence of crowding
agent. Backbone amide resonance assignments of ProTα, TC-1, α-synuclein and
Ubiquitin were obtained from (40, 46, 52, 53). The triple-resonance CBCA(CO)NH
experiment was carried out using 0.3 mM TC-1 samples in the presence and absence of
160 g/L Ficoll 70 (Sigma) for 13C chemical shift assignments.
15

Backbone N longitudinal relaxation rate (R1), relaxation rate in rotating frame
1

15

(R1ρ), and steady-state H- N NOE experiments were performed using 0.2 mM of 15Nlabeled ProTα, and TC-1 samples and 1 mM Ubiquitin sample in the presence and
absence of crowding agent in their corresponding buffers. R1 experiments were
performed with delay times 10-640 ms for ProTα and TC-1 and 10-500 ms for Ubiquitin.
R1ρ experiments employed delay times between 10 and 150 ms for all proteins. The relax
program (54, 55) was used for two-parameter exponential curve fitting of peak intensities
from the R1 and R1ρ data, and the calculation of R1 and R1ρ relaxation rates and their
15

associated errors. N transverse relaxation rate (R2) values were calculated using the R1
and R1ρ rates and the offset between the resonance and carrier frequency (Δω) in hertz,
using the equation
(1)
where tanθ = BSL/∆ω. BSL (= 1.5 kHz) was the spin-lock field used in the R1ρ
experiments. 1H-15N steady-state NOEs were obtained from the ratio of peak intensities

196

of spectra recorded with and without proton saturation. Seven and 12 s delays between
scans were used for the saturated and non-saturated spectra respectively and 5 s
saturation periods were used. Errors were estimated based on the ratios of background
noise to the signals in the spectra.

MD simulations
We conducted an atomistic MD simulation of ProTα in its free state in order to help
to interpret the NMR relaxation measurements. The starting structure was generated
based upon the amino acid sequence of ProTα (human isoform 2) by simulated annealing
using the Crystallography & NMR System (CNS) software package (56).
The simulation was performed using GROMACS (GROningen MAchine for
Chemical Simulations) version 4 (57) with the GROMOS96 53a6 united atom force-field
parameter set (58, 59). This force field has been shown to perform well in simulations of
disordered proteins and membrane proteins (60-62). Protonation states of ionizable
residues were assigned to their most probable state at pH 7. The starting structure was
centered in a cubic box with a side length of 20 nm and periodic boundary conditions
were applied. The system was solvated with simple point charge (SPC) water (63).
Sodium (Na+) and chloride (Cl-) ions were added to make the system charge neutral and
bring the salt concentration to 0.1 M. The system contained 265474 water molecules, 525
sodium and 482 chloride ions. MD simulations were performed at constant number of
particles, pressure and temperature (NPT ensemble). Protein and non-protein atoms were
coupled to their own temperature baths, which were kept constant at 310 K using the
Parrinello-Donadio-Bussi algorithm (64). Pressure was maintained isotropically at 1 bar
using the Parrinello-Rahman barostat (65). The time constants for temperature and
pressure coupling were 0.1 and 0.5 ps, respectively. Prior to the production run, the
energy of the system was minimized using the steepest descents method, followed by 2
ps of position-restrained dynamics with all non-hydrogen atoms restrained with a 1000 kJ
mol-1 force constant. The timestep was set to 2 fs. Initial atom velocities were taken from
a Maxwellian distribution at 310 K. All bond lengths were constrained using the LINCS
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algorithm (66). Cut-off of 1.0 nm was used for Lennard-Jones interactions and the real
part of the long-range electrostatic interactions, which were calculated using the ParticleMesh Ewald (PME) method (67). For a recent review on the different methods and the
importance electrostatics in simulations of biological systems, see (68). Dispersion
corrections were applied for energy and pressure. 0.12 nm grid-spacing was used for
PME. The MD simulation was run for 427 ns and the last 400 ns were used for analysis.
During this time, temperature, pressure and potential energy values remained stable and
fluctuated around their averages, without systematic drift, indicating that the system was
well equilibrated.

MD Simulation analysis
Autocorrelation functions of backbone 1H-15N bond vectors of ProTα were
extracted from the MD trajectory (region 27-427ns) (without the removal of overall
tumbling) using the g_rotacf tool in GROMACS (57). Each autocorrelation function was
fitted to two-, three-, or four-exponential decay curves (69-71) as shown in equation (2):

(2)
where C(t) is the autocorrelation function at time t, n=2, 3, or 4, ai and τi are the
amplitude and time constant of the ith exponential decay term. The fitted autocorrelation
functions were then used to calculate the spectral density J(ω) by analytical Fourier
transformation (69-71):

(3)
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To evaluate whether the multi-exponential model j with more parameters statistically
outperforms model i in fitting the autocorrelation functions, the F-ratio of statistical F-test
were calculated using the following equation:
(4)

where

(

) and Di (Dj) are the sum of square deviations and degrees of freedom of

model i (model j), respectively.

6.4

Results

IDPs remain disordered under crowded environments
To study the effect of macromolecular crowding on the structure and dynamics of
IDPs, Ficoll 70, a commonly used crowding agent, was added to the protein samples to
mimic the cellular environment (6). First, 1H-15N HSQC spectra of ProTα, TC-1, αsynuclein, and Ubiquitin, acquired in the absence and presence of 160 g/L of Ficoll 70,
were compared. Intriguingly, the spectra of the three IDPs all display narrow peak
dispersions along their 1H dimension in the presence of Ficoll 70 (Figure 6.1), indicating
these proteins remain disordered under this crowded condition. 1H-15N HSQC spectra of
ProTα and TC-1 in the presence of 400 g/L crowding agent had similar extents of peak
dispersion as those collected in buffer or 160 g/L Ficoll conditions (Figures S6.1 and
S6.2). Minor peak shifts between dilute and crowded conditions of some residues in TC-1
were observed (Figure 6.1B). To investigate the possibility that these spectral changes
were due to the crowding agents binding to TC-1, we performed isothermal calorimetry
(ITC) experiments, titrating 0.1 mM TC-1 into 160 g/L crowder solutions (Figure S6.3).
These measurements were not indicative of specific interactions between TC-1 and Ficoll
or Dextran 70 (72).
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Figure 6.1 1H-15N HSQC spectra of ProTα, TC-1, α-synuclein and Ubiquitn in the
absence and presence of 160 g/L Ficoll 70.
ProTα (A), TC-1 (B), α-synuclein (C) and Ubiquitin (D) spectra were collected in
40 mM HEPES pH 6.8, 10 mM sodium acetate pH 5, 50 mM sodium phosphate
pH 7 and 10 mM sodium acetate pH 5 respectively in the absence (black) and
presence of 160 g/L Ficoll 70 (red).
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Figure S6.1 1H-15N HSQC spectrum of ProTα in 400 g/L Ficoll 70.
The sample contained 0.3 mM ProTα in 50 mM NaPO4 pH 7, 100 mM NaCl and
1 mM DTT.
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Figure S6.2 1H-15N HSQC spectra of TC-1 in 400 g/L Ficoll 70 and Dextran 70.
The samples contained 0.2 mM TC-1 in 10 mM sodium acetate pH 5 and 400 g/L
Ficoll 70 (A) or Dextran 70 (B).
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Figure S6.3 ITC profiles of TC-1 titrations into crowded solutions.
Buffer (10 mM sodium acetate pH 5) alone or containing 0.1 mM TC-1 was
titrated into the cell, containing 160 g/L Ficoll (A) or Dextran 70 (B) in the same
buffer. 10 µL injections were used with 120-second delays.

To determine if the chemical shift changes observed in the 1H-15N HSQC
spectrum of TC-1 with 160 g/L of Ficoll 70 were the result of alteration of secondary
structure, site-specific secondary structure propensities were determined based on the
observed 13Cα and 13Cβ chemical shifts in the absence and presence of crowding agents
using the SSP program (46, 73). Residues in well-formed β-strand/extended or α-helical
conformations are expected to yield SSP scores close to -1 and 1, respectively. Figure 6.2
shows the SSP score profiles of TC-1. While the N-terminal half of the protein is largely
unstructured, three regions (D44-R53, K58-A64 and D73-T88) with high helical
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propensities (i.e. SSP scores > 0.2) were found in the C-terminal part under both
conditions. The results are consistent with our previous SSP analysis of TC-1 (46). Based
on the SSP scores reported here, it is apparent that the presence of crowding agents only
leads to a minor increase in the helical propensity of the second helical region (K58A64), while the other parts of the TC-1 structure are largely unaffected (Figure 6.2).

Figure 6.2 Secondary structure propensity (SSP) scores for TC-1 in the absence
(black) and presence (red) of 160 g/L Ficoll 70.
13

13

SSP scores were calculated on the basis of the assigned Cα and Cβ chemical
shifts (46) using the SSP program (73). The CBCA(CO)NH spectra was collected
in 10 mM sodium acetate pH 5 in the absence and presence of 160 g/L Ficoll 70.

Backbone 15N spin relaxation measurements under crowded conditions
The effects of macromolecular crowding on the dynamics of ProTα, TC-1, αsynuclein, and Ubiquitin were investigated with backbone 15N spin relaxation and 1H-15N
NOE measurements. The results are shown in Figure 6.3. For the well-folded Ubiquitin,
significant increases (decreases) in R2 (R1) of residues are observed in the presence of 160
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g/L of Ficoll 70. Because crowding does not alter the structure of Ubiquitin, judging from
the 1H-15N HSQC spectra (Figure 6.1D), the changes in R2 and R1 are expected to be due
to the increase in viscosity of the solution. Based on the R1 and R2 values, the overall
rotational correlation time of Ubiquitin is estimated to increase from 4.3 to 8.0 ns upon
addition of crowding agents (74). Even though the molecular tumbling time was
increased, crowding does not seem to have significant effects on the fast internal motion
of this globular protein since the values of NOE were mostly unaffected by the addition
of crowders.
Unlike Ubiquitin, however, the increase in viscosity upon addition of 160 g/L of
Ficoll 70 does not lead to dramatic changes in the observed R1, R2 and NOE values of
ProTα and α-synuclein (Figure 6.3). In particular, the value of R2, which is sensitive to
the rotational correlation time, remains unchanged for most of the residues of ProTα upon
addition of crowding agents. On the other hand, residues in different regions of TC-1
show differential responses to crowding. In particular, residues in the high helical
propensity regions of TC-1 generally have decreased R1 and increased R2 relaxation rates
in the presence of 160 g/L Ficoll 70 (Figure 6.3A and B), while R1 and R2 values of
residues in the flexible N-terminal region show only minor changes. In addition, most of
the residues in TC-1 also display slightly higher NOE values in the presence of 160 g/L
of Ficoll 70 (Figure 6.3C). To ensure the observed changes in relaxation rates are not due
to the particular crowding agent used, 15N relaxation experiments for TC-1 were also
repeated with Dextran 70 as a crowder and the results were similar to that aforementioned
(Figure 6.4). Figure S6.4 contains the R1, R2 and NOE values for TC-1 in buffer and 160
g/L Ficoll and Dextran 70 plotted by residue number.
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Figure 6.3 Backbone 15N relaxation measurements for ProTα, TC-1, α-synuclein and
Ubiquitin in the absence and presence of 160 g/L Ficoll 70.
Longitudinal relaxation rate, R1 (A), transverse relaxation rate, R2 (B) and steadystate 1H-15N NOE (C). ProTα (black), TC-1 (red), α-synuclein (green) and
Ubiquitin (magenta) relaxation measurements were collected in 40 mM HEPES
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pH 6.8, 10 mM sodium acetate pH 5, 50 mM sodium phosphate pH 7 and 10 mM
sodium acetate pH 5 respectively in the absence and presence of 160 g/L Ficoll
70. The blue line indicates a unitary slope.
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Figure 6.4 Backbone 15N relaxation measurements for TC-1 in the absence and
presence of 160 g/L Dextran 70.
Longitudinal relaxation rate, R1 (A), transverse relaxation rate, R2 (B) and steadystate 1H-15N NOE (C). The sample contained 10 mM sodium acetate pH 5 in the
absence and presence of 160 g/L Dextran 70.
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Figure S6.4 R1, R2 and NOE values for TC-1 in buffer and 160 g/L Ficoll 70 and
Dextran 70 plotted by residue number.
The samples contained 10 mM sodium acetate pH 5 in absence and presence of
160 g/L Ficoll 70 or Dextran 70.
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Considerable changes in the relaxation rates were observed for ProTα when the
extremely high concentration of crowding agent (400 g/L Ficoll 70) was used (Figure
6.5). In particular, most residues show higher R2 values in the presence of 400 g/L Ficoll
70 compared to buffer conditions (Figure 6.5B). The largest changes are observed in the
region around residues I12-R31. Interestingly, residues in that region also have less
negative 1H-15N steady-state NOE values in buffer conditions, suggesting this segment is
intrinsically more restricted in motion compared to the rest of the protein in the absence
of crowders. Furthermore, NOE values were systematically higher for all residues under
this crowded condition (Figure 6.5C).
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Figure 6.5 Backbone 15N relaxation measurements for ProTα in the absence and
presence of 400 g/L Ficoll 70.
Longitudinal relaxation rate, R1 (A), transverse relaxation rate, R2 (B) and steadystate 1H-15N NOE (C). The sample contained 0.3 mM ProTα in 50 mM NaPO4 pH
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7, 100 mM NaCl and 1 mM DTT in the presence of 400 g/L Ficoll 70. For the
sample without crowder, 40 mM HEPES pH 6.8 was used as the buffer.

Model for interpreting the observed relaxation data
For well-folded globular proteins, the 15N R1, R2, and NOE measurements are
commonly fitted to the Lipari-Szabo (LS) model-free model in order to extract the
amplitude and correlation time of internal motion as well as the overall molecular
tumbling time, which are denoted by the order parameter (S2), τe and τm in the spectral
density function, respectively (75). A modified LS model was later proposed by Clore
and co-worker to fit the relaxation rates observed from flexible loop regions of a folded
protein (76). In this model, an extra term was introduced to the spectral density function
of the original LS model to describe the internal motion occurring on a slower timescale.
For disordered proteins, however, the timescale of large-amplitude local segmental
motions can be close to the overall tumbling time, making the separation of these two
contributions to the relaxation rates challenging (71, 77).
To establish a simple model to describe the dynamic behaviors of IDPs and
correlate them to the observed relaxation parameters, autocorrelation functions of the
backbone amide bond vectors were extracted from a 427-ns atomistic MD trajectory of
ProTα. Autocorrelation functions of each residue (except the N-terminus and P34) were
fitted to models with different numbers of exponential decay terms. Instead of using these
models to back calculate the observed backbone 15N relaxation rates, which have been
shown by many others to be a challenging task (78, 79), our aim is to establish a simple
model to interpret the relaxation data we obtained.
Autocorrelation functions of individual amide bond vectors extracted from the
MD simulation were fitted to the sum of two, three, or four exponential decay terms
(Equation 2) in order to determine the best LS-like model that can be used to describe the
backbone dynamics of highly disordered proteins such as ProTα. The autocorrelation
functions of several residues are shown in Figure 6.6. In general, quick decreases in the
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autocorrelation functions are observed in the beginning, which are likely contributed
from the librational motions (fast internal motions) (71, 75). The fast decay is then
followed by more gradual decreases in the autocorrelation functions, reflecting the
existence of local motions on slower timescales (Figure 6.6). However, it is clear that
residues in different positions of the protein display distinct autocorrelation profiles.
Figure 6.6 (inset) shows typical fits of the autocorrelation functions to 2-, 3-, and 4exponential decay terms. We found that for most of the residues, the equation with three
exponential decay terms fits the autocorrelation function statistically better than that with
only two terms. Increasing the number of exponential decay terms further (i.e. n = 4) does
not result in dramatic decreases in the root mean square deviation of fitting (Figure S6.5).
Additionally, for many residues, different τi values obtained from the four-exponential fit
are very close, indicating that the motion described by these terms cannot be
discriminated. Because of these reasons, our analyses were focused on the threeexponential decay model (LS3 model; n=3 in Equation 3), which is very similar to the
modified LS-model described by Clore and coworkers (76).
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Figure 6.6 Correlation functions of selected backbone 1H-15N amide bond vectors.
(red: residue 2; green: residue 10; blue: residue 48; magenta: residue 57; cyan:
residue 102) extracted from a 400 ns MD trajectory of ProTα. The inset shows the
fitting of the autocorrelation function (solid black line) of residue 31 to 2- (red
dash line), 3- (blue dash line), and 4-exponential decay curves (green dash line) as
indicated in Equation 2. The blue and green dash lines overlay remarkably, and
only start to deviate when t > 1.5 ns.
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Figure S6.5 Comparison of the fitting of autocorrelations to 2-, 3-, and 4-exponential
decay curves.
Blue: F-ratios calculated from the χ2 and degrees of freedom of 2- and 3exponential models; Red: F-ratios calculated from the χ2 and degrees of freedom
of 3- and 4-exponential models (Equation 4).

The results of fitting the amide bond vector autocorrelation functions to threeexponential decay terms are summarized in Table 6.1. To illustrate how the fluctuations
in amplitude and timescale of motions translate to the observed relaxation rate changes,
15

N R1, R2, and 1H-15N steady-state NOE values were calculated using the LS3 model

with different values of ai and τi. We first apply this model to Ubiquitin. To simulate the
relaxation rates of Ubiquitin, we assumed that the fast internal motion of this rigid protein
is not altered upon crowding. By fixing the amplitude and correlation time of fast internal
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motion (a1 and τ1) to 0.15 and 10 ps, respectively, the significant increase (decrease) in
the measured R2 (R1) relaxation rates of Ubiquitin in the presence of 160 g/L of Ficoll 70
can be reproduced by changing τ3 (the overall tumbling time) from 4.3 to 8 ns, assuming
that the slower segmental motion can be neglected (i.e. a2 ~ 0; blue arrows) (Figure 6.7).
Table 6.1 Averaged values and the standard deviations of fitted parameters of LS-3
model.
i=1
i=2
i=3
τi (ps)
7±9
419±454
3400±5700
ai
0.37±0.09 0.36±0.12
0.27±0.17
average±standard
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Figure 6.7 15N Relaxation parameters calculated using the LS-3 model.
(a) a1=0.15, τ1=10 ps, τ3 = 4.3 ns, a3=1- a1- a2 (b) a1=0.15, τ1=10 ps, τ3 = 8.0 ns,
a3=1- a1- a2. τ2 and a2 values are indicated along the x and y axes, respectively.
The slower internal motion is negligible when a2 ~ 0 (blue arrows).
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We have also simulated the dependence of the 15N R1, R2, and steady-state NOE
values of ProTα on the values of ai and τi. Since ProTα remains disordered under
crowded conditions and the observed NOEs are significantly smaller than what are
expected for a folded protein of similar molecular weight (Figure 6.5), it is reasonable to
assume that large amplitude of fast internal motion persists. Figure 6.8A illustrates that
with a1=0.37, τ1=7 ps, τ2 ~500 ps, and τ3 = 3.4 ns, a wide distribution of NOE values can
be expected with the variation of the amplitude of segmental motion (value of a2).
Meanwhile, R2 is predicted to be not very sensitive to the fluctuation in a2 (R2 ~ 2 - 4 s-1).
These observations agree qualitatively with the distributions of experimental relaxation
rates measured under buffer conditions (Figure 6.5).
On the other hand, almost all residues of ProTα have the R2 and NOE increased at
the high concentration of crowding agents (~400 g/L of Ficoll 70), while the variation of
R1 along the protein sequence diminished. Based on the LS3 model, these trends can be
explained by the increase in the correlation times of the slow local segmental motions.
With τ2 increases from 500 to 1000 ps and the value of τ3 doubled (Figure 6.8B), R2
values can increase to ~6 s-1 and many NOEs will turn positive. The simulated relaxation
rates further match the experimentally observed values, especially for the R1 values, if we
assume that the amplitude of fast internal motion is reduced in a highly crowded
environment (i.e. a1=0.2; Figure 6.8C).
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Figure 6.8 15N Relaxation parameters calculated using the LS-3 model.
(a) a1=0.37, τ1=7 ps, τ3 = 3.4 ns, a3=1- a1- a2 (b) a1=0.37, τ1=7 ps, τ3 = 6.8 ns,
a3=1- a1- a2 and (c) a1=0.20, τ1=7 ps, τ3 = 6.8 ns, a3=1- a1- a2, respectively. τ2 and
a2 values are indicated along the x and y axes, respectively.

Finally, based on the amplitudes and correlation times of motions on different
timescales (fitted ai and τi values of autocorrelation functions) extracted from the MD
simulation, we have simulated the 15N R1, R2, and steady-state NOE values of ProTα. The
relaxation parameters in the presence of 160 g/L of Ficoll 70 were then predicted by
scaling the correlation time of the slow motions (τ2 and τ3) by the same factor (i.e. 1.86)
as the Ubiquitin tumbling time changes to account for the increase in viscosity. Figure 6.9
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shows the plots of the simulated relaxation data before and after the correlation time
adjustments. The result indicates that in the presence of 160 g/L of Ficoll 70, the R1, R2,
and NOE of ProTα were expected to systematically increase if the correlation times of
the slow motions were increased by viscosity. However, these changes were observed
experimentally only in the presence of 400 g/L of Ficoll 70. Again, the simulated data
suggest that the timescale of local segmental motions were slowed down only at a very
high concentration of crowders.
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Figure 6.9 Plots of the simulated relaxation data of ProTα before and after
correlation time adjustments.
15

N R1, R2, and steady-state NOE values of ProTα were simulated based on the

amplitudes and correlation times of motions extracted from the MD simulation

221

using the LS3 model. R1*, R2*, and NOE* are the relaxation data predicted by
scaling the correlation times of the slow motions (τ2 and τ3) by the same factor as
the Ubiquitin tumbling time changes to account for the increase in viscosity.

6.5

Discussion
We have investigated the effects of macromolecular crowding on the dynamics of

three IDPs, ProTα, TC-1 and α-synuclein, with different extents of residual structure
using NMR spectroscopy. This complements several recent studies of macromolecular
crowding effects on the structure and dynamics of IDPs (34, 35, 80). We used Ficoll 70
and Dextran 70 as crowding agents, which are commonly used to mimic excluded
volume effects (7, 17, 18, 72). These polymers are inert and do not interact
nonspecifically with proteins. In contrast, the use of polyethylene glycol as a crowding
agent is discouraged, due to attractive interactions with proteins (7, 72).
The IDPs examined here all had narrow dispersion of peaks along the 1H dimension
in the 1H-15N HSQC spectra compared to the well-folded Ubiquitin, both in the absence
and presence of crowding agents, suggesting that they remain disordered in the crowded
environments. Interestingly, for the partially disordered TC-1, a minor increase of the
helical propensity was observed only in the relatively structured region in the presence of
Ficoll 70. This indicates that the crowded environment may have differential effects on
the partially structured regions and the highly disordered parts of the protein. Increased
helical content in the presence of crowding agent has also been observed for the
Flavodoxin (10). Stagg et al. reported that the far-UV CD signal of Flavodoxin at the
helical signature wavelength (222 nm) increases by about 10% in the presence of 200 g/L
of Ficoll 70; however, a less dramatic effect of crowding in the denatured state was
observed.
Site-specific changes in the protein flexibility of ProTα and TC-1 have been
characterized by using 15N NMR spin relaxation experiments. In particular, we focused
on the highly disordered ProTα since this protein produces NMR data with reasonable
signal to noise ratio even at high concentration of Ficoll 70 (400 g/L). It is noteworthy
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that besides the excluded volume effect, the presence of high concentrations of crowding
agents also inevitably increases the viscosity of the solution (12, 34). This adds a layer of
complexity to the interpretation of spin relaxation data. The viscosity effect is reflected in
the systematic increase in the 15N R2 rates of Ubiquitin in the presence of 160 g/L Ficoll
70, while the values of NOE were mostly unaffected. Similar results were obtained by
Simorellis & Flynn (81). They showed that encapsulation of Ubiquitin in a confined
environment only has very minor effects on the protein backbone dynamics.
Intriguingly, the increase in viscosity did not cause significant changes in the 15N
R2 of intrinsically disordered ProTα under the same conditions. To have a better
understanding of our relaxation data, we performed an MD simulation (~ 400 ns) on
ProTα to investigate its dynamic behaviors. Although MD simulations in the presence of
atomistically represented crowders are not currently practical (because of the large
number of atoms these molecules contain and the long time scales such molecules need
for diffusion), our simulation facilitated the development of a simple model to correlate
the observed changes in relaxation rates to the alteration in protein motions under
crowding conditions. While the LS3 model proposed here might not be sufficient to
represent the complicated dynamics of IDPs, it provides insights into interpreting the
relaxation measurements.
Based on the experimental and simulation results, we conclude that even though
crowded environments can slow down the timescale of local segmental motions in the
highly disordered ProTα, it still retains a certain level of flexibility at high concentrations
of Ficoll 70. Based on the observed R2 rates (Figure 6.5B), however, it is apparent that a
few regions of ProTα become more structured at high concentration of crowders.
Interestingly, some of these regions overlap or are close to known target-binding motifs
of ProTα. For instance, residues 39-54 are involved in mediating the interaction with the
Kelch domain of Keap1 in the oxidative stress response (82) while the caspase-3
cleavage site of ProTα is located around residue 100 (83). Because the dynamics of IDPs
can have significant impacts on their target recognitions (60), this observation has a
strong biological implication of how this class of proteins functions in crowded cellular
environments.
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We are aware that while Ficoll and Dextran may be suitable agents to mimic the
crowded cellular environment, combining different crowding agents with varying
physical characteristics (sizes, shapes, charges, etc) may more accurately represent the in
vivo environment (2, 7, 84, 85). Therefore, extending the current studies by using other
crowding agents with different sizes and chemical properties are required to further our
understanding of the macromolecular crowding effects on IDPs. These in vitro studies
together with the recently developed in cell NMR techniques (86-92) will hopefully
provide further insights into understanding the environmental effects on IDP structure
and functions.
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7

Conclusions and future directions

7.1

Conclusions
Using an experimental and computational approach of NMR, MD simulations and

ITC, we have furthered the understanding of the structure and dynamics of IDPs, and
their roles in target binding. Importantly, our approach was applied to gain new insights
into the interaction mechanisms of proteins with important biological functions. The
work illustrates that experimental and computational techniques are complementary tools
that can be used to gain new insights into the relationships between IDP structure,
dynamics and function. Here, the primary conclusions from this thesis are presented.
7.1.1

MD simulations provide unique insights into the structure and dynamics of
IDPs
Conventional methods and conditions for determining structure and dynamics of

globular proteins may not be directly applicable to IDPs. NMR is a powerful technique
for examining the structure and dynamics of IDPs, but relying solely on this type of data
can be limiting. MD simulations can be used in conjunction with NMR and other
biophysical techniques to gain a deeper understanding of the structure and dynamics of
IDPs. By performing extensive MD simulations and comparing the results to
experimental data, we have established suitable parameters and force field choice for
accurately simulating this class of proteins. The methodology was shown to be applicable
to a diverse set of peptides from 9 IDPs. These MD simulations were in good agreement
with our NMR data and also provided unique insights into the mechanisms that IDPs may
use to interact with targets. The work emphasizes that MD simulations of IDPs are an
excellent complement to experimental techniques and provide new insights that are
difficult to obtain by other methods.
7.1.2

Preformed structures are crucial for the interactions between some IDPs and
targets
Using a combination of NMR, ITC and MD simulations, we studied the binding

of 9 disordered proteins to a common target. The findings illustrated how MoRFs are
important for the interaction between IDPs and targets. The IDPs that were examined had
free state preformed structures in their MoRF regions that resembled bound state
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conformations. The correlations between the binding affinities, amino acid compositions
and MoRF stability revealed how different sequence properties can modulate the various
protein-protein interactions. Using these findings, the MoRF region of a peptide from one
of the IDPs was selectively mutated to enhance its target binding affinity. The designed
peptide may be a potentially useful therapeutic agent. Together, the findings provide
valuable insights into the mechanisms used by IDPs for target binding and should also
help to elucidate the biological roles of the various protein-protein interactions.
7.1.3

Molecular crowding may affect the conformational propensity of distinct
regions of an IDP
Using inert polymers as crowding agents to mimic the cellular environment, the

effects of molecular crowding on dynamics of IDPs were assessed. We found that IDPs
remain at least partially disordered despite the presence of high concentration of other
macromolecules and that the crowded environment has differential effects on the
conformational propensity of distinct regions of an IDP, which may lead to selective
stabilization of certain target-binding motifs. This information will help to understand the
behavior of IDPs in cellular environments and to accurately study them in vitro.

7.2
7.2.1

Future directions
The origins of molecular crowding effects
In chapter 6, we found that crowding agents may act to selectively stabilize target-

binding regions of IDPs. Based upon our experimental NMR data under crowded
conditions and an MD simulation of an IDP in the absence of crowders, we proposed a
simple model to interpret the observed changes in IDP dynamics between dilute and
crowded environments. Although the model qualitatively reproduces some of the
experimental data, it is clearly insufficient to fully describe IDP dynamics in crowded
environments. MD simulations with accurately parameterized crowding agents would
undoubtedly aid in the interpretation of our experimental data. Efforts are underway to
modify an existing force field to include crowding agents. Several groups have performed
simulations with crowding agents (1-3). However, the agents are often crudely
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parameterized as hard spheres with repulsive potentials to all species within the system.
Our aim is to provide a more detailed description of the crowding agents that is consistent
with experimental data. For example, our modified GROMOS 53a6 force field includes
crowding agents with attractive and repulsive non-bonded potentials to different system
components. The interaction between crowding agents and proteins is semi-repulsive to
insure that physical contact between these species is minimized (eg. non-specific binding
does not occur). Additionally, we include an attractive potential between crowding agent
and the oxygen atom of water molecules to keep the crowders surrounded by a solvation
shell. Extensive testing and tuning of these parameters has been performed. Prior to
conducting crowding simulations with IDPs, we have performed MD simulations of
Ubiquitin in the absence and presence of crowding agents and checked agreement with
our experimental data (chapter 6). Such work should help us to provide a more thorough
understanding of crowding on IDP dynamics.
7.2.2

How MoRFs modulate target binding
The identification of MoRFs along an IDP sequence is an area of active

bioinformatic research (4). These segments are hot spots for target binding (5, 6) and
their identification is an important first step in studying the interactions that IDPs partake
in. While MoRF discovery and prediction algorithms have improved in recent years (4),
their mechanisms of function are often not well understood. The work presented in
chapter 4 illustrated that the regions within and surrounding MoRF sites can modulate
interaction affinities with targets. Such information may be useful for improving MoRF
identification and prediction of important parameters (e.g., binding affinities).
Additionally, the ability to predict how MoRF modifications can affect their binding
affinities could possibly be useful for assessing the potential consequences of somatic
mutations in these regions. Knowledge of how to selectively modify these sites could be
useful for development of targeted therapeutics. By studying the molecular mechanisms
used by other IDPs to interact with targets (e.g., using a similar approach as in chapter 4),
it should, eventually, be possible to improve predictive methods for assessing important
properties of MoRF regions and their relationship to binding.
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7.2.3

IDP binding from the perspective of targets
This work has largely focused on the structure and dynamics of IDPs in the

absence and presence of a binding target. The assignment of the backbone resonance of
the target protein (chapter 5) revealed that considerable changes in the local chemical
environments of many residues occur upon binding to an IDP. It is of particular interest
that many of these changes are distant from the binding site. It would be interesting to
analyze how the dynamics of the target protein change upon IDP binding (e.g., by NMR
spin-relaxation measurements). This information would help to interpret our observed
thermodynamic parameters of interaction (chapter 3) and further decipher the molecular
mechanisms of IDP binding.
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